Entry Name,Protein names,Gene Names,URINE,PLASMA,SERUM,BIOFLUID
A0A5F5XCT0_FELCA,Alpha-1-B glycoprotein,A1BG,31.498,31.496,31.433,URINE+SERUM+PLASMA
M3W0W4_FELCA,Alpha-1-B glycoprotein,A1BG,20.032,19.628,19.996,URINE+SERUM+PLASMA
M3W3E7_FELCA,Alpha-2-macroglobulin,A2M PZP,24.189,25.752,25.529,URINE+PLASMA
A0A5F5Y1U9_FELCA,Alpha-2-macroglobulin,A2M PZP,26.729,30.630,30.587,URINE+PLASMA
A0A5F5Y328_FELCA,Alpha-2-macroglobulin,A2M PZP,17.618,19.601,19.964,URINE+SERUM
A0A337S3K5_FELCA,Alpha-2-macroglobulin like 1,A2ML1,22.369,26.642,26.846,URINE+SERUM
M3WN23_FELCA,ATP binding cassette subfamily A member 6,ABCA6,18.705,11.712,11.402,URINE
A0A337S6A5_FELCA,ATP binding cassette subfamily B member 9,ABCB9,21.779,22.789,18.356,URINE+PLASMA
A0A337RXE3_FELCA,Putative protein-lysine deacylase ABHD14B (Alpha/beta hydrolase domain-containing protein 14B),ABHD14B,25.702,20.751,20.838,URINE
A0A337SDS2_FELCA,ABI family member 3 binding protein,ABI3BP,20.062,19.192,18.548,URINE
A0A337S133_FELCA,Costars family protein ABRACL (ABRA C-terminal-like protein),ABRACL,17.744,18.566,18.237,URINE+SERUM+PLASMA
A0A337S9Y6_FELCA,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial (EC 1.3.8.7)",ACADM,18.972,10.174,10.931,URINE
M3W0B5_FELCA,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial (EC 1.3.8.5) (2-methyl branched chain acyl-CoA dehydrogenase) (2-methylbutyryl-coenzyme A dehydrogenase)",ACADSB,21.078,18.741,19.148,URINE
A0A5F5XDQ7_FELCA,Aggrecan core protein (Cartilage-specific proteoglycan core protein),ACAN,20.532,17.895,18.655,URINE
A0A5F5XYF2_FELCA,"Acetyl-CoA acetyltransferase, mitochondrial",ACAT1,17.158,14.251,14.393,URINE
M3VZ88_FELCA,acetyl-CoA C-acetyltransferase (EC 2.3.1.9),ACAT2,13.506,10.845,11.550,URINE
A0A5F5XZX3_FELCA,acetyl-CoA C-acetyltransferase (EC 2.3.1.9),ACAT2,18.535,16.349,16.144,URINE
A0A2I2UTZ7_FELCA,Angiotensin-converting enzyme (EC 3.4.-.-),ACE,26.612,25.534,25.713,URINE
ACE2_FELCA,Angiotensin-converting enzyme 2 (EC 3.4.17.23) (ACE-related carboxypeptidase) (EC 3.4.17.-) [Cleaved into: Processed angiotensin-converting enzyme 2],ACE2,30.137,23.595,23.732,URINE
A0A337S319_FELCA,2-amino-3-carboxymuconate-6-semialdehyde decarboxylase (EC 4.1.1.45) (Picolinate carboxylase),ACMSD,18.315,19.221,14.979,URINE+PLASMA
M3VWD8_FELCA,Cytoplasmic aconitate hydratase (EC 4.2.1.3) (Citrate hydro-lyase) (Iron-responsive element-binding protein 1),ACO1,21.350,24.001,21.950,PLASMA
A0A5F5XXE9_FELCA,Acyl-coenzyme A oxidase,ACOX3,19.615,19.116,20.306,SERUM
A0A337S8L4_FELCA,Low molecular weight phosphotyrosine protein phosphatase (LMW-PTP) (LMW-PTPase) (EC 3.1.3.2) (EC 3.1.3.48) (Low molecular weight cytosolic acid phosphatase),ACP1,19.528,16.625,17.632,URINE+SERUM
A0A337S165_FELCA,Lysosomal acid phosphatase (EC 3.1.3.2),ACP2,22.576,20.321,19.714,URINE
A0A337SAA6_FELCA,Lysosomal acid phosphatase (EC 3.1.3.2),ACP2,19.553,17.373,17.942,URINE
A0A2I2UHD0_FELCA,Long-chain-fatty-acid--CoA ligase (EC 6.2.1.15) (EC 6.2.1.3) (Acyl-CoA synthetase) (Long-chain acyl-CoA synthetase),ACSL5,14.296,17.324,15.616,URINE+PLASMA
A0A5F5XWN0_FELCA,"Actin alpha 1, skeletal muscle",ACTA1 CCSAP,22.630,18.539,18.389,URINE
A0A5F5XDM4_FELCA,"Actin, cytoplasmic 1 (Beta-actin)",ACTB,26.538,23.592,23.565,URINE
M3W6I2_FELCA,"Actin, cytoplasmic 2 (Gamma-actin)",ACTG1,22.450,19.794,20.017,URINE
A0A337SCW1_FELCA,"Actin, gamma-enteric smooth muscle (Gamma-2-actin) (Smooth muscle gamma-actin)",ACTG2,26.363,23.174,23.227,URINE
A0A2I2U3E4_FELCA,Alpha-actinin-4 (Non-muscle alpha-actinin 4),ACTN4,23.003,21.383,21.244,URINE
M3W8V8_FELCA,Serine/threonine-protein kinase receptor (EC 2.7.11.30),ACVR1,19.851,14.925,14.450,URINE
A0A337RUC4_FELCA,receptor protein serine/threonine kinase (EC 2.7.11.30),ACVR1B,24.570,18.078,17.086,URINE
M3VUE2_FELCA,Serine/threonine-protein kinase receptor (EC 2.7.11.30),ACVRL1,20.803,17.059,18.181,URINE+SERUM
A0A337RV46_FELCA,N-acyl-aliphatic-L-amino acid amidohydrolase (EC 3.5.1.14) (N-acyl-L-amino-acid amidohydrolase),ACY1,23.710,21.841,22.040,URINE
A0A337SC15_FELCA,N-acyl-aliphatic-L-amino acid amidohydrolase (EC 3.5.1.14) (N-acyl-L-amino-acid amidohydrolase),ACY1,21.412,18.172,18.572,URINE
A0A2I2UWI1_FELCA,Disintegrin and metalloproteinase domain-containing protein 10 (EC 3.4.24.81) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease),ADAM10,21.829,20.452,20.291,URINE
A0A2I2V2H3_FELCA,ADAM metallopeptidase domain 8,ADAM8,14.569,11.453,10.876,URINE
A0A337S9H1_FELCA,ADAM metallopeptidase domain 9,ADAM9,18.355,14.156,13.567,URINE
M3X5J0_FELCA,ADAM metallopeptidase with thrombospondin type 1 motif 13,ADAMTS13,19.023,19.129,18.070,PLASMA
A0A5F5XCM7_FELCA,ADAM metallopeptidase with thrombospondin type 1 motif 2,ADAMTS2,22.468,13.790,14.078,URINE
M3WNU5_FELCA,ADAMTS like 2,ADAMTSL2,20.094,17.726,17.626,URINE
M3VVC4_FELCA,ADAMTS like 4,ADAMTSL4,21.507,20.589,20.077,URINE
A0A337SUP1_FELCA,Adhesion G protein-coupled receptor E2,ADGRE2,23.036,12.032,12.345,URINE
A0A5F5XF14_FELCA,Adhesion G protein-coupled receptor E5,ADGRE5,21.233,14.077,14.035,URINE
A0A2I2UTI9_FELCA,Adhesion G protein-coupled receptor F5,ADGRF5,19.823,19.769,19.566,URINE+SERUM+PLASMA
A0A2I2UM02_FELCA,Adhesion G-protein coupled receptor G1 (G-protein coupled receptor 56),ADGRG1,23.898,19.810,19.945,URINE
A0A5F5XG72_FELCA,Adhesion G-protein coupled receptor G1 (G-protein coupled receptor 56),ADGRG1,22.704,20.453,20.809,URINE
A0A2I2U088_FELCA,Adhesion G protein-coupled receptor G6,ADGRG6,18.862,17.464,17.688,URINE
A0A2I2UB34_FELCA,Adhesion G protein-coupled receptor L1,ADGRL1,25.202,19.575,19.751,URINE
A0A2I2U0D3_FELCA,Adhesion G protein-coupled receptor L2,ADGRL2,21.774,20.416,20.737,URINE
A0A2I2U5R8_FELCA,Adhesion G protein-coupled receptor L3,ADGRL3,23.071,16.596,16.442,URINE
A0A337SL34_FELCA,Adhesion G protein-coupled receptor L4,ADGRL4,20.012,15.928,15.673,URINE
A0A3B0IPC1_FELCA,Adiponectin A,ADIA,19.908,24.242,24.348,URINE+SERUM
A0A3B0J2D0_FELCA,Adiponectin D,ADID,20.759,24.341,24.284,URINE+PLASMA
A0A337SQU4_FELCA,ADP dependent glucokinase,ADPGK,18.881,19.277,19.826,URINE+SERUM+PLASMA
A0A2I2U1Z3_FELCA,Afamin,AFM,26.165,28.798,28.667,URINE+PLASMA
M3XC81_FELCA,Kynurenine formamidase (KFA) (KFase) (EC 3.5.1.9) (Arylformamidase) (N-formylkynurenine formamidase) (FKF),AFMID,19.776,18.802,19.108,URINE+SERUM+PLASMA
M3X557_FELCA,Alpha-fetoprotein (Alpha-1-fetoprotein) (Alpha-fetoglobulin),AFP,19.898,21.593,21.471,URINE+PLASMA
A0A5F5XS55_FELCA,Aspartylglucosaminidase,AGA,23.464,19.252,18.950,URINE
M3X0F1_FELCA,Aspartylglucosaminidase,AGA,19.494,15.933,16.106,URINE
Q6KCA0_FELCA,Alpha1-glycoprotein acid,agp,26.023,27.400,27.071,URINE+PLASMA
A0A5F5XI81_FELCA,Agrin,AGRN,21.752,20.089,19.024,URINE+SERUM
A0A2I2UUP6_FELCA,Angiotensinogen (Serpin A8),AGT,31.812,27.971,27.933,URINE
A0A2I2U551_FELCA,Adenosylhomocysteinase (S-adenosyl-L-homocysteine hydrolase),AHCY,19.874,17.029,17.613,URINE
A0A337SD37_FELCA,Alpha-2-HS-glycoprotein (Fetuin-A),AHSG,28.304,30.802,30.778,URINE+PLASMA
A0A5F5XVZ8_FELCA,Alpha-2-HS-glycoprotein (Fetuin-A),AHSG,20.594,15.844,14.738,URINE+SERUM
A0A5F5XHI8_FELCA,Aldo-keto reductase family 1 member A1 (EC 1.1.1.19) (EC 1.1.1.2) (EC 1.1.1.20) (EC 1.1.1.372) (EC 1.1.1.54) (Alcohol dehydrogenase [NADP(+)]) (Aldehyde reductase) (Glucuronate reductase) (Glucuronolactone reductase),AKR1A1,23.097,20.732,20.142,URINE
A0A5F5XWS8_FELCA,Aldo-keto reductase family 1 member B1 (EC 1.1.1.21) (EC 1.1.1.300) (Aldose reductase),AKR1B1,22.763,19.716,19.610,URINE
A0A5F5XQC7_FELCA,NADP-dependent oxidoreductase domain-containing protein,AKR1C3,15.348,11.258,10.593,URINE
M3WA76_FELCA,Aldo-keto reductase family 7 like (gene/pseudogene),AKR7L,21.001,19.543,19.900,URINE
ALBU_FELCA,Albumin (allergen Fel d 2),ALB,35.059,36.602,36.597,URINE+PLASMA
A0A2I2U7Y0_FELCA,Albumin,ALB,29.901,31.582,31.453,URINE+PLASMA
A0A2I2UX74_FELCA,CD166 antigen (Activated leukocyte cell adhesion molecule),ALCAM,24.235,22.965,21.866,URINE+SERUM
M3WAV4_FELCA,aldehyde dehydrogenase (NAD(+)) (EC 1.2.1.3),ALDH1A1,24.674,23.884,24.339,URINE+SERUM+PLASMA
A0A337RUT4_FELCA,10-formyltetrahydrofolate dehydrogenase (EC 1.5.1.6),ALDH1L1,20.175,11.601,12.549,URINE
A0A337STY8_FELCA,"Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2)",ALDH2,18.231,15.224,14.357,URINE
A0A337RWN1_FELCA,aldehyde dehydrogenase (NAD(+)) (EC 1.2.1.3),ALDH7A1,12.442,11.319,12.690,URINE+SERUM
A0A337S2J9_FELCA,Aldehyde dehydrogenase 8 family member A1,ALDH8A1,21.608,19.388,19.331,URINE
A0A337SF20_FELCA,Aldehyde dehydrogenase 8 family member A1,ALDH8A1,17.243,19.455,17.089,PLASMA
M3W1Z4_FELCA,4-trimethylaminobutyraldehyde dehydrogenase (EC 1.2.1.19) (EC 1.2.1.3) (EC 1.2.1.46) (EC 1.2.1.47) (Aldehyde dehydrogenase family 9 member A1) (Formaldehyde dehydrogenase) (Gamma-aminobutyraldehyde dehydrogenase),ALDH9A1,21.878,20.133,19.680,URINE
A0A337S416_FELCA,Fructose-bisphosphate aldolase (EC 4.1.2.13),ALDOA,24.620,23.488,23.604,URINE
A0A5F5XME0_FELCA,Fructose-bisphosphate aldolase (EC 4.1.2.13),ALDOB,24.828,22.010,21.298,URINE
A0A337SRA7_FELCA,Alkaline phosphatase (EC 3.1.3.1),ALPI,20.075,15.304,15.217,URINE
PPBT_FELCA,"Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase liver/bone/kidney isozyme) (Phosphoamidase) (Phosphocreatine phosphatase) (EC 3.9.1.1)",ALPL,25.778,21.899,22.001,URINE
A0A337SNZ0_FELCA,Protein amnionless,AMN,23.084,21.983,21.917,URINE
A0A337SBE3_FELCA,Protein amnionless,AMN,24.686,22.648,22.353,URINE
A0A5F5Y013_FELCA,Alpha-amylase (EC 3.2.1.1),AMY2B,26.184,25.467,25.571,URINE+SERUM+PLASMA
M3X5H0_FELCA,Alpha-amylase (EC 3.2.1.1),AMY2B,20.270,18.045,17.741,URINE
A0A337SEZ4_FELCA,Angiopoietin-2,ANGPT2,23.489,22.222,22.104,URINE
M3X749_FELCA,Angiopoietin 4,ANGPT4,23.675,19.562,19.630,URINE
A0A5F5XNX6_FELCA,Angiopoietin like 1,ANGPTL1,22.814,20.759,21.487,URINE
M3WA23_FELCA,Angiopoietin like 2,ANGPTL2,26.807,23.521,23.653,URINE
M3WET8_FELCA,Angiopoietin like 3,ANGPTL3,27.126,19.973,20.042,URINE
A0A5F5Y1K1_FELCA,Angiopoietin like 6,ANGPTL6,23.732,18.024,18.307,URINE
A0A337SS27_FELCA,Aminopeptidase N (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (Microsomal aminopeptidase),ANPEP,20.936,18.500,17.849,URINE
AMPN_FELCA,Aminopeptidase N (AP-N) (fAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (CD antigen CD13),ANPEP APN,26.564,23.411,23.426,URINE
A0A337SIV7_FELCA,ANTXR cell adhesion molecule 1,ANTXR1,25.374,19.921,20.117,URINE
A0A337SPR7_FELCA,ANTXR cell adhesion molecule 2,ANTXR2,18.042,18.871,18.806,URINE+SERUM+PLASMA
A0A5F5XLK1_FELCA,Annexin,ANXA1,20.220,18.189,19.139,URINE
M3W3I3_FELCA,Annexin A10,ANXA10,19.494,14.696,14.616,URINE
A0A5F5XPA1_FELCA,Annexin,ANXA11,26.053,21.884,21.804,URINE
M3XFZ3_FELCA,Annexin,ANXA11,20.036,11.683,10.896,URINE
A0A337SIG2_FELCA,Annexin,ANXA13,22.644,20.512,20.444,URINE
A0A337SCD2_FELCA,Annexin,ANXA2,24.503,20.754,21.070,URINE
A0A337S137_FELCA,Annexin,ANXA4,24.843,21.995,22.153,URINE
A0A337S5C0_FELCA,Annexin,ANXA5,22.864,21.581,21.392,URINE
A0A5F5Y7J8_FELCA,Annexin,ANXA5,17.763,14.740,15.346,URINE
A0A337SBJ0_FELCA,Annexin,ANXA5,21.504,18.238,16.897,URINE+SERUM
A0A337SF88_FELCA,Annexin,ANXA6,23.083,20.290,20.501,URINE
A0A5F5XRH7_FELCA,Annexin,ANXA6,23.051,21.337,21.278,URINE
A0A2I2UN04_FELCA,Annexin,ANXA7,23.225,21.980,22.014,URINE
A0A2I2U0U5_FELCA,Amine oxidase (EC 1.4.3.-),AOC2,15.091,15.525,15.951,URINE+SERUM+PLASMA
A0A337SWK3_FELCA,Amine oxidase (EC 1.4.3.-),AOC3,23.739,21.976,21.955,URINE
A0A2I2U7C2_FELCA,Adaptor related protein complex 1 subunit beta 1,AP1B1,18.689,15.235,12.815,URINE+SERUM
A0A337SCH1_FELCA,Amyloid beta protein binding family B member 1,APBB1 HPX,27.731,32.286,32.305,URINE+SERUM
A0A5F5XCW1_FELCA,Amyloid beta protein binding family B member 1,APBB1 HPX,26.633,31.113,31.047,URINE+PLASMA
M3W2J4_FELCA,Amyloid beta protein binding family B member 1,APBB1 HPX,25.357,29.192,29.094,URINE+PLASMA
A0A5F5XQY3_FELCA,Amyloid beta like protein 1,APLP1,22.060,18.732,18.778,URINE
A0A2I2UM58_FELCA,Amyloid beta like protein 2,APLP2,24.042,21.345,21.525,URINE
A0A337S837_FELCA,Apolipoprotein A-I (Apolipoprotein A1),APOA1,27.486,33.111,33.423,URINE+SERUM
M3WPG6_FELCA,Apolipoprotein A-I (Apolipoprotein A1),APOA1,23.770,30.104,30.417,URINE+SERUM
APOA4_FELCA,Apolipoprotein A-IV (Apo-AIV) (ApoA-IV) (Apolipoprotein A4),APOA4,25.209,28.662,28.980,URINE+SERUM
A0A337SHX7_FELCA,Apolipoprotein B,APOB,26.623,26.171,26.213,URINE+SERUM+PLASMA
APOC1_FELCA,Apolipoprotein C-I (Apo-CI) (ApoC-I) (Apolipoprotein C1) [Cleaved into: Truncated apolipoprotein C-I],APOC1,21.823,24.723,24.776,URINE+SERUM
M3WNX1_FELCA,Apolipoprotein C-II (Apo-CII) (ApoC-II) (Apolipoprotein C2),APOC2,21.730,26.505,26.505,URINE+PLASMA
M3WSC8_FELCA,Apolipoprotein C-III (Apolipoprotein C3),APOC3,23.624,30.078,30.205,URINE+SERUM
M3W2V3_FELCA,Apolipoprotein C-IV (Apolipoprotein C4),APOC4,13.621,23.679,23.671,URINE+PLASMA
M3X8P7_FELCA,Apolipoprotein D (Apo-D),APOD,23.960,27.092,27.252,URINE+SERUM
A0A5F5XHD8_FELCA,Beta-2-glycoprotein 1 (Apolipoprotein H) (Beta-2-glycoprotein I),APOH,27.195,30.523,30.472,URINE+PLASMA
A0A5F5XPI7_FELCA,Beta-2-glycoprotein 1 (Apolipoprotein H) (Beta-2-glycoprotein I),APOH,27.008,26.518,26.696,URINE+SERUM+PLASMA
A0A2I2U3L7_FELCA,Apolipoprotein M,APOM,22.812,27.076,27.187,URINE+SERUM
M3W828_FELCA,Apolipoprotein M,APOM,20.126,24.641,24.838,URINE+SERUM
A0A0A0MPX8_FELCA,Amyloid-beta A4 protein,APP,24.855,20.359,20.924,URINE
A0A2I2UMH4_FELCA,Adenine phosphoribosyltransferase (EC 2.4.2.7),APRT,19.752,20.649,20.469,URINE+SERUM+PLASMA
A0A2I2UAM6_FELCA,Aquaporin-1 (Aquaporin-CHIP) (Water channel protein for red blood cells and kidney proximal tubule),AQP1,22.828,17.753,17.850,URINE
A0A2I2U5A2_FELCA,Aquaporin-2 (ADH water channel) (Aquaporin-CD) (Collecting duct water channel protein) (WCH-CD) (Water channel protein for renal collecting duct),AQP2,23.336,20.679,19.793,URINE
M3VUM2_FELCA,Amphiregulin,AREG,20.925,17.003,17.983,URINE
A0A2I2U8Y1_FELCA,ADP-ribosylation factor 3,ARF3,21.278,18.828,18.440,URINE
M3VXU3_FELCA,Arginase (EC 3.5.3.1),ARG1,17.264,15.263,15.327,URINE
A0A2I2UBL3_FELCA,Rho GDP-dissociation inhibitor 1 (Rho-GDI alpha),ARHGDIA,21.832,18.752,19.168,URINE
A0A2I2UL98_FELCA,Rho GDP dissociation inhibitor beta,ARHGDIB,14.006,14.946,13.848,PLASMA
M3WSL5_FELCA,Actin-related protein 2/3 complex subunit 4,ARPC4,18.643,16.729,16.669,URINE
M3WMY0_FELCA,Actin-related protein 2/3 complex subunit 5,ARPC5,18.007,17.145,17.102,URINE+SERUM+PLASMA
M3XEH2_FELCA,Arrestin domain containing 1,ARRDC1,22.714,19.751,19.245,URINE
A0A5F5Y690_FELCA,Arrestin domain containing 1,ARRDC1,21.043,19.258,18.957,URINE
M3WDK2_FELCA,Arylsulfatase A,ARSA,23.970,19.660,19.753,URINE
A0A5F5XKR0_FELCA,Arylsulfatase G,ARSG,19.033,19.945,18.456,PLASMA
M3XAU5_FELCA,NAD(P)(+)--arginine ADP-ribosyltransferase (EC 2.4.2.31) (Mono(ADP-ribosyl)transferase),ART1,22.870,19.623,19.630,URINE
A0A2I2UC45_FELCA,NAD(P)(+)--arginine ADP-ribosyltransferase (EC 2.4.2.31) (Mono(ADP-ribosyl)transferase),ART3,22.182,21.068,21.288,URINE
M3XDK8_FELCA,NAD(P)(+)--arginine ADP-ribosyltransferase (EC 2.4.2.31) (Mono(ADP-ribosyl)transferase),ART4,24.020,19.550,19.274,URINE
A0A2I2V0N3_FELCA,Acid ceramidase (EC 3.5.1.23),ASAH1,29.022,20.985,21.142,URINE
A0A5F5XFU3_FELCA,Ankyrin repeat and SOCS box containing 1,ASB1,16.935,21.849,21.926,URINE+SERUM
A0A337SSG0_FELCA,Asialoglycoprotein receptor 1,ASGR1,19.133,16.451,16.148,URINE
A0A337SX21_FELCA,Asialoglycoprotein receptor 1,ASGR1,20.080,12.108,13.189,URINE+SERUM
A0A337SAN3_FELCA,Asialoglycoprotein receptor 1,ASGR1,19.951,13.216,14.928,URINE+SERUM
A0A2I2U788_FELCA,Argininosuccinate lyase,ASL,20.457,21.489,21.459,URINE+PLASMA
M3WLS9_FELCA,Aspartate dehydrogenase domain-containing protein,ASPDH,21.581,20.649,20.620,URINE+SERUM+PLASMA
M3WWN6_FELCA,Asporin,ASPN,20.832,17.590,16.930,URINE
M3W3H5_FELCA,Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase),ASS1,20.723,18.521,19.057,URINE
M3W551_FELCA,Copper transport protein ATOX1 (Metal transport protein ATX1),ATOX1,27.099,20.032,20.192,URINE
A0A2I2UGY1_FELCA,Sodium/potassium-transporting ATPase subunit alpha,ATP1A1,24.576,20.554,20.913,URINE
M3WB86_FELCA,Sodium/potassium-transporting ATPase subunit beta,ATP1B1,24.283,24.977,24.699,URINE+SERUM+PLASMA
M3WZB0_FELCA,ATP synthase subunit alpha,ATP5F1A,19.352,20.191,19.507,URINE+SERUM+PLASMA
M3WF16_FELCA,ATPase H+ transporting accessory protein 1,ATP6AP1,22.100,14.723,13.470,URINE+SERUM
A0A337SFQ2_FELCA,Renin receptor (ATPase H(+)-transporting lysosomal accessory protein 2) (ATPase H(+)-transporting lysosomal-interacting protein 2) (Renin/prorenin receptor),ATP6AP2,23.381,23.090,22.837,URINE+SERUM+PLASMA
A0A2I2UMK7_FELCA,V-type proton ATPase subunit a,ATP6V0A1,18.568,16.539,17.445,URINE
A0A5F5XUE7_FELCA,V-type proton ATPase proteolipid subunit,ATP6V0C,18.030,14.488,14.692,URINE
A0A337SG88_FELCA,V-type proton ATPase subunit,ATP6V0D1,19.904,19.678,19.022,URINE+SERUM+PLASMA
A0A2I2U1C8_FELCA,H(+)-transporting two-sector ATPase (EC 7.1.2.2),ATP6V1A,23.045,21.406,21.352,URINE
A0A2I2V4V3_FELCA,Vacuolar proton pump subunit B (V-ATPase subunit B) (Vacuolar proton pump subunit B),ATP6V1B2,22.938,21.697,22.058,URINE
A0A337SKQ1_FELCA,V-type proton ATPase subunit C,ATP6V1C1,19.690,18.252,18.872,URINE
A0A337SK67_FELCA,V-type proton ATPase subunit E 1 (V-type proton ATPase subunit e 1) (Vacuolar proton pump subunit E 1),ATP6V1E1,20.026,17.216,16.841,URINE
A0A2I2V0F1_FELCA,V-type proton ATPase subunit G,ATP6V1G1,19.534,12.664,12.955,URINE
A0A337SHV5_FELCA,V-type proton ATPase subunit H,ATP6V1H,17.327,15.759,17.525,URINE+SERUM
A0A337SFT2_FELCA,Attractin,ATRN,27.533,26.537,26.890,URINE+SERUM+PLASMA
A0A2I2U5X4_FELCA,Arginine vasopressin,AVP,19.788,13.165,13.307,URINE
A0A2I2UTQ4_FELCA,receptor protein-tyrosine kinase (EC 2.7.10.1),AXL,26.008,20.802,20.463,URINE
B2MG_FELCA,Beta-2-microglobulin,B2M,26.495,21.574,21.493,URINE
M3WAQ7_FELCA,Hexosyltransferase (EC 2.4.1.-),B3GNT2,24.562,22.300,22.706,URINE
A0A2I2UH51_FELCA,"Beta-1,4-galactosyltransferase (Beta-1,4-GalTase) (EC 2.4.1.-)",B4GALT1,22.786,20.458,20.747,URINE
A0A5F5XM71_FELCA,"Beta-1,4-galactosyltransferase (Beta-1,4-GalTase) (EC 2.4.1.-)",B4GALT5,21.259,18.137,18.316,URINE
M3WQ57_FELCA,"Beta-1,4-glucuronyltransferase 1 (I-beta-1,3-N-acetylglucosaminyltransferase) (N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase) (Poly-N-acetyllactosamine extension enzyme) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1)",B4GAT1,25.721,23.484,24.413,URINE
A0A2I2V0L4_FELCA,Brain-specific angiogenesis inhibitor 1-associated protein 2,BAIAP2,20.970,19.662,19.775,URINE
A0A5F5XSY0_FELCA,BAR/IMD domain containing adaptor protein 2 like 1,BAIAP2L1,20.330,22.691,22.501,URINE+PLASMA
A0A337S942_FELCA,BMP and activin membrane-bound inhibitor homolog,BAMBI,23.247,21.616,16.677,URINE+SERUM
A0A337STZ5_FELCA,Brain abundant membrane attached signal protein 1,BASP1,19.634,20.973,20.580,PLASMA
M3W2U8_FELCA,Basal cell adhesion molecule (Lutheran blood group),BCAM,26.952,21.722,22.048,URINE
A0A2I2UQE2_FELCA,Branched-chain-amino-acid aminotransferase (EC 2.6.1.42),BCAT1,17.193,18.771,18.963,URINE+SERUM
A0A2I2U2A7_FELCA,BCL6 corepressor like 1,BCORL1,11.839,14.386,14.263,URINE+PLASMA
A0A5F5XI01_FELCA,Dehydrogenase/reductase SDR family member 6 (EC 1.1.1.104) (EC 1.1.1.30) ((R)-beta-hydroxybutyrate dehydrogenase) (3-hydroxybutyrate dehydrogenase type 2) (4-oxo-L-proline reductase) (Oxidoreductase UCPA) (Short chain dehydrogenase/reductase family 15C member 1),BDH2,20.846,18.976,19.574,URINE
A0A5F5XF81_FELCA,Osteocalcin,BGLAP,18.768,13.973,14.628,URINE
A0A2I2UZ39_FELCA,Bridging integrator 1,BIN1,20.477,18.142,17.910,URINE
A0A337SQ46_FELCA,Biliverdin reductase B,BLVRB,24.026,20.489,22.189,URINE+SERUM
M3VVW0_FELCA,Biliverdin reductase B,BLVRB,20.049,19.892,21.398,SERUM
M3XCQ9_FELCA,receptor protein serine/threonine kinase (EC 2.7.11.30),BMPR1A,16.531,13.591,16.463,URINE+SERUM
A0A2I2U0V3_FELCA,receptor protein serine/threonine kinase (EC 2.7.11.30),BMPR2,21.614,18.413,18.053,URINE
M3VUA4_FELCA,"BOC cell adhesion associated, onco regulated",BOC,15.920,20.845,21.428,URINE+SERUM
M3WM50_FELCA,BPI fold-containing family A member 1 (Palate lung and nasal epithelium clone protein),BPIFA1,21.514,22.737,20.972,PLASMA
A0A2I2UYJ3_FELCA,Bactericidal permeability-increasing protein (BPI),BPIFC,14.670,16.266,15.659,PLASMA
A0A5F5XJH2_FELCA,BRO1 domain-containing protein BROX (BRO1 domain- and CAAX motif-containing protein),BROX,22.174,20.941,20.134,URINE
A0A5F5XRG8_FELCA,BRO1 domain-containing protein BROX (BRO1 domain- and CAAX motif-containing protein),BROX,21.886,18.240,18.360,URINE
A0A337S935_FELCA,Bromodomain and WD repeat domain containing 1,BRWD1,13.648,18.537,17.090,URINE+PLASMA
A0A5F5XCB9_FELCA,Basigin,BSG,24.856,20.696,20.722,URINE
A0A2I2UA49_FELCA,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase (EC 3.2.2.6),BST1,24.087,19.994,20.111,URINE
A0A2I2U769_FELCA,Bone marrow stromal cell antigen 2,BST2,20.991,21.933,22.299,SERUM
A0A2I2U4L9_FELCA,Biotinidase (EC 3.5.1.12),BTD,24.944,24.247,24.305,URINE+SERUM+PLASMA
A0A337SAQ9_FELCA,B and T lymphocyte associated,BTLA,20.761,18.289,18.289,URINE
A0A2I2V139_FELCA,Chromosome 19 open reading frame 33,C19orf33,18.035,20.223,18.388,PLASMA
M3WS63_FELCA,Complement C1q subcomponent subunit A,C1QA,23.370,23.834,23.898,URINE+SERUM+PLASMA
A0A337SJG7_FELCA,Complement C1q C chain,C1QC,18.870,24.344,24.417,URINE+SERUM
A0A5F5XD66_FELCA,C1q and TNF related 5,C1QTNF5,18.729,13.332,13.746,URINE
A0A337SDE6_FELCA,complement subcomponent C1r (EC 3.4.21.41),C1R,24.218,24.478,25.513,SERUM
A0A337S217_FELCA,CUB domain-containing protein,C1R,19.272,24.027,25.052,URINE+SERUM
A0A5F5XHF5_FELCA,Complement C1s,C1S,22.230,25.806,26.390,URINE+SERUM
A0A2I2V4P2_FELCA,Complement C2 (EC 3.4.21.43) (C3/C5 convertase),C2,25.608,25.367,25.441,URINE+SERUM+PLASMA
A0A5F5Y0X6_FELCA,Complement component 4 binding protein alpha,C4BPA,24.006,25.465,25.380,URINE+PLASMA
A0A5F5Y5F1_FELCA,Complement component 4 binding protein alpha,C4BPA,19.648,21.586,20.343,PLASMA
M3WJK3_FELCA,Complement component 4 binding protein alpha,C4BPA,21.797,24.006,23.873,URINE+PLASMA
A0A5F5Y442_FELCA,Complement component 4 binding protein alpha,C4BPA,23.149,25.532,25.446,URINE+PLASMA
M3WJK2_FELCA,Complement component 4 binding protein beta,C4BPB,20.350,20.927,20.913,URINE+SERUM+PLASMA
M3VV58_FELCA,Complement C5,C5,24.321,26.110,26.158,URINE+SERUM
M3WLH3_FELCA,Complement component C6,C6,22.889,23.095,23.162,URINE+SERUM+PLASMA
A0A5F5XTG9_FELCA,Complement C7,C7,26.618,26.973,27.518,URINE+SERUM+PLASMA
A0A5F5XPJ5_FELCA,Complement C8 alpha chain,C8A,24.496,24.967,25.412,URINE+SERUM+PLASMA
M3W158_FELCA,Complement C8 alpha chain,C8A,15.896,16.755,17.568,SERUM
A0A2I2U5W5_FELCA,Complement component C8 beta chain (Complement component 8 subunit beta),C8B,22.988,25.872,26.170,URINE+SERUM
M3VUN7_FELCA,Complement C8 gamma chain,C8G,21.800,24.683,25.215,URINE+SERUM
M3WI95_FELCA,Complement component C9,C9,24.225,27.118,27.415,URINE+SERUM
A0A2I2U5V0_FELCA,Carbonic anhydrase (EC 4.2.1.1),CA12,24.052,20.575,20.881,URINE
A0A5F5XSK3_FELCA,Carbonic anhydrase 14,CA14,21.184,26.276,26.433,URINE+SERUM
A0A5F5Y3X9_FELCA,carbonic anhydrase (EC 4.2.1.1),CA15,21.570,20.302,19.994,URINE
M3WTZ2_FELCA,Chromosome A1 C5orf15 homolog,CA1H5orf15,21.551,20.959,21.680,URINE+SERUM+PLASMA
A0A5F5XMJ0_FELCA,Carbonic anhydrase (EC 4.2.1.1),CA2,25.787,24.161,25.446,URINE+SERUM
M3WS40_FELCA,Carbonic anhydrase (EC 4.2.1.1),CA3,24.936,19.736,20.270,URINE
M3WAR8_FELCA,Carbonic anhydrase (EC 4.2.1.1),CA4,24.365,19.518,19.238,URINE
A0A2I2U448_FELCA,Calcium binding protein 39,CAB39,20.224,18.256,18.626,URINE
M3WKE5_FELCA,Calcium binding protein 39 like,CAB39L,19.172,15.861,16.718,URINE
A0A2I2U2E0_FELCA,Calcium voltage-gated channel auxiliary subunit alpha2delta 1,CACNA2D1,24.824,27.274,26.414,URINE+PLASMA
A0A2I2UR43_FELCA,Cell adhesion molecule 1,CADM1,23.544,18.281,18.222,URINE
A0A2I2UUH5_FELCA,Cell adhesion molecule 2,CADM2,21.127,22.559,22.204,URINE+PLASMA
M3WMA2_FELCA,Cell adhesion molecule 3,CADM3,24.230,20.201,20.481,URINE
A0A2I2ULF8_FELCA,Cell adhesion molecule 4,CADM4,26.892,19.074,19.311,URINE
A0A337RZZ8_FELCA,Calbindin,CALB1,19.631,17.938,18.183,URINE
A0A337SVD2_FELCA,EF-hand domain-containing protein,CALM1,21.862,19.475,19.872,URINE
A0A337SJA7_FELCA,Calmodulin 2 (Calmodulin 3),CALM3 CALM2,20.316,17.608,17.809,URINE
M3VUU7_FELCA,Calreticulin,CALR,23.796,24.535,23.964,URINE+SERUM+PLASMA
A0A2I2U8F6_FELCA,Calreticulin,CALR3,22.717,22.184,23.044,URINE+SERUM+PLASMA
A0A2I2U457_FELCA,Calumenin,CALU,21.464,18.651,19.896,URINE+SERUM
A0A2I2UC97_FELCA,Calumenin,CALU,19.150,19.460,18.976,URINE+SERUM+PLASMA
F1C962_FELCA,Cathelicidin,CAMP,30.096,25.591,25.746,URINE
A0A2I2U679_FELCA,Galectin-3-binding protein (Lectin galactoside-binding soluble 3-binding protein),CANT1,28.861,21.556,21.709,URINE
A0A2I2U787_FELCA,Adenylyl cyclase-associated protein,CAP2,19.435,12.925,11.833,URINE+SERUM
M3XEV5_FELCA,Calpain 7,CAPN7,23.276,23.593,22.018,URINE+PLASMA
M3WK60_FELCA,Calpain small subunit 1,CAPNS1,15.613,18.389,17.090,URINE+PLASMA
CAZA2_FELCA,F-actin-capping protein subunit alpha-2 (CapZ alpha-2),CAPZA2,19.624,11.513,12.541,URINE+SERUM
A0A337S7D7_FELCA,F-actin-capping protein subunit beta,CAPZB,19.338,16.079,16.437,URINE
A0A5F5XBX1_FELCA,CASK interacting protein 1,CASKIN1,10.825,19.876,19.871,URINE+PLASMA
M3X6G1_FELCA,Caveolae associated protein 1,CAVIN1,19.886,15.435,15.476,URINE
A0A337S4Q8_FELCA,Chromosome B4 C12orf56 homolog,CB4H12orf56,22.824,16.568,17.049,URINE
M3W7W5_FELCA,Cobalamin binding intrinsic factor,CBLIF,20.155,20.203,19.458,URINE+SERUM+PLASMA
A0A337S4U7_FELCA,Cerebellin 2,CBLN2,18.644,15.454,16.679,URINE+SERUM
A0A337SFW3_FELCA,Coiled-coil domain containing 126,CCDC126,18.027,17.493,17.556,URINE+SERUM+PLASMA
A0A2I2U794_FELCA,Coiled-coil domain containing 150,CCDC150,17.155,14.283,14.717,URINE
A0A2I2U1I0_FELCA,Coiled-coil domain containing 154,CCDC154,20.416,20.588,20.558,URINE+SERUM+PLASMA
M3WGB1_FELCA,Coiled-coil domain containing 68,CCDC68,16.527,16.760,17.830,SERUM
M3WCI9_FELCA,C-C motif chemokine,CCL16,19.564,22.577,22.109,URINE+PLASMA
M3WX79_FELCA,CCN family member 1 (Cellular communication network factor 1) (Protein CYR61),CCN1,21.447,19.032,19.345,URINE
A0A337S566_FELCA,CCN family member 2 (Cellular communication network factor 2) (Connective tissue growth factor),CCN2,24.798,19.828,20.664,URINE
A0A2I2UV24_FELCA,CCN family member 3 (Cellular communication network factor 3),CCN3,27.586,18.504,19.112,URINE
A0A337SGQ6_FELCA,Cellular communication network factor 4,CCN4,22.353,17.042,16.921,URINE
A0A337S736_FELCA,T-complex protein 1 subunit delta,CCT4,14.961,13.643,13.594,URINE
A0A337SB54_FELCA,CD109 molecule,CD109,26.995,17.996,18.610,URINE
M3VWC6_FELCA,Monocyte differentiation antigen CD14 (Myeloid cell-specific leucine-rich glycoprotein),CD14,24.127,24.224,24.222,URINE+SERUM+PLASMA
M3VZG5_FELCA,CD163 molecule,CD163,22.229,22.632,22.728,URINE+SERUM+PLASMA
A0A2I2UYP6_FELCA,CD177 molecule,CD177,20.958,18.718,19.429,URINE
A0A337SMM1_FELCA,Prostate androgen-regulated mucin-like protein 1,CD1H11orf24,18.422,16.018,16.212,URINE
A0A2I2U7D8_FELCA,Chromosome D1 C11orf54 homolog,CD1H11orf54,23.340,21.881,21.883,URINE
M3W8D8_FELCA,CD200 molecule,CD200,21.343,16.445,15.737,URINE
A0A5F5XNG4_FELCA,CD248 molecule,CD248,27.163,20.214,20.580,URINE
A0A5F5Y5L0_FELCA,CD27 molecule,CD27,22.372,13.800,14.716,URINE
A0A2I2UYF4_FELCA,CD276 molecule,CD276,22.005,17.199,18.085,URINE
M3XCH2_FELCA,CD2 associated protein,CD2AP,17.335,14.271,15.893,URINE+SERUM
A0A337S6R6_FELCA,CD300 molecule like family member g,CD300LG,25.875,18.303,18.549,URINE
A0A5F5Y2H9_FELCA,CD34 molecule,CD34,21.889,17.133,16.565,URINE
A0A337S4N5_FELCA,Tumor necrosis factor receptor superfamily member 5 (B-cell surface antigen CD40) (CD40L receptor),CD40,19.257,16.272,16.954,URINE
A0A2I2UH63_FELCA,CD44 antigen (GP90 lymphocyte homing/adhesion receptor) (HUTCH-I) (Hermes antigen) (Hyaluronate receptor) (Phagocytic glycoprotein 1) (Phagocytic glycoprotein I),CD44,27.998,20.862,20.842,URINE
A0A337SX28_FELCA,Leukocyte surface antigen CD47 (Integrin-associated protein),CD47,17.959,16.725,16.432,URINE
A0A5F5XDA0_FELCA,CD58 molecule,CD58,18.892,14.042,12.621,URINE+SERUM
A0A5F5XQT8_FELCA,MAC-inhibitory protein (Membrane attack complex inhibition factor) (Protectin),CD59,32.487,20.729,20.753,URINE
A0A1E1GEV5_FELCA,CD5 antigen-like,cd5l AIM,18.837,22.241,21.375,URINE+PLASMA
A0A1E1GEW8_FELCA,CD5 antigen-like,cd5l AIM,17.528,17.058,16.277,URINE
CD63_FELCA,CD63 antigen (CD antigen CD63),CD63,20.985,22.925,23.951,URINE+SERUM
A0A2I2UTM6_FELCA,CD69 molecule,CD69,20.075,15.608,15.142,URINE
A0A5F5XTX9_FELCA,CD80 molecule,CD80,23.009,20.360,21.030,URINE
A0A337S8U6_FELCA,CD81 molecule,CD81,18.812,10.047,10.199,URINE
A0A337SBU9_FELCA,Tetraspanin,CD82,20.446,17.798,17.212,URINE
A0A337S2I4_FELCA,CD84 molecule,CD84,23.805,18.761,19.019,URINE
CD9_FELCA,CD9 antigen (CD antigen CD9),CD9,20.737,18.462,19.199,URINE
A0A5F5XPS6_FELCA,CD93 molecule,CD93,21.463,21.503,21.537,URINE+SERUM+PLASMA
A0A337S9J3_FELCA,CD99 antigen-like protein 2,CD99L2,23.102,18.186,17.480,URINE
A0A337SRW5_FELCA,Cell division control protein 42 homolog (EC 3.6.5.2),CDC42,21.581,23.136,22.940,URINE+PLASMA
A0A5F5XFC6_FELCA,Cell division cycle 5 like,CDC5L,21.557,21.136,21.282,URINE+SERUM+PLASMA
A0A337SG59_FELCA,Cadherin-1 (Epithelial cadherin),CDH1,24.381,19.214,19.491,URINE
A0A337S5G0_FELCA,Cadherin-1 (Epithelial cadherin),CDH1,29.690,23.300,22.991,URINE
M3W046_FELCA,Cadherin 11,CDH11,26.127,21.470,20.704,URINE
A0A337SUI1_FELCA,Cadherin 13,CDH13,26.207,20.926,21.359,URINE
A0A337ST48_FELCA,Cadherin 13,CDH13,27.539,21.498,22.836,URINE+SERUM
A0A5F5XXK1_FELCA,Cadherin 15,CDH15,22.362,19.923,19.808,URINE
A0A337S9Q3_FELCA,Cadherin 16,CDH16,24.473,22.321,21.080,URINE+SERUM
A0A5F5Y2W6_FELCA,Cadherin 17,CDH17,21.257,18.172,18.024,URINE
A0A337SSN3_FELCA,Cadherin 19,CDH19,23.794,20.450,20.285,URINE
A0A2I2U9W3_FELCA,Cadherin-2 (Neural cadherin),CDH2,25.951,24.974,24.691,URINE
A0A337SEZ0_FELCA,Cadherin 24,CDH24,21.550,15.727,15.859,URINE
A0A2I2UB75_FELCA,Cadherin 3,CDH3,20.507,15.925,16.160,URINE
A0A337SGU2_FELCA,Cadherin-4,CDH4,19.392,16.963,16.776,URINE
M3WM81_FELCA,Cadherin-5 (Vascular endothelial cadherin),CDH5,15.839,16.322,15.886,URINE+SERUM+PLASMA
A0A337SJ76_FELCA,Cadherin domain-containing protein,CDH5,21.491,20.542,20.802,URINE+SERUM+PLASMA
A0A337S9H7_FELCA,Cadherin-6,CDH6,22.720,20.544,21.242,URINE
M3VUL6_FELCA,Cadherin-6,CDH6,17.444,19.413,19.184,URINE+PLASMA
A0A2I2USA1_FELCA,Cadherin 8,CDH8,21.941,18.609,18.911,URINE
M3VX11_FELCA,Cadherin-related family member 1 (Photoreceptor cadherin) (Protocadherin-21),CDHR1,22.474,20.236,19.853,URINE
M3VZN4_FELCA,Cadherin related family member 2,CDHR2,22.858,21.016,21.805,URINE
A0A5F5XIV3_FELCA,Cadherin related family member 5,CDHR5,25.341,22.153,22.859,URINE
A0A5F5Y466_FELCA,Cadherin related family member 5,CDHR5,23.951,16.561,16.924,URINE
A0A2I2V2G8_FELCA,"Cell adhesion associated, onco regulated",CDON,17.521,18.471,17.129,PLASMA
M3X143_FELCA,Corneodesmosin,CDSN,23.029,11.283,11.202,URINE
A0A5F5Y101_FELCA,Corneodesmosin,CDSN,28.421,18.784,19.112,URINE
M3WSX6_FELCA,Chromosome E3 C16orf89 homolog,CE3H16orf89,15.011,15.845,15.591,URINE+SERUM+PLASMA
A0A337S2C9_FELCA,Ig-like domain-containing protein,CEACAM1,21.784,15.524,14.427,URINE+SERUM
A0A337RVE0_FELCA,"CEA cell adhesion molecule 16, tectorial membrane component",CEACAM16,20.662,18.368,18.586,URINE
M3VUF8_FELCA,CEA cell adhesion molecule 19,CEACAM19,22.634,14.825,15.982,URINE+SERUM
M3X096_FELCA,Carboxylic ester hydrolase (EC 3.1.1.-),CEL,22.685,23.634,23.758,SERUM
CELA1_FELCA,Chymotrypsin-like elastase family member 1 (EC 3.4.21.36) (Elastase-1),CELA1 ELA1 ELS1,23.645,19.332,19.273,URINE
M3X2X6_FELCA,Centromere protein C,CENPC,21.212,21.313,21.282,URINE+SERUM+PLASMA
M3W105_FELCA,Carboxylic ester hydrolase (EC 3.1.1.-),CES2,27.348,25.828,25.721,URINE
A0A337SQR3_FELCA,Carboxylic ester hydrolase (EC 3.1.1.-),CES4A,16.301,14.360,14.182,URINE
A0A2I2UFP6_FELCA,Carboxylic ester hydrolase (EC 3.1.1.-),CES5A CES1,30.891,22.599,24.707,URINE+SERUM
M3WKH4_FELCA,Carboxylic ester hydrolase (EC 3.1.1.-),CES5A CES1,20.733,19.340,18.667,URINE
EST5A_FELCA,Carboxylesterase 5A (EC 3.1.1.1) (Carboxylesterase-like urinary excreted protein) (Cauxin),CES5A CES7,34.400,22.447,23.158,URINE
M3W2B8_FELCA,Complement factor B (EC 3.4.21.47) (C3/C5 convertase),CFB,28.032,29.736,29.999,URINE+SERUM
A0A337SQJ3_FELCA,Complement factor D (EC 3.4.21.46) (Adipsin) (C3 convertase activator) (Properdin factor D),CFD,22.820,23.144,23.132,URINE+SERUM+PLASMA
M3XG35_FELCA,Complement factor H related 5,CFHR5,21.033,21.237,21.291,URINE+SERUM+PLASMA
A0A2I2U350_FELCA,Complement factor I,CFI,24.492,27.525,27.605,URINE+SERUM
M3WIJ6_FELCA,"Cofilin-1 (Cofilin, non-muscle isoform)",CFL1,22.685,20.500,20.451,URINE
A0A337SEF0_FELCA,Cofilin-2,CFL2,22.839,18.904,19.121,URINE
M3W950_FELCA,Complement factor properdin,CFP,19.591,23.872,23.642,URINE+PLASMA
GLHA_FELCA,Glycoprotein hormones alpha chain (Anterior pituitary glycoprotein hormones common subunit alpha) (Follicle-stimulating hormone alpha chain) (FSH-alpha) (Follitropin alpha chain) (Luteinizing hormone alpha chain) (LSH-alpha) (Lutropin alpha chain) (Thyroid-stimulating hormone alpha chain) (TSH-alpha) (Thyrotropin alpha chain),CGA,18.164,10.735,10.659,URINE
A0A5F5XGZ4_FELCA,Cingulin like 1,CGNL1,25.919,26.875,27.123,SERUM
A0A337SFJ9_FELCA,Chromogranin-A,CHGA,19.612,12.730,11.922,URINE
A0A5F5XCZ2_FELCA,Chromogranin-A,CHGA,21.233,10.904,10.668,URINE
A0A2I2UDB3_FELCA,Chitinase-3-like protein 1,CHI3L1,19.374,17.501,17.509,URINE
A0A337SU79_FELCA,Cell adhesion molecule L1 like,CHL1,17.897,18.644,18.638,URINE+SERUM+PLASMA
M3W0W8_FELCA,Charged multivesicular body protein 2a (Chromatin-modifying protein 2a),CHMP2A,22.960,17.715,18.099,URINE
A0A337S8C4_FELCA,Charged multivesicular body protein 2B,CHMP2B,19.784,13.537,15.841,URINE+SERUM
A0A5F5Y7M8_FELCA,Charged multivesicular body protein 3 (Chromatin-modifying protein 3) (Vacuolar protein sorting-associated protein 24),CHMP3,18.948,19.623,18.921,URINE+SERUM+PLASMA
M3WXJ4_FELCA,Charged multivesicular body protein 4B,CHMP4B,22.576,20.390,20.565,URINE
M3X6F1_FELCA,Charged multivesicular body protein 5 (Chromatin-modifying protein 5),CHMP5,20.116,13.431,12.745,URINE
A0A337SL92_FELCA,Charged multivesicular body protein 5 (Chromatin-modifying protein 5),CHMP5,21.951,18.846,18.725,URINE
A0A337SGE0_FELCA,Chondrolectin,CHODL,23.697,18.938,19.961,URINE+SERUM
M3WI48_FELCA,Sulfotransferase (EC 2.8.2.-),CHST3,19.348,16.716,16.849,URINE
M3WF53_FELCA,Cartilage intermediate layer protein,CILP,21.864,19.362,19.560,URINE
M3WKI3_FELCA,Cartilage intermediate layer protein 2,CILP2,26.782,22.511,22.422,URINE
A0A2I2UED7_FELCA,Cytoplasmic linker associated protein 1,CLASP1,15.096,14.930,13.718,URINE+SERUM
A0A2I2U6F0_FELCA,C-type lectin domain containing 11A,CLEC11A,22.832,22.265,22.124,URINE+SERUM+PLASMA
M3VWY2_FELCA,C-type lectin domain family 4 member G,CLEC4G,21.006,19.097,18.650,URINE
A0A2I2UE55_FELCA,C-type lectin domain containing 7A,CLEC7A,21.989,22.821,23.009,SERUM
A0A337SW69_FELCA,C-type lectin domain containing 7A,CLEC7A,19.869,15.009,15.109,URINE
M3WNY6_FELCA,Chloride intracellular channel protein,CLIC1,21.897,20.719,20.612,URINE
A0A337SD38_FELCA,Chloride intracellular channel protein,CLIC4,23.691,20.889,20.985,URINE
A0A2I2UVX8_FELCA,Chloride intracellular channel protein,CLIC5,19.123,15.984,16.151,URINE
M3VW19_FELCA,CXADR like membrane protein,CLMP,20.557,18.406,17.137,URINE+SERUM
A0A2I2U499_FELCA,Battenin,CLN3,17.562,20.432,21.925,URINE+SERUM
A0A2I2UWU9_FELCA,CLN5 intracellular trafficking protein,CLN5,23.408,19.110,18.962,URINE
M3W2V0_FELCA,Apolipoprotein E,CLPTM1 APOE,24.116,25.765,25.956,URINE+SERUM
A0A337S9Y3_FELCA,Apolipoprotein E,CLPTM1 APOE,24.230,24.460,24.867,URINE+SERUM+PLASMA
M3VU87_FELCA,Calsyntenin-3,CLSTN3,21.417,20.706,20.378,URINE
M3WKP2_FELCA,Clusterin,CLU,23.375,23.862,23.902,URINE+SERUM+PLASMA
A0A5F5XGP3_FELCA,Clusterin,CLU,29.088,29.345,29.334,URINE+SERUM+PLASMA
A0A5F5XKE9_FELCA,Cytidine/uridine monophosphate kinase 2,CMPK2,22.264,19.964,21.556,URINE+SERUM
A0A337SUS1_FELCA,Carnosine dipeptidase 2,CNDP2,23.306,21.535,20.936,URINE
M3W9A2_FELCA,Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Threonyl dipeptidase),CNDP2,22.490,18.966,19.059,URINE
A0A337SGM0_FELCA,Metal transporter,CNNM4 CNNM3,20.471,15.880,17.055,URINE+SERUM
M3WWG3_FELCA,"2',3'-cyclic-nucleotide 3'-phosphodiesterase (CNP) (CNPase) (EC 3.1.4.37)",CNP,18.933,19.520,19.256,URINE+SERUM+PLASMA
A0A337RVG5_FELCA,Ciliary neurotrophic factor receptor subunit alpha,CNTFR,23.211,21.038,20.968,URINE
A0A2I2U968_FELCA,Contactin-1,CNTN1,21.372,18.778,19.250,URINE
A0A2I2UN28_FELCA,Cochlin,COCH,28.896,17.134,17.287,URINE
M3WFG2_FELCA,Cochlin,COCH,17.642,15.117,15.406,URINE
A0A337S496_FELCA,Collagen type XI alpha 1 chain,COL11A1,21.897,17.760,17.230,URINE
A0A2I2U432_FELCA,Collagen type XII alpha 1 chain,COL12A1,27.328,23.649,23.523,URINE
A0A337RZD5_FELCA,Collagen type XIV alpha 1 chain,COL14A1,23.686,21.940,21.824,URINE
A0A337RV83_FELCA,Collagen type XV alpha 1 chain,COL15A1,25.830,22.005,22.023,URINE
A0A5F5XC75_FELCA,Collagen type XVIII alpha 1 chain,COL18A1,25.320,21.244,21.558,URINE
M3W2F5_FELCA,Collagen type I alpha 1 chain,COL1A1,23.180,17.538,17.766,URINE
A0A5F5XYM1_FELCA,Collagen type I alpha 2 chain,COL1A2,23.545,18.205,19.373,URINE+SERUM
M3WVN3_FELCA,Collagen type I alpha 2 chain,COL1A2,20.749,17.200,16.798,URINE
M3WPE0_FELCA,Collagen type XXVIII alpha 1 chain,COL28A1,21.599,11.938,11.406,URINE
A0A5F5Y1B8_FELCA,Collagen type III alpha 1 chain,COL3A1,24.570,20.907,20.429,URINE
A0A5F5Y4J4_FELCA,Collagen type IV alpha 1 chain,COL4A1,19.780,17.509,17.268,URINE
A0A5F5XGS9_FELCA,Collagen type IV alpha 2 chain,COL4A2,23.362,20.109,20.344,URINE
A0A337RYM9_FELCA,Collagen type IV alpha 3 chain,COL4A3,20.405,18.185,18.442,URINE
A0A337SN04_FELCA,Collagen type IV alpha 5 chain,COL4A5,21.578,20.629,19.836,URINE
A0A2I2UD65_FELCA,Collagen type V alpha 2 chain,COL5A2,25.830,25.424,23.017,URINE+SERUM
A0A5F5XGI4_FELCA,Collagen type V alpha 3 chain,COL5A3,23.427,18.553,18.687,URINE
M3WLD9_FELCA,Collagen type VI alpha 1 chain,COL6A1,20.808,19.260,18.989,URINE
A0A2I2U2C4_FELCA,Collagen type VI alpha 2 chain,COL6A2,21.911,19.190,19.047,URINE
A0A337S4V9_FELCA,Collagen type VI alpha 3 chain,COL6A3,27.692,20.987,21.075,URINE
A0A337RW59_FELCA,Collagen type VI alpha 3 chain,COL6A3,27.174,24.526,24.564,URINE
M3WHG4_FELCA,Collagen type VI alpha 3 chain,COL6A3,24.514,19.037,18.890,URINE
A0A2I2U7G3_FELCA,Collagen type VIII alpha 1 chain,COL8A1,19.535,16.118,16.127,URINE
A0A2I2UH03_FELCA,Collectin subfamily member 10,COLEC10,17.534,18.453,18.684,SERUM
A0A2I2U3V7_FELCA,Collectin-11,COLEC11,20.665,20.917,21.378,URINE+SERUM+PLASMA
A0A2I2U1P2_FELCA,Collectin-12,COLEC12,27.363,21.912,23.568,URINE+SERUM
M3WN82_FELCA,Collectin-12,COLEC12,18.913,15.281,15.285,URINE
A0A5F5XKH5_FELCA,Cartilage oligomeric matrix protein,COMP,17.355,16.037,15.307,URINE
A0A337S2A4_FELCA,Cartilage oligomeric matrix protein,COMP,23.125,21.686,22.545,URINE
M3VWP9_FELCA,Coatomer subunit beta',COPB2,21.813,19.052,17.554,URINE+SERUM
A0A337RVF9_FELCA,ADF-H domain-containing protein,COTL1,25.539,22.221,22.163,URINE
A0A2I2U8E4_FELCA,ferroxidase (EC 1.16.3.1),CP,27.742,28.427,28.858,SERUM
A0A5F5XZM2_FELCA,Carboxypeptidase A1,CPA1,24.690,22.204,22.451,URINE
M3WKB7_FELCA,Carboxypeptidase A1 (EC 3.4.17.1),CPA1,23.327,20.567,20.780,URINE
A0A2I2U0Y4_FELCA,Carboxypeptidase B (EC 3.4.17.2),CPB1,23.006,19.313,19.511,URINE
A0A2I2UAE6_FELCA,Carboxypeptidase B2,CPB2,23.776,24.431,24.632,URINE+SERUM+PLASMA
A0A337SN31_FELCA,Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D),CPD,20.828,20.473,19.777,URINE
M3WGH2_FELCA,Carboxypeptidase E (EC 3.4.17.10) (Carboxypeptidase H) (Enkephalin convertase) (Prohormone-processing carboxypeptidase),CPE,23.507,23.678,24.254,URINE+SERUM+PLASMA
M3WMF1_FELCA,Carboxypeptidase N subunit 2,CPN2,24.709,26.274,26.299,URINE+SERUM
A0A2I2V326_FELCA,Copine 1,CPNE1,21.693,17.635,17.878,URINE
A0A337SJW2_FELCA,Copine 3,CPNE3,24.350,21.547,21.616,URINE
A0A2I2U0K1_FELCA,Copine 4,CPNE4,22.419,17.198,17.541,URINE
A0A337SEH6_FELCA,"Carboxypeptidase X, M14 family member 2",CPXM2,18.689,17.878,16.047,URINE+SERUM
U5TLB4_COWPX,CPXV028 protein,CPXV028,21.326,20.767,20.887,URINE+SERUM+PLASMA
A0A0K2YWB3_COWPX,CPXV211 protein,CPXV211,18.075,16.626,16.344,URINE
A0A337SSG2_FELCA,Carboxypeptidase Z,CPZ,20.417,16.350,18.299,URINE+SERUM
A0A337SJR3_FELCA,Complement C3d receptor 2,CR2,20.710,17.910,18.047,URINE
A0A337SV16_FELCA,Crumbs cell polarity complex component 1,CRB1,21.649,15.717,16.115,URINE
A0A337SRL8_FELCA,Crumbs cell polarity complex component 2,CRB2,24.731,23.292,23.605,URINE
A0A5F5XYI6_FELCA,Cyclic AMP-responsive element-binding protein 3-like protein 2,CREB3L2,14.932,14.266,15.384,SERUM
M3WK50_FELCA,cAMP responsive element binding protein 3 like 3,CREB3L3,24.026,20.170,20.869,URINE
A0A5F5XJY1_FELCA,Cellular repressor of E1A stimulateds 1,CREG1,22.142,19.590,19.937,URINE
A0A337S172_FELCA,Cysteine rich transmembrane BMP regulator 1,CRIM1,22.030,19.528,18.796,URINE
M3WNB8_FELCA,Cysteine rich protein 1,CRIP1,17.413,16.512,15.510,URINE+SERUM
A0A2I2UC81_FELCA,Cysteine rich secretory protein 3,CRISP3,29.273,19.637,19.602,URINE
A0A5F5XVE8_FELCA,Cysteine rich secretory protein 3,CRISP3,16.254,18.904,18.305,URINE+PLASMA
A0A5F5Y1N6_FELCA,Cysteine rich secretory protein 3,CRISP3,13.117,18.881,18.389,URINE+PLASMA
A0A337SBA6_FELCA,Adapter molecule crk,CRK,22.276,21.159,20.313,URINE
M3W544_FELCA,"CRK like proto-oncogene, adaptor protein",CRKL,16.116,15.974,16.382,URINE+SERUM+PLASMA
A0A5F5XWB9_FELCA,Pentraxin family member,CRP,26.635,27.202,27.105,URINE+SERUM+PLASMA
A0A2I2UDI7_FELCA,Cartilage acidic protein 1,CRTAC1,27.290,21.994,21.804,URINE
A0A5F5XI25_FELCA,L-gulonate 3-dehydrogenase (EC 1.1.1.45) (L-gulonate 3-dehydrogenase),CRYL1,21.579,17.940,18.187,URINE
A0A5F5XUR3_FELCA,Ketimine reductase mu-crystallin (EC 1.5.1.25) (NADP-regulated thyroid-hormone-binding protein),CRYM,16.484,13.398,13.282,URINE
A0A337SVX9_FELCA,Crystallin zeta,CRYZ,18.735,19.262,18.435,URINE+SERUM+PLASMA
A0A337SMK6_FELCA,Colony stimulating factor 1,CSF1,22.609,19.908,20.902,URINE
CSF1R_FELCA,Macrophage colony-stimulating factor 1 receptor (CSF-1 receptor) (CSF-1-R) (CSF-1R) (M-CSF-R) (EC 2.7.10.1) (Proto-oncogene c-Fms) (CD antigen CD115),CSF1R FMS,18.028,13.229,12.996,URINE
M3WGW7_FELCA,Chondroitin sulfate proteoglycan 4,CSPG4,26.198,20.596,20.473,URINE
D5MTH1_FELCA,Cystatin C,CST3,23.013,20.620,21.011,URINE
M3WIK5_FELCA,Cystatin E/M,CST6,27.437,21.111,20.952,URINE
CYTA_FELCA,Cystatin-A (allergen Fel d 3),CSTA,21.774,17.983,17.328,URINE
A0A337SE08_FELCA,Cystatin domain-containing protein,CSTB,21.443,16.229,16.507,URINE
A0A337SJE3_FELCA,Cystathionine gamma-lyase (EC 4.4.1.1) (Cysteine-protein sulfhydrase) (Gamma-cystathionase),CTH,24.278,22.826,22.079,URINE
A0A337SHY2_FELCA,Collagen triple helix repeat containing 1,CTHRC1,21.336,20.830,20.212,URINE
A0A2I2U5B1_FELCA,Catenin beta-1 (Beta-catenin),CTNNB1,18.569,17.492,17.675,URINE
A0A5F5XDM8_FELCA,Chymotrypsin C,CTRC,25.509,20.609,20.660,URINE
M3W019_FELCA,Chymotrypsin C,CTRC,23.958,17.252,18.168,URINE
M3WHR1_FELCA,Chymotrypsin like,CTRL,22.949,19.729,20.735,URINE+SERUM
A0A337SMR1_FELCA,Carboxypeptidase (EC 3.4.16.-),CTSA,23.451,22.004,21.471,URINE
M3WLU0_FELCA,Cathepsin B (EC 3.4.22.1),CTSB,25.257,22.767,23.112,URINE
M3W9M0_FELCA,Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (Dipeptidyl transferase),CTSC,25.229,21.416,21.538,URINE
M3W8G3_FELCA,Cathepsin D (EC 3.4.23.5),CTSD,25.961,20.860,21.148,URINE
M3W7M8_FELCA,Cathepsin F,CTSF,20.775,19.225,18.984,URINE
M3WGI2_FELCA,Pro-cathepsin H,CTSH,20.480,13.835,13.851,URINE
A0A337SUC3_FELCA,Pro-cathepsin H,CTSH,21.764,19.666,19.537,URINE
M3W0Q2_FELCA,Cathepsin K (EC 3.4.22.38),CTSK,18.495,19.138,18.906,URINE+SERUM+PLASMA
M3WUC1_FELCA,Cathepsin O,CTSO,21.842,18.699,17.790,URINE
A0A337RZ12_FELCA,Cathepsin S,CTSS,24.994,20.309,20.021,URINE
M3W0Q1_FELCA,Cathepsin S (EC 3.4.22.27),CTSS,23.891,17.872,17.896,URINE
A0A5F5XBP7_FELCA,cathepsin X (EC 3.4.18.1),CTSZ,26.074,19.915,19.159,URINE
M3VVI7_FELCA,cathepsin X (EC 3.4.18.1),CTSZ,25.469,20.374,18.451,URINE+SERUM
M3WJ25_FELCA,Cubilin,CUBN,29.243,25.676,25.578,URINE
A0A2I2UJG2_FELCA,CutA divalent cation tolerance homolog,CUTA,20.171,15.206,15.663,URINE
A0A2I2UQ66_FELCA,CXADR Ig-like cell adhesion molecule,CXADR,24.231,20.857,20.849,URINE
SDF1_FELCA,Stromal cell-derived factor 1 (SDF-1) (C-X-C motif chemokine 12),CXCL12 SDF1,22.238,19.558,20.449,URINE
M3WSR7_FELCA,C-X-C motif chemokine 16 (Transmembrane chemokine CXCL16),CXCL16,22.072,18.153,17.850,URINE
M3VWB9_FELCA,Cysteine-rich and transmembrane domain-containing protein 1,CYSTM1,21.988,19.831,19.827,URINE
A0A337S6Y2_FELCA,DAB adaptor protein 2,DAB2,22.055,19.949,19.192,URINE
A0A337SFQ4_FELCA,Dystroglycan 1 (Dystroglycan) (Dystrophin-associated glycoprotein 1),DAG1,23.709,21.999,22.247,URINE
A0A2I2U6R0_FELCA,Acyl-CoA-binding protein,DBI,22.229,16.318,17.117,URINE
A0A337SMV2_FELCA,"Discoidin, CUB and LCCL domain containing 2",DCBLD2,22.885,17.997,17.915,URINE
A0A337S0Q6_FELCA,Decorin (Bone proteoglycan II),DCN,20.194,16.548,16.784,URINE
M3WFI7_FELCA,L-xylulose reductase (EC 1.1.1.10) (Dicarbonyl/L-xylulose reductase),DCXR,19.548,16.382,16.757,URINE
A0A2I2U3S0_FELCA,Dimethylarginine dimethylaminohydrolase 1,DDAH1,22.453,19.837,19.686,URINE
M3XC02_FELCA,Dimethylarginine dimethylaminohydrolase 2,DDAH2,25.897,23.814,23.341,URINE
A0A337SE70_FELCA,receptor protein-tyrosine kinase (EC 2.7.10.1),DDR1,24.046,21.816,21.850,URINE
A0A2I2UUM4_FELCA,"Beta-defensin 1 (Defensin, beta 1)",DEFB1,25.995,17.249,16.633,URINE
A0A337S785_FELCA,"Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase (EC 1.1.1.179) (EC 1.3.1.20) (D-xylose 1-dehydrogenase) (D-xylose-NADP dehydrogenase) (Dimeric dihydrodiol dehydrogenase)",DHDH,25.781,23.014,23.350,URINE
A0A337SIN6_FELCA,Delta like non-canonical Notch ligand 1,DLK1,22.325,16.307,15.892,URINE
A0A2I2U119_FELCA,Delta like non-canonical Notch ligand 1,DLK1,23.861,17.139,17.064,URINE
M3X710_FELCA,Delta like non-canonical Notch ligand 2,DLK2,24.020,21.008,21.209,URINE
M3W5T1_FELCA,"Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial (EC 2.3.1.61) (E2K)",DLST,23.552,19.048,19.042,URINE
A0A5F5XLL3_FELCA,Dermokine,DMKN,19.729,14.463,13.045,URINE+SERUM
A0A5F5XE39_FELCA,Dermokine,DMKN,22.315,18.394,18.616,URINE
A0A337S6Z7_FELCA,Dentin matrix acidic phosphoprotein 1,DMP1,16.648,10.367,10.264,URINE
A0A5F5XJC4_FELCA,Dynein axonemal heavy chain 11,DNAH11,23.968,23.167,23.019,URINE+SERUM+PLASMA
A0A5F5XEB8_FELCA,Dynein axonemal heavy chain 8,DNAH8,21.862,20.736,20.871,URINE
A0A337S1A5_FELCA,DnaJ heat shock protein family (Hsp40) member C11,DNAJC11,18.114,18.841,18.082,URINE+SERUM+PLASMA
A0A5F5XF61_FELCA,DnaJ heat shock protein family (Hsp40) member C28,DNAJC28,16.834,18.724,17.910,URINE+PLASMA
M3WGM9_FELCA,Deoxyribonuclease,DNASE1,30.926,21.038,22.786,URINE+SERUM
A0A2I2UNJ5_FELCA,Deoxyribonuclease 1 like 2,DNASE1L2,22.442,17.616,17.688,URINE
M3VUU5_FELCA,Deoxyribonuclease-2-alpha (EC 3.1.22.1) (Acid DNase) (Deoxyribonuclease II alpha) (Lysosomal DNase II),DNASE2,24.356,19.034,19.061,URINE
A0A5F5XGS4_FELCA,Docking protein 7,DOK7,22.027,16.551,17.027,URINE
M3W0Z1_FELCA,Dipeptidase (EC 3.4.13.19),DPEP1,24.587,22.567,22.141,URINE
A0A337S046_FELCA,Dipeptidyl peptidase like 10,DPP10,15.754,12.786,11.762,URINE+SERUM
DPP4_FELCA,Dipeptidyl peptidase 4 (EC 3.4.14.5) (Dipeptidyl peptidase IV) (DPP IV) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form)],DPP4 CD26,29.070,22.074,21.989,URINE
A0A5F5XVS8_FELCA,Dipeptidyl peptidase 7,DPP7,25.527,21.113,21.234,URINE
M3XE34_FELCA,Dermatopontin,DPT,28.887,20.239,20.153,URINE
A0A2I2U844_FELCA,Dihydropyrimidinase,DPYS,23.481,19.833,20.100,URINE
A0A5F5XFR8_FELCA,Dihydropyrimidinase,DPYS,21.087,17.784,18.343,URINE
A0A2I2UZA9_FELCA,Desmocollin 1,DSC1,25.220,20.004,19.561,URINE
A0A2I2UGD4_FELCA,Desmocollin 2,DSC2,24.806,24.161,24.387,URINE+SERUM+PLASMA
A0A2I2UCR1_FELCA,Desmocollin 2,DSC2,21.621,19.515,19.187,URINE
A0A337SP25_FELCA,Desmoglein 1,DSG1,21.493,18.956,18.393,URINE
M3WCK3_FELCA,Desmoplakin,DSP,22.606,22.620,21.131,URINE+PLASMA
A0A2I2UFE0_FELCA,Destrin (Actin-depolymerizing factor),DSTN,21.396,16.515,16.373,URINE
M3WM59_FELCA,"Enoyl-CoA hydratase, mitochondrial (EC 4.2.1.17) (EC 5.3.3.8) (Enoyl-CoA hydratase 1) (Short-chain enoyl-CoA hydratase)",ECHS1,18.674,18.072,18.002,URINE+SERUM+PLASMA
M3W858_FELCA,Enoyl-CoA delta isomerase 1,ECI1,15.705,15.328,15.398,URINE+SERUM+PLASMA
M3WRY2_FELCA,Extracellular matrix protein 1,ECM1,25.117,27.492,26.171,URINE+PLASMA
A0A337SPQ5_FELCA,Ectodysplasin A receptor,EDAR,20.245,17.081,17.739,URINE
A0A337SND7_FELCA,Endothelin-3 (Preproendothelin-3),EDN3,22.503,14.336,14.933,URINE
A0A337SDI4_FELCA,Endothelin receptor type B (Endothelin receptor non-selective type),EDNRB,17.732,16.728,16.036,URINE
A0A2I2U0I8_FELCA,Early endosome antigen 1,EEA1,22.191,16.728,16.932,URINE
EF1A1_FELCA,Elongation factor 1-alpha 1 (EF-1-alpha-1) (EC 3.6.5.-) (Elongation factor Tu) (EF-Tu) (Eukaryotic elongation factor 1 A-1) (eEF1A-1),EEF1A1 EEF1A,24.816,24.707,24.357,URINE+SERUM+PLASMA
M3W2D2_FELCA,EF-hand calcium binding domain 14,EFCAB14,16.920,16.471,17.650,SERUM
M3VVE6_FELCA,EGF containing fibulin extracellular matrix protein 1,EFEMP1,28.236,25.531,25.315,URINE
A0A337SCW7_FELCA,EGF containing fibulin extracellular matrix protein 2,EFEMP2,24.660,22.839,22.927,URINE
A0A337SFI6_FELCA,Elongation factor like GTPase 1,EFL1,19.216,18.799,19.235,URINE+SERUM+PLASMA
A0A337S356_FELCA,Ephrin-A1,EFNA1,26.261,17.898,18.284,URINE
A0A337SBN3_FELCA,Ephrin A4,EFNA4,23.525,17.954,18.170,URINE
A0A337S0H8_FELCA,EPH-related receptor tyrosine kinase ligand 7,EFNA5,20.116,22.099,21.604,URINE+PLASMA
M3WR70_FELCA,Ephrin-B1,EFNB1,24.459,22.964,21.162,URINE+SERUM
B0LDS5_FELCA,Ephrin-B2,efnB2,24.732,22.516,21.889,URINE
A0A337SFQ1_FELCA,Ephrin B3,EFNB3,23.061,22.444,19.213,URINE+SERUM
EGF_FELCA,Pro-epidermal growth factor (EGF) [Cleaved into: Epidermal growth factor],EGF,30.292,24.283,23.910,URINE
A0A2I2U1L8_FELCA,Pro-epidermal growth factor,EGF,21.243,13.993,13.885,URINE
A0A0P0GH12_FELCA,receptor protein-tyrosine kinase (EC 2.7.10.1),EGFR,18.869,18.924,18.228,URINE+SERUM+PLASMA
A0A337S424_FELCA,Receptor protein-tyrosine kinase (EC 2.7.10.1),EGFR,20.071,22.534,22.238,URINE+PLASMA
M3X1U0_FELCA,EH domain containing 1,EHD1,22.392,22.332,22.190,URINE+SERUM+PLASMA
M3WXE7_FELCA,EH domain containing 4,EHD4,20.659,19.701,20.049,URINE+SERUM+PLASMA
A0A5F5XQI4_FELCA,Choline transporter-like protein,EHMT2,20.680,17.162,16.300,URINE
A0A2I2UKH0_FELCA,Choline transporter-like protein,EHMT2,17.140,15.908,15.927,URINE
M3XDI4_FELCA,Eukaryotic translation initiation factor 2-alpha kinase 1 (EC 2.7.11.1) (Heme-regulated eukaryotic initiation factor eIF-2-alpha kinase) (Hemin-sensitive initiation factor 2-alpha kinase),EIF2AK1,19.979,20.836,20.795,URINE+SERUM+PLASMA
M3WCG8_FELCA,Translation initiation factor eIF2B subunit gamma (eIF2B GDP-GTP exchange factor subunit gamma),EIF2B3,23.351,19.003,18.991,URINE
A0A2I2U322_FELCA,Eukaryotic translation initiation factor 4 gamma 3,EIF4G3,18.453,18.827,17.849,URINE+SERUM+PLASMA
A0A5F5XCL3_FELCA,Eukaryotic translation initiation factor 5,EIF5,19.345,14.872,14.600,URINE
A0A337RZ59_FELCA,Eukaryotic translation initiation factor 5A-1 (Eukaryotic initiation factor 5A isoform 1) (eIF-4D),EIF5A,17.556,14.328,16.286,URINE+SERUM
M3W5W5_FELCA,Eukaryotic translation initiation factor 6 (eIF-6),EIF6 ITGB4BP,24.626,20.778,21.382,URINE
M3XDQ5_FELCA,"Elastase, neutrophil expressed",ELANE,17.316,13.418,14.531,URINE+SERUM
A0A5F5XSQ0_FELCA,"Elastase, neutrophil expressed",ELANE,25.072,16.913,17.751,URINE
A0A2I2UVP6_FELCA,EMAP like 5,EML5,21.895,17.787,18.458,URINE
M3XGC9_FELCA,Endonuclease domain containing 1,ENDOD1,21.154,20.247,19.955,URINE
A0A2I2UTE6_FELCA,phosphopyruvate hydratase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase),ENO1,22.017,19.552,19.424,URINE
A0A337S0P1_FELCA,phosphopyruvate hydratase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase),ENO1,18.699,12.141,12.311,URINE
A0A2I2UHT3_FELCA,phosphopyruvate hydratase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase),ENO2,20.450,17.390,17.583,URINE
A0A2I2UJ14_FELCA,Beta-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (Enolase 3) (Muscle-specific enolase) (Skeletal muscle enolase),ENO3,21.938,19.714,19.920,URINE
A0A2I2V5H4_FELCA,Enolase 4 (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase),ENO4,20.978,16.054,17.444,URINE+SERUM
M3VU18_FELCA,Aminopeptidase (EC 3.4.11.-),ENPEP,25.628,21.054,21.468,URINE
A0A2I2V3L7_FELCA,Ectonucleotide pyrophosphatase/phosphodiesterase 2,ENPP2,22.111,20.778,21.132,URINE
A0A2I2V568_FELCA,Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 (EC 3.1.4.1) (EC 3.6.1.9) (Phosphodiesterase I beta) (Phosphodiesterase I/nucleotide pyrophosphatase 3),ENPP3,24.057,21.436,21.632,URINE
A0A2I2U6N9_FELCA,bis(5'-adenosyl)-triphosphatase (EC 3.6.1.29) (AP3A hydrolase) (Ectonucleotide pyrophosphatase/phosphodiesterase family member 4),ENPP4,17.645,10.075,10.000,URINE
M3X1B4_FELCA,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,ENPP5,20.288,21.495,21.482,URINE+PLASMA
M3VWW1_FELCA,glycerophosphocholine cholinephosphodiesterase (EC 3.1.4.38) (Choline-specific glycerophosphodiester phosphodiesterase) (Ectonucleotide pyrophosphatase/phosphodiesterase family member 6),ENPP6,23.980,19.861,19.914,URINE
ENV_FLVLB,Envelope glycoprotein (Env polyprotein) [Cleaved into: Surface protein (SU) (Glycoprotein 70) (gp70); Transmembrane protein (TM) (Envelope protein p15E); R-peptide (p2E)],env,20.556,20.575,20.541,URINE+SERUM+PLASMA
A0A0D5ZXZ6_FELCA,Env protein,env,12.561,11.669,10.563,URINE+SERUM
M3WIV4_FELCA,Epithelial cell adhesion molecule (Tumor-associated calcium signal transducer 1),EPCAM,23.303,19.650,20.296,URINE
A0A5F5XZT1_FELCA,receptor protein-tyrosine kinase (EC 2.7.10.1),EPHA1,24.838,20.491,20.536,URINE
A0A2I2UHA0_FELCA,EPH receptor A10,EPHA10,18.308,13.828,12.368,URINE+SERUM
A0A2I2UV62_FELCA,receptor protein-tyrosine kinase (EC 2.7.10.1),EPHA4,21.712,18.393,18.631,URINE
A0A2I2UTP3_FELCA,receptor protein-tyrosine kinase (EC 2.7.10.1),EPHA5,21.008,10.000,10.283,URINE
A0A5F5XNL0_FELCA,receptor protein-tyrosine kinase (EC 2.7.10.1),EPHA7,23.418,20.400,19.679,URINE
M3WPK6_FELCA,receptor protein-tyrosine kinase (EC 2.7.10.1),EPHA7,23.378,13.693,13.778,URINE
A0A337RY03_FELCA,receptor protein-tyrosine kinase (EC 2.7.10.1),EPHB1,18.936,14.499,14.318,URINE
A0A2I2UI65_FELCA,receptor protein-tyrosine kinase (EC 2.7.10.1),EPHB2,23.407,21.491,19.967,URINE+SERUM
A0A5F5Y2L8_FELCA,Ephrin type-B receptor 3 (EC 2.7.10.1),EPHB3,23.757,20.025,19.468,URINE
A0A2I2V293_FELCA,receptor protein-tyrosine kinase (EC 2.7.10.1),EPHB4,24.658,23.568,22.609,URINE
A0A5F5XXF9_FELCA,EPH receptor B6,EPHB6,25.825,21.594,21.457,URINE
M3WSY6_FELCA,Epidermal growth factor receptor pathway substrate 8,EPS8,23.131,21.197,21.648,URINE
M3X4X2_FELCA,EPS8 like 1,EPS8L1,19.040,15.361,17.309,URINE+SERUM
A0A2I2UQW0_FELCA,Aminopeptidase (EC 3.4.11.-),ERAP1,19.950,19.308,19.091,URINE+SERUM+PLASMA
M3WVD3_FELCA,Epiregulin,EREG,18.343,17.391,14.033,URINE+SERUM
M3VV12_FELCA,ER lipid raft associated 1,ERLIN1,23.994,24.077,24.061,URINE+SERUM+PLASMA
A0A5F5XI42_FELCA,Erlin-1 (Endoplasmic reticulum lipid raft-associated protein 1),ERLIN1,16.616,22.127,22.132,URINE+SERUM
M3WMZ2_FELCA,Endoplasmic reticulum protein 44,ERP44,21.532,19.199,19.556,URINE
A0A2I2V4V9_FELCA,Endothelial cell adhesion molecule,ESAM,25.014,20.950,20.137,URINE
M3XAF3_FELCA,S-formylglutathione hydrolase (EC 3.1.2.12),ESD,20.189,16.261,16.809,URINE
A0A2I2UQQ2_FELCA,Eva-1 homolog C,EVA1C,19.675,19.500,19.193,URINE+SERUM+PLASMA
M3XFW7_FELCA,Ribosomal RNA-processing protein 42,EXOSC7,22.136,27.385,27.318,URINE+PLASMA
A0A337S6A6_FELCA,Exostosin like glycosyltransferase 2,EXTL2,18.898,21.813,21.827,URINE+SERUM
A0A337S6P4_FELCA,Exostosin like glycosyltransferase 2,EXTL2,20.008,21.987,21.818,URINE+PLASMA
A0A2I2U6X9_FELCA,Ezrin (Cytovillin) (Villin-2) (p81),EZR,26.195,26.874,26.374,URINE+SERUM+PLASMA
M3WKC7_FELCA,Coagulation factor X (EC 3.4.21.6) (Stuart factor),F10,22.228,26.161,26.109,URINE+PLASMA
JAM1_FELCA,Junctional adhesion molecule A (JAM-A) (Junctional adhesion molecule 1) (JAM-1) (CD antigen CD321),F11R JAM1,28.175,21.032,21.147,URINE
A0A1W7HNZ6_FELCA,Coagulation factor XII (EC 3.4.21.38) (Hageman factor),F12,23.428,25.799,25.839,URINE+SERUM
A0A2I2U5J7_FELCA,Coagulation factor XIII A chain,F13A1,23.350,24.850,23.941,PLASMA
A0A5F5XF87_FELCA,Coagulation factor XIII B chain,F13B,22.981,24.795,24.101,URINE+PLASMA
M3WSI8_FELCA,Prothrombin (EC 3.4.21.5) (Coagulation factor II),F2,29.833,29.143,29.254,URINE+SERUM+PLASMA
M3W050_FELCA,Proteinase-activated receptor 1 (Thrombin receptor),F2R,21.959,17.535,18.006,URINE
A0A337SQW4_FELCA,Coagulation factor V,F5,24.599,24.694,26.678,SERUM
M3W922_FELCA,Coagulation factor V,F5,19.194,19.499,20.533,SERUM
M3WKC6_FELCA,Coagulation factor VII (EC 3.4.21.21) (Serum prothrombin conversion accelerator),F7,20.259,22.328,22.294,URINE+PLASMA
A0A5F5XH53_FELCA,Coagulation factor VIII,F8,22.393,21.005,20.786,URINE
FA9_FELCA,Coagulation factor IX (EC 3.4.21.22) (Christmas factor) [Cleaved into: Coagulation factor IXa light chain; Coagulation factor IXa heavy chain],F9,23.371,25.235,24.870,URINE+PLASMA
M3WR74_FELCA,"Fatty acid-binding protein, liver (L-FABP) (Liver-type fatty acid-binding protein)",FABP1,19.527,18.141,18.224,URINE
A0A5F5XG15_FELCA,Fatty acid binding protein 2,FABP2,23.934,17.938,18.481,URINE
M3WQY4_FELCA,"Fatty acid-binding protein, intestinal (Fatty acid-binding protein 2) (Intestinal-type fatty acid-binding protein)",FABP2,18.855,16.759,16.269,URINE
M3X9Z0_FELCA,"Fatty acid-binding protein, heart (Fatty acid-binding protein 3) (Heart-type fatty acid-binding protein)",FABP3,24.077,21.301,20.644,URINE
A0A5F5XIT1_FELCA,Fatty acid binding protein 5,FABP5,17.859,14.518,14.218,URINE
A0A5F5XFP7_FELCA,Fumarylacetoacetase (EC 3.7.1.2) (Beta-diketonase) (Fumarylacetoacetate hydrolase),FAH,22.297,19.723,20.692,URINE
M3W1C3_FELCA,Protein FAM151A,FAM151A,25.684,23.130,21.504,URINE+SERUM
A0A337RY82_FELCA,Family with sequence similarity 174 member B,FAM174B,18.283,15.090,14.499,URINE
A0A337RZ83_FELCA,FAM20C golgi associated secretory pathway kinase,FAM20C,21.139,20.779,20.948,URINE+SERUM+PLASMA
A0A5F5XGS1_FELCA,Family with sequence similarity 234 member A,FAM234A,20.444,17.357,17.832,URINE
A0A5F5Y0R2_FELCA,Family with sequence similarity 234 member A,FAM234A,18.853,12.478,13.432,URINE
A0A337S9Y1_FELCA,FAM3 metabolism regulating signaling molecule B,FAM3B,22.029,16.551,17.027,URINE
A0A2I2UZV7_FELCA,Protein FAM3C,FAM3C,22.703,21.569,20.242,URINE+SERUM
A0A2I2U2C0_FELCA,Tumor necrosis factor receptor superfamily member 6 (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor),FAS,19.555,18.439,18.350,URINE
M3WFK0_FELCA,Fatty acid synthase (EC 1.1.1.100) (EC 1.3.1.39) (EC 2.3.1.38) (EC 2.3.1.39) (EC 2.3.1.41) (EC 2.3.1.85) (EC 3.1.2.14) (EC 4.2.1.59),FASN,25.326,23.474,23.350,URINE
A0A2I2UCL3_FELCA,FAT atypical cadherin 4,FAT4,22.631,21.666,21.768,URINE+SERUM+PLASMA
A0A337SRF9_FELCA,Fibulin-1,FBLN1,27.288,24.083,23.911,URINE
M3WZ15_FELCA,Fibulin-1,FBLN1,23.171,23.854,22.922,URINE+SERUM+PLASMA
A0A2I2UFJ4_FELCA,Fibulin 2,FBLN2,24.717,20.402,20.498,URINE
A0A337S164_FELCA,Fibulin-5,FBLN5,27.481,23.271,22.875,URINE
A0A337SXC1_FELCA,Fibulin 7,FBLN7,23.864,15.995,15.161,URINE
A0A337S7Y7_FELCA,Fibulin 7,FBLN7,27.006,21.037,21.771,URINE
M3WMG2_FELCA,Fibrillin 1,FBN1,27.464,23.191,23.400,URINE
M3WB78_FELCA,"Fructose-1,6-bisphosphatase 1 (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 1) (Liver FBPase)",FBP1,24.470,22.028,22.382,URINE
M3VXP7_FELCA,"Fructose-1,6-bisphosphatase isozyme 2 (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 2) (Muscle FBPase)",FBP2,18.971,17.192,17.578,URINE
A0A5F5Y0F7_FELCA,Fc epsilon receptor II,FCER2,24.351,26.025,24.917,PLASMA
A0A2I2UDZ7_FELCA,VWFD domain-containing protein,FCGBP,22.341,21.899,19.196,URINE+SERUM
A0A5F5Y6R9_FELCA,Fc gamma receptor Ia,FCGR1A,16.372,14.310,13.203,URINE+SERUM
FCG3A_FELCA,Low affinity immunoglobulin gamma Fc region receptor III-A (IgG Fc receptor III-A) (Fc-gamma RIII-alpha) (FcgammaRIIIA) (CD antigen CD16a),FCGR3A CD16,23.760,20.895,22.083,URINE+SERUM
A0A337S1R1_FELCA,Fc mu receptor,FCMR,17.193,19.202,18.987,URINE+PLASMA
M3X177_FELCA,Fem-1 homolog A,FEM1A,13.341,17.038,16.907,URINE+PLASMA
A0A5F5XXG1_FELCA,Fer-1 like family member 6,FER1L6,17.466,13.742,15.024,URINE+SERUM
A0A337RZH0_FELCA,Fetuin B,FETUB,24.248,26.372,26.302,URINE+PLASMA
FIBA_FELCA,Fibrinogen alpha chain [Cleaved into: Fibrinopeptide A],FGA,16.586,25.513,16.703,PLASMA
M3W022_FELCA,Fibrinogen alpha chain,FGA,27.225,32.004,25.021,URINE+PLASMA
FIBB_FELCA,Fibrinogen beta chain [Cleaved into: Fibrinopeptide B],FGB,23.160,25.765,19.537,URINE+PLASMA
M3WII3_FELCA,Fibrinogen beta chain,FGB,24.647,31.947,24.413,PLASMA
A0A5F5XVE3_FELCA,"FYVE, RhoGEF and PH domain containing 3",FGD3,23.732,23.737,23.847,URINE+SERUM+PLASMA
A0A2I2UK29_FELCA,Fibroblast growth factor receptor (EC 2.7.10.1),FGFR1,25.273,21.894,21.981,URINE
A0A337S7G1_FELCA,Fibroblast growth factor receptor (EC 2.7.10.1),FGFR3,20.980,17.249,17.121,URINE
A0A5F5XGZ0_FELCA,Fibrinogen gamma chain,FGG,24.191,31.224,22.953,URINE+PLASMA
A0A5F5XLT1_FELCA,Fibrinogen gamma chain,FGG,12.078,20.393,10.388,URINE+PLASMA
A0A516V1E7_FELCA,MHC class I antigen,FLA-E,14.997,11.903,10.954,URINE
A0A516V1E1_FELCA,MHC class I antigen,FLA-E,16.124,15.616,16.910,SERUM
A0A516V164_FELCA,MHC class I antigen,FLAI-E,22.793,20.009,19.714,URINE
S4Z3G3_FELCA,MHC class I antigen,FLAI-E,12.637,14.923,15.375,URINE+SERUM
A0A516V168_FELCA,MHC class I antigen,FLAI-H,21.892,20.990,20.761,URINE
A0A516V172_FELCA,MHC class I antigen,FLAI-H,15.423,13.830,12.795,URINE+SERUM
A0A516V166_FELCA,MHC class I antigen,FLAI-H,21.527,19.194,18.935,URINE
A0A516V181_FELCA,MHC class I antigen,FLAI-H,14.594,14.107,13.055,URINE+SERUM
A0A516V177_FELCA,MHC class I antigen,FLAI-H,14.594,14.107,13.055,URINE+SERUM
A0A516V1A6_FELCA,MHC class I antigen,FLAI-K,17.771,17.949,17.355,URINE+SERUM+PLASMA
A0A337SDQ4_FELCA,"Saoe class I histocompatibility antigen, A alpha chain-like",FLAI-K,19.950,14.134,14.241,URINE
A0A2I2V3V8_FELCA,Filamin A,FLNA,26.092,22.884,22.503,URINE
A0A2I2US09_FELCA,Filamin B,FLNB,25.783,21.149,21.339,URINE
A0A2I2UDN6_FELCA,Filamin C,FLNC,24.758,20.255,19.796,URINE
M3X0B9_FELCA,Fibronectin leucine rich transmembrane protein 2,FLRT2,18.861,16.228,16.048,URINE
A0A2I2UES4_FELCA,Vascular endothelial growth factor receptor 3 (EC 2.7.10.1),FLT4,18.183,20.117,19.972,URINE+PLASMA
A0A2I2U011_FELCA,Fibronectin,FN1,29.501,28.030,27.450,URINE
A0A2I2UAM2_FELCA,Fibronectin,FN1,18.497,21.088,20.388,URINE+PLASMA
A0A5F5XFC0_FELCA,Fibronectin type III domain containing 1,FNDC1,16.406,14.839,17.309,URINE+SERUM
A0A337SB41_FELCA,Folate hydrolase 1,FOLH1,19.065,16.861,16.475,URINE
M3WR11_FELCA,Folate receptor alpha,FOLR1,26.412,19.963,20.208,URINE
M3XEV8_FELCA,Ferric chelate reductase 1,FRRS1,21.764,20.473,20.826,URINE
A0A2I2V2F6_FELCA,Secreted frizzled-related protein 3 (Frizzled-related protein 1) (FrzB-1),FRZB,22.512,18.829,18.650,URINE
M3WL17_FELCA,Follitropin subunit beta (Follicle-stimulating hormone beta subunit) (Follitropin beta chain),FSHB,23.846,26.853,26.826,URINE+PLASMA
A0A337S130_FELCA,Follistatin-related protein 1 (Follistatin-like protein 1),FSTL1,25.597,20.984,20.906,URINE
A0A2I2U6V1_FELCA,Follistatin like 3,FSTL3,20.319,17.949,18.162,URINE
FRIL_FELCA,Ferritin light chain (Ferritin L subunit),FTL,21.888,21.159,20.854,URINE
A0A060PNW6_FELCA,Thrombomodulin,fTM,23.356,17.831,18.273,URINE
A0A337S4I1_FELCA,Alpha-L-fucosidase 1,FUCA1,23.827,19.621,20.195,URINE
M3W912_FELCA,Alpha-L-fucosidase (EC 3.2.1.51),FUCA2,20.071,12.878,13.128,URINE
A0A5F5XT00_FELCA,alpha-L-fucosidase (EC 3.2.1.51),FUCA2,21.576,21.902,22.639,SERUM
A0A5F5XZJ7_FELCA,furin (EC 3.4.21.75) (Dibasic-processing enzyme) (Paired basic amino acid residue-cleaving enzyme),FURIN,23.869,23.504,23.964,URINE+SERUM+PLASMA
M3X4M3_FELCA,Frizzled-1,FZD1,20.848,21.540,19.632,URINE+PLASMA
M3X1P3_FELCA,Frizzled-2,FZD2,14.460,15.786,15.394,PLASMA
A0A2I2UH80_FELCA,Frizzled-4,FZD4,22.242,17.134,19.013,URINE+SERUM
M3W3B8_FELCA,Frizzled-6,FZD6,22.888,16.177,15.918,URINE
A0A2I2U7V2_FELCA,Frizzled class receptor 7,FZD7,23.737,18.486,19.432,URINE
A0A5F5XKV2_FELCA,Frizzled class receptor 8,FZD8,21.506,15.984,15.780,URINE
A0A5F5XIY0_FELCA,Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase),GAA,27.245,22.806,23.390,URINE
A0A5F5XGF8_FELCA,Gamma-aminobutyric acid type B receptor subunit 1,GABBR1,18.727,24.397,24.526,URINE+SERUM
A0A2I2U122_FELCA,Galactose-3-O-sulfotransferase 1,GAL3ST1,24.294,24.680,25.286,URINE+SERUM+PLASMA
M3X9U2_FELCA,Galactose-3-O-sulfotransferase 4,GAL3ST4,19.139,13.318,12.642,URINE
A0A2I2UQ95_FELCA,Galactocerebrosidase (EC 3.2.1.46) (Galactosylceramidase),GALC,20.244,16.119,16.908,URINE
A0A5F5Y4N4_FELCA,Galactosamine (N-acetyl)-6-sulfatase,GALNS,21.882,18.781,17.644,URINE+SERUM
A0A5F5XTD3_FELCA,Galactosamine (N-acetyl)-6-sulfatase,GALNS,24.433,22.161,22.145,URINE
A0A5F5Y2N0_FELCA,Polypeptide N-acetylgalactosaminyltransferase (EC 2.4.1.-) (Protein-UDP acetylgalactosaminyltransferase),GALNT18,22.344,23.320,22.939,URINE+SERUM+PLASMA
A0A2I2UA27_FELCA,Glucosidase II alpha subunit,GANAB,21.447,20.665,20.579,URINE+SERUM+PLASMA
G3P_FELCA,Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12) (Peptidyl-cysteine S-nitrosylase GAPDH) (EC 2.6.99.-),GAPDH GAPD,24.351,19.976,21.094,URINE+SERUM
A0A5F5XUR6_FELCA,Growth arrest specific 1,GAS1,25.474,16.894,16.709,URINE
A0A5F5XGA1_FELCA,Growth arrest specific 6,GAS6,26.494,22.086,21.495,URINE
A0A5F5XDS7_FELCA,Golgi associated kinase 1A,GASK1A,16.915,18.029,18.414,URINE+SERUM
M3VVL7_FELCA,Glucosylceramidase (EC 3.2.1.45),GBA1,19.489,20.284,19.633,URINE+SERUM+PLASMA
A0A337SNL3_FELCA,Glucosylceramidase (EC 3.2.1.45),GBA1,21.705,20.109,21.372,URINE+SERUM
A0A2I2UCJ0_FELCA,Glucosylceramidase beta 3,GBA3,21.559,18.495,18.326,URINE
M3W2Z1_FELCA,Vitamin D-binding protein (Gc-globulin) (Group-specific component),GC,27.537,32.145,32.050,URINE+PLASMA
A0A2I2U4I8_FELCA,Growth differentiation factor 10,GDF10,17.883,19.573,19.567,URINE+PLASMA
A0A337S915_FELCA,Rab GDP dissociation inhibitor,GDI2,23.473,21.797,22.118,URINE
M3WHB4_FELCA,Rab GDP dissociation inhibitor,GDI2,20.387,19.721,19.421,URINE+SERUM+PLASMA
A0A337SH50_FELCA,Glycerophosphodiester phosphodiesterase domain containing 2,GDPD2,20.997,18.415,19.012,URINE
A0A5F5XDL4_FELCA,Glycerophosphodiester phosphodiesterase domain containing 3,GDPD3,19.326,17.589,17.451,URINE
A0A2I2UI95_FELCA,Glial fibrillary acidic protein,GFAP,20.766,19.547,19.585,URINE
A0A337SD81_FELCA,GDNF family receptor alpha 1,GFRA1,21.061,17.498,17.525,URINE
A0A2I2UFV4_FELCA,GDNF family receptor alpha-2 (GDNF receptor alpha-2),GFRA2,22.843,21.768,22.328,URINE
M3WQ38_FELCA,Gamma-glutamylaminecyclotransferase (EC 4.3.2.8),GGACT,24.473,19.541,19.519,URINE
A0A5F5XWZ9_FELCA,folate gamma-glutamyl hydrolase (EC 3.4.19.9),GGH,23.810,20.200,20.268,URINE
M3VWS9_FELCA,Glutathione hydrolase (EC 2.3.2.2) (EC 3.4.19.13) (Gamma-glutamyltransferase) (Gamma-glutamyltranspeptidase),GGT1,25.880,23.574,25.257,URINE+SERUM
A0A2I2UZ31_FELCA,Gamma-glutamyltransferase 6,GGT6,17.969,16.726,17.023,URINE
M3WEU6_FELCA,Glycosylated integral membrane protein 1,GINM1,21.889,20.291,20.679,URINE
A0A2I2UF05_FELCA,GIPC PDZ domain containing family member 2,GIPC2,15.333,13.150,12.978,URINE
M3W803_FELCA,Gastrokine 1,GKN1,14.641,16.920,17.205,URINE+SERUM
A0A2I2U1V5_FELCA,Alpha-galactosidase (EC 3.2.1.-),GLA,26.196,21.976,22.496,URINE
BGAL_FELCA,Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase),GLB1 BGAL,25.206,22.461,21.141,URINE+SERUM
A0A2I2URA0_FELCA,Golgi apparatus protein 1,GLG1,24.742,22.356,22.639,URINE
A0A2I2U855_FELCA,GLI pathogenesis related 2,GLIPR2,17.024,19.320,19.654,URINE+SERUM
A0A5F5XL86_FELCA,Lactoylglutathione lyase (EC 4.4.1.5) (Glyoxalase I),GLO1,19.546,19.424,18.239,URINE+SERUM
M3X3M9_FELCA,Glutaredoxin-1,GLRX,19.490,19.398,18.534,URINE+SERUM+PLASMA
M3WHT1_FELCA,Ganglioside GM2 activator,GM2A,29.099,21.244,21.581,URINE
A0A337S5X4_FELCA,Guanine nucleotide-binding protein subunit alpha-11,GNA11,20.550,15.806,16.032,URINE
A0A2I2UZP1_FELCA,G protein subunit alpha 13,GNA13,22.567,17.672,17.402,URINE
A0A2I2U673_FELCA,Guanine nucleotide-binding protein G(i) subunit alpha-3 (G(i) alpha-3),GNAI3,23.597,22.297,23.299,URINE+SERUM
A0A2I2U651_FELCA,Guanine nucleotide-binding protein G(o) subunit alpha,GNAO1,19.197,15.577,15.690,URINE
A0A2I2U1S9_FELCA,G protein subunit alpha transducin 3,GNAT3,22.567,17.672,17.402,URINE
M3WU86_FELCA,Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 (Transducin beta chain 1),GNB1,22.741,20.003,19.564,URINE
M3X5T9_FELCA,G protein subunit beta 2,GNB2,20.700,19.111,19.256,URINE
A0A2I2U2P0_FELCA,G protein subunit beta 4,GNB4,22.330,18.371,19.535,URINE+SERUM
A0A2I2UXE2_FELCA,Guanine nucleotide-binding protein subunit gamma,GNG12,20.456,19.918,21.721,SERUM
A0A5F5XZA0_FELCA,N-acetylglucosamine-1-phosphate transferase subunit gamma,GNPTG,21.007,20.287,19.849,URINE
M3VUR6_FELCA,N-acetylglucosamine-6-sulfatase (EC 3.1.6.14) (Glucosamine-6-sulfatase),GNS,27.550,20.978,21.252,URINE
A0A5F5XP94_FELCA,Golgi membrane protein 1,GOLM1,25.532,29.209,29.470,URINE+SERUM
M3WCA0_FELCA,Golgi membrane protein 1,GOLM1,22.158,18.699,18.924,URINE
A0A5F5XGH7_FELCA,Aspartate aminotransferase (EC 2.6.1.1),GOT1,23.436,24.939,25.533,URINE+SERUM
A0A5F5XIK0_FELCA,Glycoprotein Ib platelet subunit alpha,GP1BA,26.069,22.986,23.370,URINE
A0A5F5XJV1_FELCA,Glycoprotein 2,GP2,19.426,17.783,18.175,URINE
A0A2I2U027_FELCA,Glycoprotein V platelet,GP5,22.245,21.430,21.101,URINE
M3WSF8_FELCA,Immunoglobulin subtype domain-containing protein,GP6,21.580,18.853,17.240,URINE+SERUM
A0A2I2U6L5_FELCA,Glypican-1,GPC1,24.468,20.514,21.718,URINE+SERUM
A0A337S4V2_FELCA,Glypican-3,GPC3,18.211,17.348,17.401,URINE+SERUM+PLASMA
A0A5F5XH67_FELCA,Glypican 4,GPC4,23.177,19.803,19.578,URINE
M3WBH7_FELCA,Glycerol-3-phosphate dehydrogenase [NAD(+)] (EC 1.1.1.8),GPD1,23.019,20.678,20.594,URINE
A0A337S9I7_FELCA,Glucose-6-phosphate isomerase (EC 5.3.1.9),GPI,21.243,18.686,18.521,URINE
A0A337ST09_FELCA,Glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1,GPIHBP1,19.314,19.388,19.527,URINE+SERUM+PLASMA
A0A5F5XQW6_FELCA,Phosphatidylinositol-glycan-specific phospholipase D (EC 3.1.4.50) (Glycosyl-phosphatidylinositol-specific phospholipase D),GPLD1,24.099,26.582,27.004,URINE+SERUM
A0A5F5XTB2_FELCA,Phosphatidylinositol-glycan-specific phospholipase D (EC 3.1.4.50) (Glycosyl-phosphatidylinositol-specific phospholipase D),GPLD1,21.891,24.961,25.181,URINE+SERUM
A0A337S764_FELCA,Neuronal membrane glycoprotein M6-a,GPM6A,20.995,21.269,21.047,URINE+SERUM+PLASMA
A0A2I2UBJ4_FELCA,Glycoprotein M6B,GPM6B,16.599,16.260,15.882,URINE+SERUM+PLASMA
A0A5F5XQN9_FELCA,G protein-coupled receptor 108,GPR108,21.873,25.992,26.134,URINE+SERUM
M3WUB8_FELCA,G protein-coupled receptor 180,GPR180,21.010,19.534,19.477,URINE
A0A2I2UTY3_FELCA,G protein-coupled receptor 37,GPR37,18.987,15.699,14.618,URINE+SERUM
A0A2I2UB41_FELCA,G protein-coupled receptor class C group 5 member B,GPRC5B,20.296,17.485,17.601,URINE
A0A2I2UI30_FELCA,G protein-coupled receptor class C group 5 member C,GPRC5C,26.102,19.681,20.032,URINE
A0A2I2UII4_FELCA,Glutathione peroxidase,GPX1,19.352,18.040,19.464,URINE+SERUM
A0A2I2V5E5_FELCA,Glutathione peroxidase,GPX3,21.971,28.334,28.141,URINE+PLASMA
A0A5F5XWC4_FELCA,Glutamate receptor,GRIA4,23.068,23.151,23.226,URINE+SERUM+PLASMA
A0A5F5XTI2_FELCA,Granulin,GRN,22.228,18.279,18.220,URINE
A0A2I2V346_FELCA,Granulin,GRN,23.912,19.308,19.901,URINE
A0A2I2UTS2_FELCA,Gelsolin (ADF) (Actin-depolymerizing factor),GSN,26.814,28.051,28.559,URINE+SERUM
A0A337SJ23_FELCA,Glutathione synthetase (GSH-S) (EC 6.3.2.3),GSS,19.376,16.593,17.380,URINE
A0A337SLL9_FELCA,Glutathione S-transferase omega (GSTO) (EC 1.20.4.2) (EC 1.8.5.1) (EC 2.5.1.18) (Glutathione-dependent dehydroascorbate reductase) (Monomethylarsonic acid reductase),GSTO1,20.204,17.447,18.018,URINE
A0A2I2U8R6_FELCA,glutathione transferase (EC 2.5.1.18) (GST class-pi),GSTP1,22.360,17.631,18.824,URINE+SERUM
A0A2I2UUQ5_FELCA,maleylacetoacetate isomerase (EC 5.2.1.2),GSTZ1,24.055,24.569,24.611,URINE+SERUM+PLASMA
M3W5G2_FELCA,Guanylin (Guanylate cyclase activator 2A),GUCA2A,21.903,19.535,19.812,URINE
A0A5F5XR95_FELCA,Guanylate cyclase activator 2B,GUCA2B,16.963,12.402,11.801,URINE
M3W5G1_FELCA,Guanylate cyclase activator 2B,GUCA2B,18.994,15.167,15.946,URINE
BGLR_FELCA,Beta-glucuronidase (EC 3.2.1.31),GUSB,26.512,20.985,20.897,URINE
A0A5F5XKM9_FELCA,"H1.4 linker histone, cluster member",H1-4,22.916,18.898,18.799,URINE
A0A337S2X4_FELCA,Histone H2A,H2AC14,16.786,16.386,16.340,URINE+SERUM+PLASMA
A0A2I2U2D3_FELCA,Histone H2A,H2AZ1,23.371,18.629,20.106,URINE+SERUM
A0A2I2USF3_FELCA,Histone H2B,H2BC17,20.901,18.442,18.142,URINE
A0A2I2UIG2_FELCA,Histone H3,H3C5,23.421,25.153,23.212,PLASMA
M3WSM7_FELCA,Histone H4,H4C4 H4C1 H4C11 H4C12 H4C13 H4C14 H4C19 H4C2 H4C3 H4C6 H4C8 H4C9 LOC123385657,22.658,18.287,18.482,URINE
A0A2I2UIZ2_FELCA,Hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase,H6PD,23.471,24.641,24.734,URINE+SERUM
M3VUF1_FELCA,"3-hydroxyanthranilate 3,4-dioxygenase (EC 1.13.11.6) (3-hydroxyanthranilate oxygenase) (3-HAO) (3-hydroxyanthranilic acid dioxygenase) (HAD)",HAAO,29.311,23.987,23.512,URINE
A0A5F5Y062_FELCA,Hyaluronan binding protein 2,HABP2,21.517,25.248,25.292,URINE+SERUM
M3WFU5_FELCA,Hyaluronan binding protein 2,HABP2,16.934,22.431,22.309,URINE+PLASMA
A0A2I2U3V1_FELCA,3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.35),HADH,21.109,20.790,20.906,URINE+SERUM+PLASMA
A0A2I2UQN2_FELCA,"Hydroxyacylglutathione hydrolase, mitochondrial (EC 3.1.2.6) (Glyoxalase II)",HAGH,18.080,17.256,17.599,URINE+SERUM+PLASMA
A0A2I2UFL9_FELCA,Hepcidin antimicrobial peptide,HAMP,24.756,11.151,11.100,URINE
A0A024A8A5_FELCA,Hepatitis A virus cellular receptor 1 variant A,HAVCR1,22.251,22.824,22.401,URINE+SERUM+PLASMA
HBA_FELCA,Hemoglobin subunit alpha (Alpha-globin) (Hemoglobin alpha chain) [Cleaved into: Hemopressin],HBA,24.547,29.043,30.460,URINE+SERUM
HBB_FELCA,Hemoglobin subunit beta-A/B (Beta-A/B-globin) (Hemoglobin beta-A/B chain),HBB,25.860,30.393,31.864,URINE+SERUM
A0A2I2U9B2_FELCA,Tyrosine-protein kinase (EC 2.7.10.2),HCK,19.559,16.607,16.585,URINE
M3W3P5_FELCA,Hyperpolarization activated cyclic nucleotide gated potassium channel 4,HCN4,25.843,16.239,15.996,URINE
A0A337S0K9_FELCA,E3 ubiquitin-protein ligase (EC 2.3.2.26),HECTD1,16.000,21.775,13.107,URINE+PLASMA
M3WLX7_FELCA,Heart development protein with EGF like domains 1,HEG1,25.773,20.570,20.938,URINE
G4XSV9_FELCA,Beta-hexosaminidase (EC 3.2.1.52),HEXA,26.038,20.637,20.359,URINE
HEXB_FELCA,Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (N-acetyl-beta-glucosaminidase subunit beta),HEXB,25.336,24.151,24.281,URINE
M3WHB2_FELCA,HGF activator,HGFAC,24.018,26.711,26.563,URINE+PLASMA
A0A337SUG1_FELCA,Hemojuvelin BMP co-receptor,HJV,21.720,18.776,19.460,URINE
M3X1M2_FELCA,Hemicentin 1,HMCN1,25.794,19.718,19.768,URINE
M3X7U8_FELCA,Hemicentin 2,HMCN2,25.577,21.425,21.448,URINE
A0A2I2UVJ9_FELCA,Heterogeneous nuclear ribonucleoproteins A2/B1,HNRNPA2B1,16.705,12.635,11.037,URINE+SERUM
A0A2I2UI32_FELCA,Heterogeneous nuclear ribonucleoprotein K,HNRNPK,17.351,16.115,16.221,URINE
A0A5F5XGD0_FELCA,Haptoglobin,HP,30.500,32.222,32.426,URINE+SERUM
A0A5F5XBX6_FELCA,4-hydroxyphenylpyruvate dioxygenase,HPD,22.088,22.787,22.607,URINE+SERUM+PLASMA
A0A5F5Y3T3_FELCA,4-hydroxyphenylpyruvate dioxygenase,HPD,19.657,17.168,16.941,URINE
A0A2I2UDC4_FELCA,Hepsin,HPN,22.671,18.943,18.842,URINE
M3WJM9_FELCA,Histidine-rich glycoprotein (Histidine-proline-rich glycoprotein),HRG,24.479,26.332,26.335,URINE+SERUM
A0A337S6T1_FELCA,Heat shock protein HSP 90-alpha,HSP90AA1,19.596,19.784,20.232,URINE+SERUM+PLASMA
A0A2I2U7X4_FELCA,Heat shock protein HSP 90-beta,HSP90AB1,23.272,21.445,21.002,URINE
A0A5F5XWD4_FELCA,Endoplasmin (94 kDa glucose-regulated protein) (Heat shock protein 90 kDa beta member 1),HSP90B1,19.162,16.104,16.575,URINE
M3X6Z7_FELCA,Heat shock 70 kDa protein 13 (Stress-70 protein chaperone microsome-associated 60 kDa protein),HSPA13,22.851,20.486,21.072,URINE
M3WFT4_FELCA,78 kDa glucose-regulated protein (Binding-immunoglobulin protein) (Heat shock protein 70 family protein 5) (Heat shock protein family A member 5) (Immunoglobulin heavy chain-binding protein),HSPA5,24.096,22.145,22.191,URINE
A0A2I2UZM2_FELCA,Heat shock cognate 71 kDa protein (Heat shock 70 kDa protein 8),HSPA8,25.195,22.492,22.416,URINE
A0A5F5XK17_FELCA,Heat shock protein family B (small) member 1,HSPB1,21.409,17.002,16.610,URINE
M3WXZ4_FELCA,"60 kDa heat shock protein, mitochondrial (EC 5.6.1.7) (60 kDa chaperonin) (Chaperonin 60) (Heat shock protein 60)",HSPD1,19.571,17.167,18.454,URINE+SERUM
A0A337SEI8_FELCA,"10 kDa heat shock protein, mitochondrial (10 kDa chaperonin) (Chaperonin 10)",HSPE1,20.203,17.694,17.046,URINE
A0A5F5Y6R8_FELCA,Heparan sulfate proteoglycan 2,HSPG2,30.062,24.467,24.754,URINE
M3W0Q9_FELCA,HtrA serine peptidase 1,HTRA1,22.515,17.193,17.994,URINE
M3WMB7_FELCA,HtrA serine peptidase 3,HTRA3,19.415,18.792,19.584,URINE+SERUM+PLASMA
M3VYS9_FELCA,HtrA serine peptidase 4,HTRA4,20.534,14.091,13.685,URINE
A0A337SAA4_FELCA,Hyaluronidase (EC 3.2.1.35),HYAL2,21.596,19.697,19.639,URINE
A0A5F5XBM7_FELCA,Putative hydroxypyruvate isomerase (EC 5.3.1.22),HYI,22.662,21.017,21.056,URINE
A0A337SRM7_FELCA,Intercellular adhesion molecule 1,ICAM1,22.072,22.168,22.240,URINE+SERUM+PLASMA
M3WBF1_FELCA,Intercellular adhesion molecule 1,ICAM1,23.324,22.409,22.440,URINE+SERUM+PLASMA
A0A337SJL0_FELCA,Intercellular adhesion molecule 2,ICAM2,24.082,20.628,20.648,URINE
A0A337SQM4_FELCA,Inducible T cell costimulator ligand,ICOSLG,23.890,20.485,21.013,URINE
M3W1B8_FELCA,Isocitrate dehydrogenase [NADP] (EC 1.1.1.42),IDH1,20.604,18.665,19.331,URINE
A0A337SJX9_FELCA,Iduronate 2-sulfatase,IDS,20.640,15.504,15.757,URINE
A0A097HWG4_FELCA,Alpha-L-iduronidase (EC 3.2.1.76),IDUA,21.309,18.346,18.449,URINE
M3WSA1_FELCA,Gamma-interferon-inducible lysosomal thiol reductase (EC 1.8.-.-) (Gamma-interferon-inducible protein IP-30),IFI30,27.106,20.335,20.166,URINE
A0A2I2UFF7_FELCA,Interferon alpha inducible protein 6,IFI6,18.201,16.093,15.651,URINE
M3XFG7_FELCA,Interferon alpha/beta receptor 1 (IFN-R-1) (IFN-alpha/beta receptor 1) (Type I interferon receptor 1),IFNAR1,18.773,17.025,17.431,URINE
A0A2I2UIQ7_FELCA,Insulin-like growth factor I (Somatomedin),IGF1,17.108,22.920,22.595,URINE+PLASMA
A0A2I2UMR3_FELCA,Insulin-like growth factor II,IGF2,19.910,23.984,23.566,URINE+PLASMA
A0A5F5XQ21_FELCA,Insulin like growth factor 2 receptor,IGF2R,24.512,23.909,23.968,URINE+SERUM+PLASMA
M3VZ93_FELCA,Insulin like growth factor 2 receptor,IGF2R,20.341,18.701,18.572,URINE
A0A337SDJ8_FELCA,Insulin like growth factor binding protein acid labile subunit,IGFALS,24.253,26.782,26.909,URINE+SERUM
M3W4L2_FELCA,Insulin-like growth factor-binding protein 1,IGFBP1,26.365,20.803,20.734,URINE
A0A2I2UEZ6_FELCA,Insulin-like growth factor-binding protein 2,IGFBP2,26.923,24.004,23.852,URINE
A0A2I2USR5_FELCA,Insulin-like growth factor-binding protein 3,IGFBP3,24.856,26.893,26.827,URINE+PLASMA
A0A337RVY2_FELCA,Insulin-like growth factor-binding protein 4,IGFBP4,19.602,21.211,21.051,URINE+PLASMA
A0A2I2UF06_FELCA,Insulin-like growth factor-binding protein 5,IGFBP5,18.004,20.038,19.837,URINE+PLASMA
M3VUH9_FELCA,Insulin like growth factor binding protein 6,IGFBP6,18.935,20.263,20.189,URINE+PLASMA
A0A2I2U3H1_FELCA,Insulin like growth factor binding protein 7,IGFBP7,29.662,21.811,21.939,URINE
A0A337SLQ6_FELCA,IGF like family receptor 1,IGFLR1,20.517,17.319,17.429,URINE
A0A2I2UAS8_FELCA,IgLON family member 5,IGLON5,24.258,18.740,18.643,URINE
A0A2I2UBK6_FELCA,Immunoglobulin superfamily member 5,IGSF5,20.003,18.382,17.434,URINE
A0A2I2U7U8_FELCA,Immunoglobulin superfamily member 8,IGSF8,26.153,22.286,22.681,URINE
A0A2I2UF36_FELCA,Interleukin 18 binding protein,IL18BP,25.877,18.710,18.682,URINE
A0A2I2UA72_FELCA,Interleukin 1 receptor accessory protein,IL1RAP,26.416,25.901,26.019,URINE+SERUM+PLASMA
A0A337SPR9_FELCA,Interleukin-1,IL1RN,18.110,13.433,13.660,URINE
IL2RA_FELCA,Interleukin-2 receptor subunit alpha (IL-2 receptor subunit alpha) (IL-2-RA) (IL-2R subunit alpha) (IL2-RA) (CD antigen CD25),IL2RA,21.902,17.853,17.577,URINE
A0A2I2U0A6_FELCA,Interleukin-1,IL36RN,18.994,15.416,13.840,URINE+SERUM
A0A337S2C8_FELCA,Interleukin-4 receptor subunit alpha,IL4R,20.576,13.625,13.905,URINE
M3X8X7_FELCA,Interleukin 6 receptor,IL6R,21.261,18.420,19.331,URINE
A0A337S1N7_FELCA,Interleukin 6 cytokine family signal transducer,IL6ST,23.502,23.145,23.327,URINE+SERUM+PLASMA
A0A5F5XF39_FELCA,Interleukin 6 cytokine family signal transducer,IL6ST,19.185,17.101,16.655,URINE
A0A337S505_FELCA,Interleukin 6 cytokine family signal transducer,IL6ST,20.157,18.160,18.315,URINE
M3VZN9_FELCA,Interleukin 9 receptor,IL9R,16.016,10.000,10.155,URINE
M3W832_FELCA,Integrator complex subunit 1,INTS1,20.549,22.374,22.449,URINE+SERUM
M3XDA8_FELCA,Integrator complex subunit 4,INTS4,17.369,18.168,18.532,SERUM
A0A337SRV8_FELCA,Interferon regulatory factor 2 binding protein like,IRF2BPL,16.625,10.577,10.759,URINE
M3X315_FELCA,Immunoglobulin superfamily containing leucine rich repeat,ISLR,26.610,22.149,22.196,URINE
A0A5F5XEF9_FELCA,Isthmin 1,ISM1,17.875,12.704,11.421,URINE+SERUM
A0A2I2UAK7_FELCA,IST1 homolog (Charged multivesicular body protein 8),IST1,25.048,21.801,23.277,URINE+SERUM
A0A5F5Y493_FELCA,Integrin alpha FG-GAP repeat containing 1,ITFG1,23.621,23.429,22.503,URINE
A0A2I2USG0_FELCA,Integrin subunit alpha 3,ITGA3,17.358,14.328,15.072,URINE
A0A2I2UVP7_FELCA,Integrin subunit alpha 6,ITGA6,17.847,16.397,16.849,URINE
A0A5F5Y6V1_FELCA,VWFA domain-containing protein,ITGAX,20.108,16.729,16.926,URINE
ITB1_FELCA,Integrin beta-1 (Fibronectin receptor subunit beta) (VLA-4 subunit beta) (CD antigen CD29),ITGB1,22.538,18.733,19.630,URINE
A0A222NT34_FELCA,Integrin beta,ITGB2,19.388,15.760,13.578,URINE+SERUM
M3WN59_FELCA,Inter-alpha-trypsin inhibitor heavy chain H1,ITIH1,25.573,27.880,28.001,URINE+SERUM
A0A337SQW0_FELCA,Inter-alpha-trypsin inhibitor heavy chain 2,ITIH2,25.124,28.733,28.872,URINE+SERUM
A0A337SL30_FELCA,Inter-alpha-trypsin inhibitor heavy chain 3,ITIH3,20.070,25.737,25.751,URINE+SERUM
A0A337SEU6_FELCA,Inter-alpha-trypsin inhibitor heavy chain H3,ITIH3,23.421,27.092,27.113,URINE+SERUM
M3WN60_FELCA,Inter-alpha-trypsin inhibitor heavy chain H3,ITIH3,16.139,19.801,19.254,URINE+PLASMA
A0A2I2U7R4_FELCA,Inter-alpha-trypsin inhibitor heavy chain 4,ITIH4,26.929,28.980,29.338,URINE+SERUM
M3WEM7_FELCA,Inter-alpha-trypsin inhibitor heavy chain 5,ITIH5,25.954,23.876,22.348,URINE+SERUM
A0A5F5XMZ9_FELCA,Inter-alpha-trypsin inhibitor heavy chain 5,ITIH5,24.511,18.109,18.739,URINE
A0A2I2UVC1_FELCA,Integral membrane protein 2,ITM2B,22.881,20.163,20.125,URINE
A0A2I2U9Y7_FELCA,Integral membrane protein 2,ITM2C,14.511,15.873,14.684,PLASMA
A0A2I2U3Z6_FELCA,"Isovaleryl-CoA dehydrogenase, mitochondrial (EC 1.3.8.1) (EC 1.3.8.4) (Butyryl-CoA dehydrogenase)",IVD,19.846,19.242,18.687,URINE
A0A2I2UBC8_FELCA,Delta-like protein,JAG1,20.309,15.916,15.640,URINE
A0A337SEF1_FELCA,Junctional adhesion molecule 3,JAM3,23.914,23.672,20.331,URINE+SERUM
A0A5F5XX70_FELCA,Junctional adhesion molecule 3,JAM3,22.796,19.748,20.028,URINE
A0A337SAT8_FELCA,Junction adhesion molecule like,JAML,17.890,15.572,16.467,URINE
A0A5F5XC52_FELCA,Joining chain of multimeric IgA and IgM,JCHAIN,29.379,24.155,24.322,URINE
A0A2I2UBN8_FELCA,Junction plakoglobin,JUP,22.853,24.663,24.650,URINE+PLASMA
A0A2I2UA55_FELCA,Kazal type serine peptidase inhibitor domain 1,KAZALD1,21.969,18.062,17.860,URINE
A0A337RZ36_FELCA,Potassium channel tetramerization domain containing 12,KCTD12,19.540,18.223,17.770,URINE
A0A2I2UIN2_FELCA,Vascular endothelial growth factor receptor 2 (EC 2.7.10.1),KDR,18.369,14.817,14.501,URINE
A0A2I2U3F2_FELCA,KIAA0319 like,KIAA0319L,23.391,19.983,21.128,URINE+SERUM
A0A5F5XE91_FELCA,Kinesin-like protein,KIF12,32.173,27.710,27.860,URINE
A0A5F5Y533_FELCA,Kinesin-like protein,KIF12,19.234,16.498,16.690,URINE
M3VU73_FELCA,Kinesin-like protein,KIF12,22.442,19.354,19.504,URINE
A0A2I2U1G6_FELCA,Kinesin family member 21A,KIF21A,22.785,15.860,15.341,URINE
A0A5F5XE96_FELCA,Kinesin family member 26A,KIF26A,18.309,12.144,12.419,URINE
A0A337S5Y7_FELCA,Kirre like nephrin family adhesion molecule 1,KIRREL1,22.033,20.557,20.282,URINE
A0A337RZN4_FELCA,Kirre like nephrin family adhesion molecule 1,KIRREL1,17.391,17.174,17.825,URINE+SERUM+PLASMA
KIT_FELCA,Mast/stem cell growth factor receptor Kit (SCFR) (EC 2.7.10.1) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (CD antigen CD117),KIT,21.607,20.042,20.257,URINE
SCF_FELCA,Kit ligand (Mast cell growth factor) (MGF) (Stem cell factor) (SCF) (c-Kit ligand) [Cleaved into: Soluble KIT ligand (sKITLG)],KITLG SCF,20.450,15.315,15.839,URINE
A0A5F5XC24_FELCA,Kallikrein B1,KLKB1,23.987,25.554,25.524,URINE+PLASMA
A0A337SQ55_FELCA,Natural killer cells antigen CD94 (Killer cell lectin-like receptor subfamily D member 1),KLRD1,21.421,14.916,15.346,URINE
A0A2I2U294_FELCA,Kininogen 1,KNG1,31.951,29.710,29.736,URINE
A0A5F5XVF5_FELCA,Kininogen 1,KNG1,21.631,23.120,22.545,PLASMA
A0A2I2UHH3_FELCA,small monomeric GTPase (EC 3.6.5.2),KRAS,21.389,16.015,15.970,URINE
A0A337SC09_FELCA,Kremen protein (Kringle-containing protein marking the eye and the nose),KREMEN1,20.261,22.066,22.947,URINE+SERUM
M3VXR1_FELCA,"Keratin, type I cytoskeletal 10 (Cytokeratin-10) (Keratin-10)",KRT10,27.262,24.193,24.192,URINE
A0A337SCP9_FELCA,IF rod domain-containing protein,KRT13,27.546,24.395,24.056,URINE
A0A337SM15_FELCA,Keratin 17,KRT17,24.826,21.243,21.334,URINE
A0A5F5XLA0_FELCA,"Keratin, type I cytoskeletal 17 (Cytokeratin-17) (Keratin-17)",KRT17,21.340,19.050,18.948,URINE
A0A5F5XF56_FELCA,"Keratin, type I cytoskeletal 17 (Cytokeratin-17) (Keratin-17)",KRT17,20.146,19.420,18.681,URINE
A0A5F5Y768_FELCA,Keratin 17,KRT17,20.357,21.057,20.998,URINE+SERUM+PLASMA
M3VXK4_FELCA,"Keratin, type I cytoskeletal 17 (Cytokeratin-17) (Keratin-17)",KRT17,19.565,20.042,19.816,URINE+SERUM+PLASMA
M3VUH3_FELCA,Keratin 18,KRT18,23.132,22.483,22.751,URINE+SERUM+PLASMA
A0A2I2U642_FELCA,"Keratin, type I cytoskeletal 20 (Cytokeratin-20) (Keratin-20)",KRT20,22.704,18.906,19.357,URINE
A0A2I2UVW3_FELCA,"Keratin, type I cytoskeletal 27 (Cytokeratin-27) (Keratin-27) (Type I inner root sheath-specific keratin-K25irs3)",KRT25 KRT27,25.829,22.781,22.724,URINE
M3VUG8_FELCA,Keratin 3,KRT3,24.283,21.394,21.288,URINE
M3VUE5_FELCA,"Keratin, type II cytoskeletal 7 (Cytokeratin-7) (Keratin-7) (Type-II keratin Kb7)",KRT7,22.264,20.676,20.478,URINE
K2C71_FELCA,"Keratin, type II cytoskeletal 71 (Cytokeratin-71) (CK-71) (Keratin-71) (K71)",KRT71,25.214,21.486,21.635,URINE
M1RGZ2_FELCA,Keratin 73,KRT73,17.843,19.199,18.580,PLASMA
M3VUF9_FELCA,Keratin 74,KRT74,25.207,21.365,21.435,URINE
A0A337S538_FELCA,Keratin 74,KRT74,24.417,20.018,19.843,URINE
M3VUG7_FELCA,Keratin 76,KRT76,25.096,21.629,21.650,URINE
A0A5F5XKG5_FELCA,Keratin 77,KRT77,25.561,22.793,22.644,URINE
M3WZD7_FELCA,IF rod domain-containing protein,KRT89,20.596,17.732,18.287,URINE
A0A5F5XMX8_FELCA,Kynureninase (EC 3.7.1.3) (L-kynurenine hydrolase),KYNU,18.948,15.119,15.665,URINE
A0A2I2U6T7_FELCA,L1 cell adhesion molecule,L1CAM,23.913,23.089,23.043,URINE+SERUM+PLASMA
A0A337SDW1_FELCA,LINE1 type transposase domain containing 1,L1TD1,21.708,22.078,17.916,URINE+PLASMA
A0A5F5XCK9_FELCA,Endoribonuclease LACTB2 (Beta-lactamase-like protein 2),LACTB2,17.542,18.881,20.685,URINE+SERUM
A0A5F5XQP4_FELCA,Leukocyte associated immunoglobulin like receptor 1,LAIR1,25.110,17.521,17.882,URINE
A0A5F5XIU1_FELCA,Laminin subunit alpha 4,LAMA4,24.561,17.312,17.358,URINE
A0A5F5Y366_FELCA,Laminin subunit alpha 5,LAMA5,22.372,23.129,24.729,SERUM
M3W292_FELCA,Laminin subunit beta 1,LAMB1,24.020,23.805,22.966,URINE
M3WC88_FELCA,Laminin subunit beta 2,LAMB2,17.651,16.797,17.732,URINE+SERUM+PLASMA
M3WXS7_FELCA,Laminin subunit gamma 1,LAMC1,22.566,20.620,20.115,URINE
A0A337RYK1_FELCA,Laminin subunit gamma 2,LAMC2,20.180,13.766,12.499,URINE+SERUM
A7XPK6_FELCA,Lysosomal associated membrane protein 1,LAMP1,19.286,17.527,17.024,URINE
C6GGN9_FELCA,Lysosomal associated membrane protein 1 (Lysosomal-associated membrane glycoprotein 1),LAMP1 LAMP-1,24.709,20.613,20.843,URINE
A0A337STH0_FELCA,Lysosomal associated membrane protein 2,LAMP2,28.639,22.310,22.644,URINE
A0A2I2V3S9_FELCA,Lysosomal associated membrane protein 3,LAMP3,17.270,16.049,16.006,URINE
A0A5F5XSP5_FELCA,Cytosol aminopeptidase (EC 3.4.11.1) (EC 3.4.11.5) (EC 3.4.13.23) (Cysteinylglycine-S-conjugate dipeptidase) (Leucine aminopeptidase 3) (Leucyl aminopeptidase) (Proline aminopeptidase) (Prolyl aminopeptidase),LAP3,21.988,21.285,20.979,URINE
A0A337SJA8_FELCA,Layilin,LAYN,21.958,18.432,18.908,URINE
M3WXB6_FELCA,Layilin,LAYN,20.685,19.643,18.180,URINE+SERUM
A0A5F5Y0Z4_FELCA,Lipopolysaccharide-binding protein (LBP),LBP,19.288,22.466,22.426,URINE+PLASMA
A0A5F5XKS1_FELCA,Lipopolysaccharide-binding protein (LBP),LBP,21.003,23.103,23.278,URINE+SERUM
M3XCK7_FELCA,Lipocalin like 1,LCNL1,26.873,20.902,21.372,URINE
A0A2I2U572_FELCA,Lymphocyte cytosolic protein 1,LCP1,21.027,20.742,19.573,URINE+SERUM
A0A2I2UZG1_FELCA,L-lactate dehydrogenase (EC 1.1.1.27),LDHA,21.346,17.482,17.641,URINE
A0A337S8L1_FELCA,L-lactate dehydrogenase (EC 1.1.1.27),LDHA,20.386,17.213,17.805,URINE
A0A2I2U9C6_FELCA,L-lactate dehydrogenase (EC 1.1.1.27),LDHB,24.009,19.930,19.883,URINE
A0A2I2U4Z0_FELCA,L-lactate dehydrogenase (EC 1.1.1.27),LDHC,21.941,15.654,16.349,URINE
A0A337SRL4_FELCA,Low-density lipoprotein receptor,LDLR,22.164,18.834,18.229,URINE
A0A2I2UMV3_FELCA,Liver-expressed antimicrobial peptide 2,LEAP2,25.936,19.544,19.589,URINE
A0A5F5XUA4_FELCA,Leukocyte cell derived chemotaxin 2,LECT2,15.158,17.600,16.779,URINE+PLASMA
M3WKX0_FELCA,Leukocyte cell derived chemotaxin 2,LECT2,15.963,19.167,19.373,URINE+SERUM
LEP_FELCA,Leptin (Obesity factor),LEP OB,18.423,18.420,17.624,URINE+SERUM+PLASMA
A0A337SEC0_FELCA,Galectin,LGALS1,21.369,21.213,21.692,URINE+SERUM+PLASMA
A0A337S4Q5_FELCA,Galectin,LGALS3,21.960,22.066,22.251,URINE+SERUM+PLASMA
A0A2I2U709_FELCA,Galectin,LGALS9,22.908,17.710,17.953,URINE
A0A337S0D5_FELCA,"Legumain (EC 3.4.22.34) (Protease, cysteine 1)",LGMN,20.607,18.733,18.831,URINE
M3W8K5_FELCA,"Legumain (EC 3.4.22.34) (Protease, cysteine 1)",LGMN,20.754,13.995,15.016,URINE+SERUM
A0A5F5XGD3_FELCA,LIF receptor subunit alpha,LIFR,24.494,25.431,25.232,URINE+SERUM+PLASMA
A0A5F5XPV2_FELCA,Lipase,LIPA,30.317,21.045,21.133,URINE
A0A5F5XQ31_FELCA,"Lectin, mannose binding 2",LMAN2,30.258,22.069,22.186,URINE
A0A5F5XTW1_FELCA,Lysosomal cobalamin transport escort protein LMBD1 (LMBR1 domain-containing protein 1),LMBRD1,15.095,10.727,12.661,URINE+SERUM
A0A5K1VP01_FELCA,Lamin A/C,LMNA,24.177,12.814,12.986,URINE
M3VU75_FELCA,Lipocalin/cytosolic fatty-acid binding domain-containing protein,LOC100144393,27.966,29.937,30.005,URINE+SERUM
E5D2Z5_FELCA,Fel d 7 allergen,LOC100533977,25.432,19.318,20.241,URINE
M3WJA1_FELCA,Pepsin A (EC 3.4.23.1),LOC101080826,29.927,17.574,17.530,URINE
A0A5F5XDG7_FELCA,Pregnancy zone protein,LOC101080976,25.936,29.421,29.438,URINE+SERUM
A0A5F5XG49_FELCA,Pregnancy zone protein-like,LOC101080976,21.474,26.035,26.010,URINE+PLASMA
A0A337S803_FELCA,Ovostatin homolog 2-like,LOC101081475,22.710,26.981,26.978,URINE+PLASMA
A0A2I2U8D7_FELCA,C-type lectin domain-containing protein,LOC101082144,21.205,18.337,18.577,URINE
A0A2I2UMM1_FELCA,Uncharacterized protein,LOC101082733,20.134,18.591,18.987,URINE
A0A2I2UP08_FELCA,Sushi domain-containing protein,LOC101085428,23.278,27.459,27.352,URINE+PLASMA
M3WP64_FELCA,Peptidase S1 domain-containing protein,LOC101085453,19.239,18.154,18.261,URINE
A0A337S8S6_FELCA,Peptidase S1 domain-containing protein,LOC101085453,29.351,25.527,25.555,URINE
A0A5F5XMU9_FELCA,Coiled-coil domain-containing protein 170-like,LOC101086571,18.447,19.027,19.062,URINE+SERUM+PLASMA
A0A2I2UUI4_FELCA,Cathepsin L,LOC101086605,24.152,21.014,20.903,URINE
A0A337SVW6_FELCA,Annexin,LOC101087010,20.937,17.697,17.105,URINE
A0A337RWP8_FELCA,Ly-6/neurotoxin-like protein 1,LOC101087710,26.136,18.687,18.488,URINE
A0A2I2UV75_FELCA,Cystatin domain-containing protein,LOC101088567,21.295,17.500,17.220,URINE
A0A5F5XV52_FELCA,Peptidase S1 domain-containing protein,LOC101089318,20.112,15.684,15.766,URINE
A0A2I2U4V9_FELCA,Peptidase S1 domain-containing protein,LOC101089318,18.697,12.105,12.736,URINE
M3X2R3_FELCA,Mesothelin,LOC101091333,24.258,21.410,21.349,URINE
A0A5F5XVL7_FELCA,Sulfotransferase (EC 2.8.2.-),LOC101091370,25.081,18.738,18.932,URINE
A0A5F5XTD9_FELCA,Sulfotransferase (EC 2.8.2.-),LOC101091370,24.306,19.347,19.424,URINE
A0A5F5XKI3_FELCA,Sulfotransferase (EC 2.8.2.-),LOC101091370,22.063,18.406,18.624,URINE
A0A2I2UYB0_FELCA,Lipocalin/cytosolic fatty-acid binding domain-containing protein,LOC101091569,21.887,16.522,16.931,URINE
A0A337SM43_FELCA,Olfactory receptor,LOC101093693 LOC111560946,21.301,26.023,26.160,URINE+SERUM
A0A337SE00_FELCA,C-X-C motif chemokine,LOC101094096,21.917,23.974,26.705,URINE+SERUM
A0A2I2U006_FELCA,Nicotinamide N-methyltransferase,LOC101094108,19.655,13.868,12.423,URINE+SERUM
A0A5F5XZS8_FELCA,Peptidase S1 domain-containing protein,LOC101094275,21.711,12.061,13.281,URINE+SERUM
A0A5F5XT89_FELCA,Peptidase S1 domain-containing protein,LOC101094275,25.002,19.949,19.536,URINE
A0A2I2UKK1_FELCA,Uncharacterized protein,LOC101094346,28.078,28.616,28.811,URINE+SERUM+PLASMA
A0A5F5XFU6_FELCA,Uncharacterized protein,LOC101094346,22.249,23.781,23.973,URINE+SERUM
A0A2I2UT16_FELCA,Albumin domain-containing protein,LOC101095098,24.809,23.809,23.609,URINE
M3WBI8_FELCA,C-type lectin domain family 18 member A,LOC101095392,20.442,16.025,17.291,URINE+SERUM
M3W3Q0_FELCA,Glutathione S-transferase (EC 2.5.1.18),LOC101096317,21.151,19.035,16.813,URINE+SERUM
A0A5F5XEY9_FELCA,Butyrophilin like 9,LOC101097782,26.667,22.044,21.904,URINE
A0A2I2UXL4_FELCA,Globin family profile domain-containing protein,LOC101098159,21.977,25.035,26.496,URINE+SERUM
A0A2I2U6J8_FELCA,Globin family profile domain-containing protein,LOC101098159,18.469,22.565,24.138,URINE+SERUM
M3WVZ4_FELCA,Globin A1,LOC101098159 GLNA1,16.897,20.416,21.134,URINE+SERUM
A0A2I2U232_FELCA,Adenylate cyclase-stimulating G alpha protein,LOC101098453,23.468,23.405,23.543,URINE+SERUM+PLASMA
A0A2I2U5B2_FELCA,Lipocalin/cytosolic fatty-acid binding domain-containing protein,LOC101098498,26.373,17.073,17.516,URINE
A0A2I2U227_FELCA,Lipocalin/cytosolic fatty-acid binding domain-containing protein,LOC101098498,30.397,23.150,23.528,URINE
A0A5F5XBZ0_FELCA,Lipocalin/cytosolic fatty-acid binding domain-containing protein,LOC101098498,21.117,17.716,18.200,URINE
A0A5F5Y107_FELCA,Enoyl reductase (ER) domain-containing protein,LOC101100387,20.006,19.245,19.303,URINE+SERUM+PLASMA
A0A337SQ74_FELCA,IGF like family member 3,LOC101101603,23.206,18.033,18.521,URINE
A0A5F5XCJ2_FELCA,Membrane cofactor protein,LOC102899273,24.299,14.965,15.277,URINE
A0A5F5XZ26_FELCA,UPAR/Ly6 domain-containing protein,LOC102899673,26.151,16.468,16.808,URINE
A0A5F5XEP4_FELCA,Sushi domain-containing protein,LOC102899713,16.529,21.076,20.712,URINE+PLASMA
A0A2I2UIM4_FELCA,Carbonyl reductase (NADPH) (EC 1.1.1.184),LOC102901316,21.971,19.145,19.578,URINE
A0A2I2UFN2_FELCA,Carbonyl reductase (NADPH) (EC 1.1.1.184),LOC102901316,12.797,14.344,15.048,URINE+SERUM
A0A5F5XD04_FELCA,Ig-like domain-containing protein,LOC105259618,26.468,24.102,24.820,URINE
A0A2I2U7X7_FELCA,Ig-like domain-containing protein,LOC105259814,21.876,19.876,19.697,URINE
A0A337S014_FELCA,Ig-like domain-containing protein,LOC105259814,23.749,20.417,19.767,URINE
A0A2I2UYG1_FELCA,MHC class I antigen,LOC105260551,18.619,16.566,16.470,URINE
A0A5F5XH25_FELCA,Tumor necrosis factor receptor superfamily member 1A,LOC105261012,21.787,16.065,17.393,URINE+SERUM
A0A5F5XJG5_FELCA,Immunoglobulin V-set domain-containing protein,LOC109494125,19.422,20.857,23.160,URINE+SERUM
A0A5F5XI37_FELCA,Lipocalin/cytosolic fatty-acid binding domain-containing protein,LOC109496317,26.658,29.186,29.017,URINE+PLASMA
A0A337SF46_FELCA,Lipocalin/cytosolic fatty-acid binding domain-containing protein,LOC111556219,25.115,18.392,19.192,URINE
A0A5F5XQF5_FELCA,Immunoglobulin V-set domain-containing protein,LOC111557803,20.669,18.004,17.479,URINE
A0A337S103_FELCA,Metallothionein,LOC111558024,21.390,14.588,14.552,URINE
M3XB79_FELCA,Metallothionein,LOC111558024,16.717,18.165,18.492,URINE+SERUM
A0A2I2V287_FELCA,Cathepsin L1-like,LOC111559124,22.294,14.703,14.488,URINE
A0A5F5XP31_FELCA,Kazal-like domain-containing protein,LOC123379994,18.461,10.039,10.804,URINE
A0A2I2UAR3_FELCA,Lysyl oxidase homolog (EC 1.4.3.13),LOX,24.407,18.539,18.009,URINE
M3WFA5_FELCA,Lysyl oxidase like 1,LOXL1,19.663,19.653,20.262,URINE+SERUM+PLASMA
M3WB92_FELCA,Lysyl oxidase like 4,LOXL4,23.160,20.581,20.572,URINE
A0A337S1P2_FELCA,Leucine rich alpha-2-glycoprotein 1,LRG1,28.683,26.756,26.662,URINE
M3VU91_FELCA,LDL receptor related protein 1,LRP1,23.339,19.347,18.697,URINE
M3W5B5_FELCA,LDL receptor related protein 2,LRP2,30.241,27.006,26.760,URINE
A0A2I2UQB6_FELCA,LDL receptor related protein 2,LRP2,28.815,23.134,22.106,URINE+SERUM
M3W2W3_FELCA,LRP2-binding protein,LRP2BP,22.867,25.127,24.467,URINE+PLASMA
A0A5F5Y4L2_FELCA,LDL receptor related protein associated protein 1,LRPAP1,21.761,20.077,20.048,URINE
M3X588_FELCA,Leucine rich repeat containing 15,LRRC15,18.623,16.137,17.743,URINE+SERUM
M3X167_FELCA,Leucine rich repeat containing 19,LRRC19,23.521,15.857,16.236,URINE
M3W4V0_FELCA,Leucine rich repeat containing 8 VRAC subunit A,LRRC8A,21.564,16.921,16.899,URINE
M3X2H7_FELCA,Leucine rich repeat containing 8 VRAC subunit D,LRRC8D,21.564,16.921,16.899,URINE
A0A2I2V4D2_FELCA,Leucine rich repeat neuronal 4,LRRN4,20.996,12.490,15.243,URINE+SERUM
A0A2I2UKX6_FELCA,Limbic system associated membrane protein,LSAMP,25.967,19.872,19.756,URINE
A0A5F5XMF4_FELCA,Leucine rich single-pass membrane protein 2,LSMEM2,20.715,15.030,15.855,URINE
A0A5F5XBY8_FELCA,Leukotriene A(4) hydrolase (LTA-4 hydrolase) (EC 3.3.2.6),LTA4H,15.530,15.799,15.870,URINE+SERUM+PLASMA
A0A337S431_FELCA,Latent transforming growth factor beta binding protein 1,LTBP1,25.795,19.984,19.721,URINE
A0A337S8E4_FELCA,Latent transforming growth factor beta binding protein 1,LTBP1,20.505,14.270,14.804,URINE
A0A140CWF2_FELCA,LTBP2,LTBP2,23.348,19.941,20.377,URINE
A0A2I2UXX3_FELCA,Latent transforming growth factor beta binding protein 4,LTBP4,28.106,22.422,22.204,URINE
A0A2I2V3V6_FELCA,Lactotransferrin,LTF,29.634,23.628,25.232,URINE+SERUM
A0A5F5XC36_FELCA,Lactotransferrin,LTF,26.319,18.190,18.475,URINE
A0A2I2U619_FELCA,Lumican,LUM,20.860,23.075,23.124,URINE+SERUM
A0A337SJ42_FELCA,Lymphocyte antigen 6 family member D,LY6D,29.151,19.961,19.246,URINE
M3VTY7_FELCA,LY6/PLAUR domain containing 1,LYPD1,19.090,15.837,15.825,URINE
M3VU52_FELCA,LY6/PLAUR domain containing 2,LYPD2,15.485,16.374,15.671,URINE+SERUM+PLASMA
M3WY30_FELCA,LY6/PLAUR domain containing 3,LYPD3,19.207,16.027,15.493,URINE
A0A2I2U035_FELCA,LY6/PLAUR domain containing 6,LYPD6,19.515,13.559,14.456,URINE
A0A2I2UP64_FELCA,LY6/PLAUR domain containing 6B,LYPD6B,21.937,20.278,20.449,URINE
A0A2I2UCN9_FELCA,Acyl-protein thioesterase 1 (EC 3.1.2.22) (Lysophospholipase 1) (Lysophospholipase I) (Palmitoyl-protein hydrolase),LYPLA1,16.233,16.243,15.750,URINE+SERUM+PLASMA
M3VUP6_FELCA,Lymphatic vessel endothelial hyaluronan receptor 1,LYVE1,29.093,20.168,20.684,URINE
A0A2I2UY37_FELCA,"Mannose-6-phosphate receptor, cation dependent",M6PR,18.570,10.299,10.560,URINE
A0A337SQ63_FELCA,Mucosal vascular addressin cell adhesion molecule 1,MADCAM1,24.768,19.218,19.516,URINE
A0A5F5Y426_FELCA,"alpha-1,2-Mannosidase (EC 3.2.1.-)",MAN1A1,24.696,24.762,25.316,URINE+SERUM+PLASMA
A0A5F5XC46_FELCA,"alpha-1,2-Mannosidase (EC 3.2.1.-)",MAN1A2,10.472,18.531,10.690,PLASMA
A0A5F5Y2G5_FELCA,Alpha-mannosidase (EC 3.2.1.-),MAN2A1,22.112,20.552,19.999,URINE
M3WBE5_FELCA,Alpha-mannosidase (EC 3.2.1.-),MAN2A1,19.850,16.752,16.354,URINE
A0A5F5XUG7_FELCA,Alpha-mannosidase (EC 3.2.1.-),MAN2A2,19.120,16.047,16.042,URINE
A0A2I2UJS0_FELCA,Alpha-mannosidase (EC 3.2.1.-),MAN2B1,18.050,17.195,17.694,URINE+SERUM+PLASMA
MA2B1_FELCA,Lysosomal alpha-mannosidase (Laman) (EC 3.2.1.24) (Lysosomal acid alpha-mannosidase) (Mannosidase alpha class 2B member 1) (Mannosidase alpha-B),MAN2B1 MANB,25.483,25.777,26.731,SERUM
A0A337RVS9_FELCA,Beta-mannosidase (EC 3.2.1.25) (Lysosomal beta A mannosidase) (Mannanase),MANBA,23.333,23.279,22.168,URINE+SERUM
A0A337SHI7_FELCA,MANSC domain containing 1,MANSC1,21.736,17.694,17.630,URINE
A0A337S396_FELCA,Monoamine oxidase B,MAOB,16.333,18.450,17.874,URINE+PLASMA
A0A337S9V8_FELCA,Mitogen-activated protein kinase kinase kinase 12 (EC 2.7.11.25),MAP3K12,17.780,18.648,19.118,SERUM
M3WAB7_FELCA,Mitogen-activated protein kinase (EC 2.7.11.24),MAPK7,21.384,18.427,15.748,URINE+SERUM
M3XB86_FELCA,RING-type E3 ubiquitin transferase (EC 2.3.2.27),MARCHF10,20.872,20.959,20.984,URINE+SERUM+PLASMA
A0A2I2UHZ6_FELCA,MBL associated serine protease 1,MASP1,21.345,21.946,22.412,SERUM
A0A337S8F8_FELCA,MBL associated serine protease 2,MASP2,26.680,20.724,20.710,URINE
A0A5F5Y096_FELCA,MBL associated serine protease 2,MASP2,19.984,20.672,20.726,URINE+SERUM+PLASMA
A0A2I2UI11_FELCA,Mannose binding lectin 1,MBL1,19.882,21.203,20.790,PLASMA
A0A5F5XHB5_FELCA,Melanoma cell adhesion molecule,MCAM,21.247,20.330,21.065,URINE+SERUM+PLASMA
MDHC_FELCA,"Malate dehydrogenase, cytoplasmic (EC 1.1.1.37) (Aromatic alpha-keto acid reductase) (KAR) (EC 1.1.1.96) (Cytosolic malate dehydrogenase)",MDH1,24.142,21.215,21.204,URINE
MDHM_FELCA,"Malate dehydrogenase, mitochondrial (EC 1.1.1.37)",MDH2,16.693,10.238,10.588,URINE
A0A337S3Q9_FELCA,Midkine,MDK,20.259,16.190,16.129,URINE
A0A2I2UC58_FELCA,Multiple EGF like domains 9,MEGF9,24.058,19.774,19.599,URINE
M3W126_FELCA,Melanotransferrin,MELTF,26.052,26.853,27.647,SERUM
M3WB64_FELCA,Metalloendopeptidase (EC 3.4.24.-),MEP1A,26.113,17.270,18.353,URINE+SERUM
A0A5F5Y369_FELCA,receptor protein-tyrosine kinase (EC 2.7.10.1),MERTK,16.079,16.911,17.439,SERUM
M3XFR1_FELCA,Meteorin-like protein,METRNL,21.784,19.666,21.238,URINE+SERUM
A0A337SHC5_FELCA,Microfibril associated protein 4,MFAP4,19.435,22.678,21.576,URINE+PLASMA
M3XGE7_FELCA,Microfibril associated protein 4,MFAP4,20.879,21.629,20.639,URINE+SERUM+PLASMA
A0A5F5XE10_FELCA,Milk fat globule EGF and factor V/VIII domain containing,MFGE8,25.689,21.704,22.578,URINE
A0A2I2UXR9_FELCA,Maltase-glucoamylase,MGAM,26.603,24.273,23.601,URINE
A0A341ZMF3_FELCA,"alpha-1,6-mannosyl-glycoprotein 6-beta-N-acetylglucosaminyltransferase (EC 2.4.1.155)",MGAT5,24.051,22.483,22.549,URINE
A0A2I2V3J5_FELCA,Matrix Gla protein (MGP),MGP,19.444,21.369,20.966,URINE+PLASMA
A0A2I2UBB6_FELCA,SH3 domain-containing protein,MIA2,19.923,15.047,15.226,URINE
A0A337RWW9_FELCA,MIA SH3 domain ER export factor 3,MIA3,23.142,18.887,18.179,URINE
A0A5F5XNZ1_FELCA,Migration and invasion enhancer 1,MIEN1,24.189,23.246,22.434,URINE
M3WPV6_FELCA,Migration and invasion enhancer 1,MIEN1,23.622,17.032,17.191,URINE
A0A5F5XHI0_FELCA,Macrophage migration inhibitory factor (EC 5.3.2.1) (EC 5.3.3.12) (L-dopachrome isomerase) (L-dopachrome tautomerase) (Phenylpyruvate tautomerase),MIF,20.914,15.464,16.745,URINE+SERUM
A0A337S3R5_FELCA,Multiple inositol-polyphosphate phosphatase 1,MINPP1,20.870,18.629,18.689,URINE
M3WV39_FELCA,"Multiple inositol polyphosphate phosphatase 1 (EC 3.1.3.62) (EC 3.1.3.80) (2,3-bisphosphoglycerate 3-phosphatase)",MINPP1,19.690,19.602,20.088,URINE+SERUM+PLASMA
A0A5F5XFE9_FELCA,Microtubule interacting and trafficking domain containing 1,MITD1,16.489,10.873,10.489,URINE
A0A337SXF4_FELCA,Neprilysin (EC 3.4.24.11) (Atriopeptidase) (Enkephalinase) (Neutral endopeptidase 24.11) (Skin fibroblast elastase),MME,25.450,21.900,22.121,URINE
A0A5F5XYE2_FELCA,Matrix metallopeptidase 11,MMP11,14.792,17.285,17.620,URINE+SERUM
A0A337S0K7_FELCA,72 kDa type IV collagenase (EC 3.4.24.24) (72 kDa gelatinase) (Matrix metalloproteinase-2),MMP2,15.335,18.311,18.344,URINE+SERUM
MMP7_FELCA,Matrilysin (EC 3.4.24.23) (Matrin) (Matrix metalloproteinase-7) (MMP-7) (Pump-1 protease) (Uterine metalloproteinase),MMP7,16.869,15.628,17.076,URINE+SERUM
A0A5F5Y5F5_FELCA,Matrix metalloproteinase-9 (EC 3.4.24.35) (92 kDa gelatinase) (92 kDa type IV collagenase) (Gelatinase B),MMP9,23.189,18.220,15.112,URINE+SERUM
A0A3S6CJJ2_FELCA,Matrix metallopeptidase 9,MMP9,23.807,18.048,17.948,URINE
M3WI37_FELCA,Multimerin 1,MMRN1,23.552,17.849,18.455,URINE
A0A5F5XUK2_FELCA,Multimerin 2,MMRN2,12.499,12.109,12.229,URINE+SERUM+PLASMA
A0A337SLC9_FELCA,Molybdopterin synthase catalytic subunit (EC 2.8.1.12) (Molybdenum cofactor synthesis protein 2 large subunit) (Molybdenum cofactor synthesis protein 2B) (MOCS2B),MOCS2,18.607,15.432,15.856,URINE
M3WCF8_FELCA,Monooxygenase DBH like 1,MOXD1,21.017,15.598,15.675,URINE
A0A337S4A6_FELCA,Megakaryocyte and platelet inhibitory receptor G6b,MPIG6B,21.537,13.926,17.364,URINE+SERUM
A0A337S0Y0_FELCA,Sulfurtransferase,MPST,25.934,23.596,22.794,URINE
A0A2I2UHE7_FELCA,Myelin protein zero like 1,MPZL1,20.704,14.910,14.151,URINE
M3WFQ7_FELCA,Myelin protein zero like 2,MPZL2,27.317,20.580,21.252,URINE
A0A5F5XC23_FELCA,Mannose receptor C-type 1,MRC1,16.409,14.526,13.460,URINE+SERUM
A0A2I2V193_FELCA,Mannose receptor C-type 1,MRC1,18.418,15.543,15.177,URINE
M3WE80_FELCA,Mannose receptor C type 2,MRC2,20.031,17.504,17.143,URINE
A0A337SNX4_FELCA,Moesin (Membrane-organizing extension spike protein),MSN,23.876,22.309,23.457,URINE+SERUM
M3WJI8_FELCA,Moesin (Membrane-organizing extension spike protein),MSN,20.020,19.813,20.177,URINE+SERUM+PLASMA
A0A2I2UAP2_FELCA,Macrophage stimulating 1,MST1,22.584,21.915,22.423,URINE+SERUM+PLASMA
M3WPT7_FELCA,Growth/differentiation factor 8 (GDF-8) (Myostatin),MSTN,16.736,18.817,19.085,URINE+SERUM
A0A2I2UW30_FELCA,methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9),MTHFD2L,23.315,16.827,17.143,URINE
A0A337SL83_FELCA,Multivesicular body subunit 12A (ESCRT-I complex subunit MVB12A) (Protein FAM125A),MVB12A,20.486,19.073,19.181,URINE
A0A337S8H7_FELCA,Matrix remodeling-associated protein 8,MXRA8,29.498,20.294,20.489,URINE
A0A337SH59_FELCA,Matrix remodeling-associated protein 8,MXRA8,25.502,18.698,19.557,URINE
A0A2I2U1C5_FELCA,"Myosin-9 (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain IIa)",MYH9,22.724,20.896,21.045,URINE
A0A2I2UHR0_FELCA,Myosin light chain 6,MYL6,18.544,18.456,18.449,URINE+SERUM+PLASMA
A0A2I2U033_FELCA,"Myosin regulatory light polypeptide 9 (Myosin regulatory light chain 2, smooth muscle isoform) (Myosin regulatory light chain 9)",MYL9,17.567,13.372,13.969,URINE
A0A337S3Q0_FELCA,Myosin light chain kinase,MYLK,24.697,19.841,20.228,URINE
A0A5F5XC70_FELCA,Myosin light chain kinase 2,MYLK2,16.824,17.371,18.294,SERUM
MYOC_FELCA,"Myocilin [Cleaved into: Myocilin, N-terminal fragment (Myocilin 20 kDa N-terminal fragment); Myocilin, C-terminal fragment (Myocilin 35 kDa N-terminal fragment)]",MYOC,24.447,19.923,20.004,URINE
A0A2I2V455_FELCA,N-acylethanolamine-hydrolyzing acid amidase (EC 3.5.1.23) (EC 3.5.1.60) (Acylsphingosine deacylase NAAA),NAAA,30.903,20.477,20.932,URINE
A0A5F5XU62_FELCA,Alpha-galactosidase (EC 3.2.1.-),NAGA,21.771,15.938,16.423,URINE
M3WFH8_FELCA,N-acetyl-alpha-glucosaminidase,NAGLU,25.609,21.036,21.729,URINE
A0A337S914_FELCA,Nucleosome assembly protein 1 like 4,NAP1L4,18.074,19.094,19.245,URINE+SERUM
A0A5F5XWA2_FELCA,Napsin A aspartic peptidase,NAPSA,29.901,18.685,18.302,URINE
A0A2I2UVF9_FELCA,"NBL1, DAN family BMP antagonist",NBL1,26.311,19.823,20.187,URINE
A0A2I2UJV2_FELCA,Neural cell adhesion molecule 1,NCAM1,24.725,24.559,25.787,SERUM
A0A337S4H2_FELCA,Neural cell adhesion molecule 1,NCAM1,20.778,19.280,19.153,URINE
A0A2I2V0Y5_FELCA,Neural cell adhesion molecule 2,NCAM2,25.929,21.259,21.334,URINE
A0A337S9P8_FELCA,Nicastrin,NCSTN,22.453,23.532,24.837,URINE+SERUM
M3VZX9_FELCA,Protein NDRG1 (N-myc downstream-regulated gene 1 protein),NDRG1,20.582,17.853,16.521,URINE+SERUM
A0A5F5Y4C0_FELCA,N-myc downstream regulated 1,NDRG1,18.837,10.912,11.083,URINE
A0A337RZV6_FELCA,Nectin cell adhesion molecule 1,NECTIN1,21.689,18.710,18.841,URINE
A0A5F5XXT2_FELCA,Nectin cell adhesion molecule 2,NECTIN2,27.134,20.938,21.424,URINE
A0A2I2U0E6_FELCA,Nectin cell adhesion molecule 3,NECTIN3,20.894,17.628,18.336,URINE
A0A5F5XLH0_FELCA,Nectin cell adhesion molecule 4,NECTIN4,26.142,19.909,19.470,URINE
A0A2I2UX82_FELCA,Neuronal growth regulator 1,NEGR1,24.486,19.272,18.586,URINE
A0A337S1S7_FELCA,Protein kinase C-binding protein NELL2 (NEL-like protein 2),NELL2,24.902,23.826,23.685,URINE
A0A2I2UTR9_FELCA,Neogenin 1,NEO1,22.471,20.574,20.146,URINE
M3X3Z7_FELCA,Sialidase-1 (EC 3.2.1.18) (Lysosomal sialidase) (N-acetyl-alpha-neuraminidase 1),NEU1,21.971,19.093,18.390,URINE
A0A2I2UTY5_FELCA,Nexilin F-actin binding protein,NEXN,20.728,18.252,18.393,URINE
A0A337SBE9_FELCA,Nerve growth factor receptor,NGFR,24.560,20.598,21.914,URINE+SERUM
A0A2I2UP60_FELCA,Na(+)/H(+) exchange regulatory cofactor NHE-RF,NHERF1,25.427,23.121,22.863,URINE
A0A2I2U5Z9_FELCA,NHL repeat containing 3,NHLRC3,25.119,20.347,20.889,URINE
A0A337SCS7_FELCA,Nidogen 1,NID1,25.242,22.925,21.786,URINE+SERUM
A0A337SMW2_FELCA,Nidogen 2,NID2,23.657,19.594,19.843,URINE
A0A337S9P2_FELCA,NIPA like domain containing 1,NIPAL1,19.401,13.090,14.447,URINE+SERUM
A0A5F5XC25_FELCA,Omega-amidase NIT2 (EC 3.5.1.3) (Nitrilase homolog 2),NIT2,21.946,17.441,16.973,URINE
A0A2I2U4B5_FELCA,Nucleoside diphosphate kinase (EC 2.7.4.6),NME2,19.481,16.254,16.475,URINE
M3X077_FELCA,Neurogenic locus notch homolog protein 1,NOTCH1,22.389,20.484,16.197,URINE+SERUM
A0A2I2U0T9_FELCA,Notch receptor 2,NOTCH2,20.240,17.052,16.529,URINE
A0A2I2UCH5_FELCA,NPC intracellular cholesterol transporter 1,NPC1,20.678,16.540,16.382,URINE
A0A2I2U310_FELCA,NPC1 like intracellular cholesterol transporter 1,NPC1L1 DDX56,21.326,17.062,16.946,URINE
M3X1L5_FELCA,NPC intracellular cholesterol transporter 2 (Epididymal secretory protein E1),NPC2,27.224,22.484,22.194,URINE
M3X5Z4_FELCA,Aminopeptidase (EC 3.4.11.-),NPEPPS,16.531,13.679,13.039,URINE
M3VXB4_FELCA,"NPHS2 stomatin family member, podocin",NPHS2,15.298,10.000,14.464,URINE+SERUM
A0A337S3Z8_FELCA,Natriuretic peptide receptor 3,NPR3,17.674,14.755,15.148,URINE
A0A2I2UZY7_FELCA,Neuroplastin,NPTN,21.580,16.155,16.074,URINE
A0A337SMV4_FELCA,N-ribosyldihydronicotinamide:quinone reductase 2,NQO2,21.641,20.513,19.707,URINE
A0A2I2U1J3_FELCA,Nuclear receptor subfamily 1 group H member 4,NR1H4,15.514,17.835,15.834,PLASMA
M3WN87_FELCA,Nuclear receptor subfamily 1 group I member 3 (Constitutive androstane receptor),NR1I3,22.319,26.503,26.483,URINE+PLASMA
A0A2I2UU92_FELCA,Neuropilin,NRP1,18.139,15.795,16.159,URINE
A0A337SMY8_FELCA,Neuropilin 2,NRP2,17.783,15.810,15.510,URINE
A0A337S9F6_FELCA,Neurexin 3,NRXN3,16.636,14.987,12.125,URINE+SERUM
A0A5F5XIM5_FELCA,NSFL1 cofactor,NSFL1C,19.652,20.984,21.593,URINE+SERUM
A0A2I2UUB3_FELCA,Neurotrimin,NTM,22.529,20.537,20.605,URINE
A0A2I2U1I4_FELCA,Tyrosine-protein kinase receptor (EC 2.7.10.1),NTRK3,21.851,15.453,16.070,URINE
M3W064_FELCA,Nucleobindin-1,NUCB1,26.110,22.090,22.000,URINE
A0A2I2UTH6_FELCA,Nucleobindin 2,NUCB2,22.465,19.948,20.066,URINE
A0A2I2UU60_FELCA,"Oxidized purine nucleoside triphosphate hydrolase (EC 3.6.1.56) (2-hydroxy-dATP diphosphatase) (7,8-dihydro-8-oxoguanine triphosphatase) (8-oxo-dGTPase) (Methylated purine nucleoside triphosphate hydrolase) (Nucleoside diphosphate-linked moiety X motif 1)",NUDT1,21.303,17.275,17.242,URINE
A0A2I2ULA8_FELCA,Nuclear mitotic apparatus protein 1,NUMA1,19.866,16.383,17.671,URINE+SERUM
M3X0F5_FELCA,Nuclear transport factor 2 (NTF-2),NUTF2,25.353,19.987,20.549,URINE
A0A2I2ULL1_FELCA,Neurexophilin,NXPH2,18.284,18.998,19.067,URINE+SERUM+PLASMA
A0A2I2U0A2_FELCA,Out at first protein homolog,OAF,22.916,22.022,21.941,URINE+SERUM+PLASMA
M3WPJ4_FELCA,2-oxoglutarate and iron dependent oxygenase domain containing 3,OGFOD3,16.203,15.648,16.868,SERUM
M3VVG9_FELCA,Mimecan (Osteoglycin),OGN,22.584,21.933,22.295,URINE+SERUM+PLASMA
A0A337S4Z9_FELCA,Olfactomedin 1,OLFM1,20.949,18.421,18.199,URINE
A0A337RWR2_FELCA,Olfactomedin like 3,OLFML3,20.371,16.901,17.552,URINE
A0A2I2UMJ9_FELCA,Opioid binding protein/cell adhesion molecule like,OPCML,22.630,19.452,19.734,URINE
A0A2I2UD00_FELCA,Oxysterol-binding protein,OSBPL2 ADRM1,18.041,13.199,13.803,URINE
A0A5F5Y561_FELCA,Otoraplin,OTOR,22.553,19.283,19.206,URINE
A0A337SC03_FELCA,P2X purinoceptor,P2RX4,19.460,19.394,18.937,URINE+SERUM+PLASMA
M3XCN6_FELCA,Protein disulfide-isomerase (EC 5.3.4.1),P4HB,19.609,18.665,19.049,URINE+SERUM+PLASMA
A0A337S9L8_FELCA,Protein kinase C and casein kinase substrate in neurons 2,PACSIN2,21.138,18.827,19.286,URINE
M3WHA5_FELCA,Protein kinase C and casein kinase substrate in neurons 3,PACSIN3,20.602,20.261,20.366,URINE+SERUM+PLASMA
LIS1_FELCA,Platelet-activating factor acetylhydrolase IB subunit beta (Lissencephaly-1 protein) (LIS-1) (PAF acetylhydrolase 45 kDa subunit) (PAF-AH 45 kDa subunit) (PAF-AH alpha) (PAFAH alpha),PAFAH1B1 LIS1,21.301,19.094,19.442,URINE
M3WEF4_FELCA,Protein PALS1 (MAGUK p55 subfamily member 5) (Protein associated with Lin-7 1),PALS1,16.423,18.485,18.969,URINE+SERUM
A0A337S9K0_FELCA,Peptidylglycine alpha-amidating monooxygenase,PAM,22.646,20.923,20.937,URINE
A0A2I2UHQ6_FELCA,"Papilin, proteoglycan like sulfated glycoprotein",PAPLN,24.591,20.257,20.183,URINE
A0A5F5XQL5_FELCA,"Papilin, proteoglycan like sulfated glycoprotein",PAPLN,20.431,17.085,16.957,URINE
M3WYR7_FELCA,protein deglycase (EC 3.5.1.124) (Maillard deglycase) (Parkinsonism-associated deglycase) (Protein DJ-1) (Protein/nucleic acid deglycase DJ-1),PARK7,19.406,15.608,16.046,URINE
A0A337STF2_FELCA,Parkinsonism associated deglycase,PARK7,22.294,18.182,18.278,URINE
A0A5F5XDU4_FELCA,Phenazine biosynthesis like protein domain containing,PBLD,22.872,20.280,20.205,URINE
A0A5F5XDD6_FELCA,Pterin-4-alpha-carbinolamine dehydratase (EC 4.2.1.96) (4-alpha-hydroxy-tetrahydropterin dehydratase) (Dimerization cofactor of hepatocyte nuclear factor 1-alpha) (Phenylalanine hydroxylase-stimulating protein) (Pterin carbinolamine dehydratase),PCBD1,21.399,18.389,18.606,URINE
A0A2I2U3P8_FELCA,Poly(rC) binding protein 2,PCBP2,18.462,14.260,14.686,URINE
M3WBC6_FELCA,Protocadherin 1,PCDH1,21.826,17.737,18.129,URINE
A0A2I2UWU3_FELCA,Protocadherin 17,PCDH17,28.367,26.105,26.139,URINE
A0A337SKM2_FELCA,Protocadherin 7,PCDH7,17.611,15.987,14.932,URINE+SERUM
A0A5F5XH49_FELCA,"Protocadherin alpha subfamily C, 2",PCDHAC2,18.999,16.181,16.308,URINE
A0A5F5XE18_FELCA,"Protocadherin gamma subfamily A, 4",PCDHGA4,22.578,19.444,19.161,URINE
A0A5F5XK05_FELCA,Procollagen C-endopeptidase enhancer,PCOLCE,26.412,24.340,24.157,URINE
M3W6K9_FELCA,Procollagen C-endopeptidase enhancer,PCOLCE,21.161,18.456,17.986,URINE
A0A5F5Y2C4_FELCA,Procollagen C-endopeptidase enhancer 2,PCOLCE2,20.662,15.952,17.113,URINE+SERUM
A0A337SNW6_FELCA,Proprotein convertase subtilisin/kexin type 5,PCSK5,13.273,21.634,21.904,URINE+SERUM
M3WSQ5_FELCA,Prenylcysteine oxidase 1 (EC 1.8.3.5),PCYOX1,14.682,15.795,16.500,URINE+SERUM
A0A2I2UD44_FELCA,Programmed cell death 6,PDCD6,25.267,26.285,25.609,PLASMA
A0A5F5Y1P9_FELCA,Programmed cell death 6 interacting protein,PDCD6IP,25.383,25.300,24.564,URINE+SERUM+PLASMA
M3XG34_FELCA,Programmed cell death 6 interacting protein,PDCD6IP,20.636,16.535,17.035,URINE
M3VVR5_FELCA,Phosphodiesterase (EC 3.1.4.-),PDE3A,16.430,15.215,13.618,URINE+SERUM
W5LV43_FELCA,Platelet-derived growth factor subunit B (PDGF-2) (Platelet-derived growth factor B chain) (Platelet-derived growth factor beta polypeptide),PDGFB,24.076,15.563,16.017,URINE
A0A5F5XER7_FELCA,Platelet-derived growth factor D,PDGFD,20.575,20.283,19.062,URINE+SERUM
K7S0M4_FELCA,Platelet derived growth factor receptor beta,PDGFR-b,20.330,19.009,19.129,URINE
M3WAV8_FELCA,Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor),PDGFRA,19.576,16.008,16.305,URINE
M3W0P6_FELCA,Platelet-derived growth factor receptor beta (PDGF-R-beta) (PDGFR-beta) (EC 2.7.10.1) (Beta platelet-derived growth factor receptor) (Beta-type platelet-derived growth factor receptor),PDGFRB,22.154,15.314,15.899,URINE
M3WFY4_FELCA,Platelet-derived growth factor receptor-like protein,PDGFRL,21.160,18.503,16.378,URINE+SERUM
M3W668_FELCA,Protein disulfide-isomerase (EC 5.3.4.1),PDIA3,21.064,19.379,18.989,URINE
M3W9X1_FELCA,Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 72),PDIA4,18.723,16.374,16.271,URINE
A0A2I2UBZ5_FELCA,PDZ domain containing 1,PDZK1,25.532,21.641,22.116,URINE
A0A5F5XK30_FELCA,PDZK1-interacting protein 1,PDZK1IP1,22.308,17.343,17.177,URINE
M3WVN7_FELCA,Platelet endothelial aggregation receptor 1,PEAR1,19.411,15.808,15.755,URINE
A0A2I2ULZ1_FELCA,Phosphatidylethanolamine-binding protein 1 (HCNPpp),PEBP1,24.991,20.088,20.338,URINE
A0A337RYP8_FELCA,Phosphatidylethanolamine binding protein 4,PEBP4,19.570,19.123,19.107,URINE+SERUM+PLASMA
A0A2I2V340_FELCA,Platelet and endothelial cell adhesion molecule 1,PECAM1,23.902,22.489,22.319,URINE
A0A5F5XCK4_FELCA,Peflin (PEF protein with a long N-terminal hydrophobic domain) (Penta-EF hand domain-containing protein 1),PEF1,20.701,19.137,19.161,URINE
A0A2I2U2M1_FELCA,Peptidase D,PEPD,21.787,21.403,21.622,URINE+SERUM+PLASMA
M3WEL8_FELCA,Profilin,PFN1,21.815,19.954,20.488,URINE
A0A337S381_FELCA,Profilin,PFN2,19.940,13.622,13.469,URINE
A0A337S2Y5_FELCA,Phosphoglycerate mutase (EC 5.4.2.11) (EC 5.4.2.4),PGAM1,19.740,17.911,17.634,URINE
A0A5F5XZL7_FELCA,Pepsinogen B1,PGB1,22.354,15.531,15.384,URINE
M3X9S4_FELCA,Pepsinogen B2,PGB2 OVGP1,19.155,12.276,11.841,URINE
A0A5F5XK20_FELCA,Protein-glucosylgalactosylhydroxylysine glucosidase,PGGHG,19.887,18.095,18.573,URINE
M3WJN8_FELCA,Protein-glucosylgalactosylhydroxylysine glucosidase,PGGHG,18.963,15.231,15.493,URINE
A0A2I2UJH0_FELCA,Phosphoglycerate kinase (EC 2.7.2.3),PGK1,23.242,18.982,18.977,URINE
M3X166_FELCA,Phosphoglycerate kinase (EC 2.7.2.3),PGK2,19.174,10.250,10.000,URINE
M3WZT2_FELCA,Peptidoglycan recognition protein 1,PGLYRP1,14.315,17.417,18.633,URINE+SERUM
M3WJ85_FELCA,Peptidoglycan recognition protein 2,PGLYRP2,21.452,24.540,24.563,URINE+SERUM
M3X816_FELCA,14 kDa phosphohistidine phosphatase (EC 3.9.1.3) (Phosphohistidine phosphatase 1) (Protein histidine phosphatase),PHPT1,24.627,19.701,19.943,URINE
A0A2I2V147_FELCA,Phytanoyl-CoA dioxygenase domain-containing protein 1,PHYHD1,18.795,19.383,19.611,URINE+SERUM+PLASMA
A0A2I2UJP1_FELCA,Peptidase inhibitor 15,PI15,24.519,18.629,18.580,URINE
M3WXF2_FELCA,Peptidase inhibitor 16,PI16,21.795,18.697,18.029,URINE
A0A5F5XJM9_FELCA,Peptidase inhibitor 16,PI16,25.011,21.213,21.397,URINE
A0A337SF63_FELCA,Piezo type mechanosensitive ion channel component 2,PIEZO2,18.965,16.332,19.072,URINE+SERUM
M3W5Z6_FELCA,Polymeric immunoglobulin receptor,PIGR,30.426,25.171,25.695,URINE
A0A337S1V9_FELCA,Phosphoinositide-3-kinase-interacting protein 1 (Kringle domain-containing protein HGFL),PIK3IP1,28.445,16.943,16.906,URINE
M3VWF4_FELCA,Phosphoinositide-3-kinase-interacting protein 1 (Kringle domain-containing protein HGFL),PIK3IP1,26.358,13.750,13.667,URINE
M3X4Z4_FELCA,Phospholipase A2 inhibitor and LY6/PLAUR domain containing,PINLYP,19.684,22.013,24.793,URINE+SERUM
A0A337SBR4_FELCA,Prolactin-induced protein,PIP,26.519,19.770,20.249,URINE
A0A337SAH5_FELCA,PITH domain containing 1,PITHD1,22.638,17.709,18.955,URINE+SERUM
A0A5F5XE98_FELCA,"Protein kinase domain containing, cytoplasmic",PKDCC,19.868,16.980,16.271,URINE
A0A337RYU6_FELCA,PKHD1 ciliary IPT domain containing fibrocystin/polyductin,PKHD1,19.577,18.468,18.213,URINE
M3X3Z1_FELCA,PKHD1 like 1,PKHD1L1,21.471,21.607,19.984,URINE+PLASMA
A0A337RYI0_FELCA,Pyruvate kinase (EC 2.7.1.40),PKM,18.688,18.290,18.861,URINE+SERUM+PLASMA
KPYM_FELCA,Pyruvate kinase PKM (EC 2.7.1.40) (Pyruvate kinase muscle isozyme) (Threonine-protein kinase PKM2) (EC 2.7.11.1) (Tyrosine-protein kinase PKM2) (EC 2.7.10.2),PKM PKM2,22.956,20.792,20.668,URINE
M3X3D3_FELCA,Phospholipase A2 group XV (EC 3.1.1.32) (EC 3.1.1.4) (EC 3.1.1.5) (1-O-acylceramide synthase) (LCAT-like lysophospholipase) (Lysophospholipase 3) (Lysosomal phospholipase A and acyltransferase) (Lysosomal phospholipase A2),PLA2G15,24.394,23.131,23.452,URINE
A0A5F5XCP1_FELCA,1-alkyl-2-acetylglycerophosphocholine esterase (EC 3.1.1.47),PLA2G7,20.161,22.455,22.445,URINE+PLASMA
A0A337S474_FELCA,Urokinase-type plasminogen activator (EC 3.4.21.73),PLAU,30.475,21.770,21.246,URINE
A0A337S388_FELCA,Urokinase plasminogen activator surface receptor,PLAUR,22.388,17.605,18.213,URINE
A0A2I2UDS4_FELCA,Phospholipase B-like (EC 3.1.1.-),PLBD2,26.636,23.888,23.133,URINE
A0A5F5XE59_FELCA,5'-3' exonuclease PLD3 (EC 3.1.16.1) (Choline phosphatase 3) (Phosphatidylcholine-hydrolyzing phospholipase D3) (Phospholipase D3),PLD3,23.474,20.284,20.208,URINE
M3X3T9_FELCA,Plasminogen (EC 3.4.21.7),PLG,27.431,28.043,27.963,URINE+SERUM+PLASMA
M3VU17_FELCA,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 (EC 1.14.11.4) (Lysyl hydroxylase 1)",PLOD1,17.644,17.330,17.149,URINE+SERUM+PLASMA
A0A2I2UIC2_FELCA,procollagen-lysine 5-dioxygenase (EC 1.14.11.4),PLOD2,21.810,20.445,21.010,URINE
A0A2I2U3Y6_FELCA,Phospholipid transfer protein,PLTP,19.982,22.559,21.144,URINE+PLASMA
M3WCF9_FELCA,Plexin domain containing 1,PLXDC1,20.671,18.209,18.739,URINE
A0A337SP16_FELCA,Plexin domain containing 2,PLXDC2,21.972,20.311,20.390,URINE
A0A5F5Y1Y2_FELCA,Plexin domain containing 2,PLXDC2,21.148,16.569,17.440,URINE
M3WG01_FELCA,Plexin B2,PLXNB2,24.448,21.646,21.888,URINE
M3VU38_FELCA,Plexin D1,PLXND1,18.588,18.632,18.443,URINE+SERUM+PLASMA
M3WKB5_FELCA,Xaa-Arg dipeptidase,PM20D2,23.064,18.146,18.178,URINE
M3W6S5_FELCA,Purine nucleoside phosphorylase (EC 2.4.2.1) (Inosine-guanosine phosphorylase),PNP,13.996,12.039,12.079,URINE
A0A5F5XX38_FELCA,POTRA domain-containing protein,PNPLA3,20.682,19.048,19.582,URINE
A0A5F5XE19_FELCA,Podocalyxin (Podocalyxin-like protein 1),PODXL,25.511,21.563,21.551,URINE
A0A2I2UU74_FELCA,Paraoxonase (EC 3.1.1.2),PON1,24.294,29.858,29.928,URINE+SERUM
M3WTQ9_FELCA,Inorganic pyrophosphatase (EC 3.6.1.1) (Pyrophosphate phospho-hydrolase),PPA1,21.187,22.346,22.387,URINE+SERUM
A0A5F5XSY1_FELCA,C-X-C motif chemokine,PPBP,22.039,24.086,27.230,URINE+SERUM
A0A0A0MPZ9_FELCA,Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8),PPIA,21.322,17.312,18.049,URINE
PPIA_FELCA,"Peptidyl-prolyl cis-trans isomerase A (PPIase A) (EC 5.2.1.8) (Cyclophilin A) (Cyclosporin A-binding protein) (Rotamase A) [Cleaved into: Peptidyl-prolyl cis-trans isomerase A, N-terminally processed]",PPIA CYPA,23.552,21.878,22.027,URINE
A0A2I2UBH3_FELCA,Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8),PPIB,22.335,20.967,19.807,URINE+SERUM
A0A2I2V3I6_FELCA,Rho-related GTP-binding protein RhoC,PPM1J,21.985,17.254,16.550,URINE
A0A2I2V4A6_FELCA,Protein phosphatase 2 scaffold subunit Aalpha,PPP2R1A,16.200,17.000,16.438,URINE+SERUM+PLASMA
A0A2I2V332_FELCA,Protein phosphatase 4 regulatory subunit 4,PPP4R4,18.615,22.644,17.824,PLASMA
A0A337SU18_FELCA,Palmitoyl-protein thioesterase 1,PPT1,19.298,14.296,14.423,URINE
A0A5F5XW18_FELCA,Palmitoyl-protein thioesterase 2,PPT2,19.416,20.102,19.529,URINE+SERUM+PLASMA
A0A2I2UW10_FELCA,Protease associated domain containing 1,PRADC1,23.915,20.940,20.995,URINE
A0A2I2UQ65_FELCA,thioredoxin-dependent peroxiredoxin (EC 1.11.1.24),PRDX1,23.732,20.267,21.087,URINE
A0A2I2UZE5_FELCA,Peroxiredoxin-1 (EC 1.11.1.24),PRDX1,23.595,21.960,22.323,URINE
M3VUU2_FELCA,Peroxiredoxin-2 (EC 1.11.1.24) (Thioredoxin-dependent peroxiredoxin 2),PRDX2,18.785,19.682,21.035,SERUM
A0A337SIG9_FELCA,Peroxiredoxin-2 (EC 1.11.1.24) (Thioredoxin-dependent peroxiredoxin 2),PRDX2,23.075,23.012,23.665,URINE+SERUM+PLASMA
A0A5F5XXB7_FELCA,"Thioredoxin-dependent peroxide reductase, mitochondrial (EC 1.11.1.24) (Thioredoxin-dependent peroxiredoxin 3)",PRDX3,26.154,21.010,21.001,URINE
A0A5F5XS51_FELCA,thioredoxin-dependent peroxiredoxin (EC 1.11.1.24),PRDX4,17.054,15.118,14.465,URINE
M3X1J5_FELCA,Peroxiredoxin-5 (EC 1.11.1.24),PRDX5,21.716,18.625,18.531,URINE
A0A2I2UL25_FELCA,Peroxiredoxin-6 (EC 1.11.1.27),PRDX6,24.206,20.927,21.075,URINE
A0A337S4R1_FELCA,cAMP-dependent protein kinase type II-alpha regulatory subunit,PRKAR2A,16.374,16.483,14.896,URINE+PLASMA
M3W340_FELCA,Glucosidase 2 subunit beta,PRKCSH,20.854,18.612,19.543,URINE
PRIO_FELCA,Major prion protein (PrP) (CD antigen CD230),PRNP PRP,25.634,18.776,19.043,URINE
PROC_FELCA,Vitamin K-dependent protein C (EC 3.4.21.69) (Anticoagulant protein C) (Autoprothrombin IIA) (Blood coagulation factor XIV),PROC,21.533,23.666,23.694,URINE+SERUM
A0A337SJB3_FELCA,Vitamin K-dependent protein C (EC 3.4.21.69) (Anticoagulant protein C) (Autoprothrombin IIA) (Blood coagulation factor XIV),PROC,24.533,23.410,23.424,URINE
A0A5F5XMS8_FELCA,Protein C receptor,PROCR,25.352,20.057,19.422,URINE
A0A2I2U9S5_FELCA,Prominin 1,PROM1,22.953,22.380,20.812,URINE+SERUM
M3WDQ9_FELCA,Prominin 2,PROM2,24.298,24.778,24.822,URINE+SERUM+PLASMA
A0A2I2USJ0_FELCA,Vitamin K-dependent protein S,PROS1,25.640,27.171,26.791,URINE+PLASMA
A0A5F5XIU4_FELCA,Vitamin K-dependent protein S,PROS1,21.666,22.030,20.102,URINE+PLASMA
A0A5F5XCK5_FELCA,Proline rich transmembrane protein 4,PRRT4 RBM28,17.637,14.639,12.827,URINE+SERUM
A0A5F5XUE5_FELCA,trypsin (EC 3.4.21.4),PRSS2,23.493,19.176,19.205,URINE
A0A337RTP4_FELCA,Serine protease 22,PRSS22,23.967,20.197,19.314,URINE
M3W107_FELCA,Inactive serine protease 35,PRSS35,19.616,16.921,15.946,URINE
A0A5F5XEN1_FELCA,Serine protease 53,PRSS53,20.990,19.029,19.262,URINE
A0A5F5XKF7_FELCA,Serine protease 8,PRSS8,26.604,19.183,18.630,URINE
A0A5F5XI47_FELCA,Prosaposin,PSAP,30.800,21.695,22.237,URINE
A0A2I2UM62_FELCA,Prostate stem cell antigen,PSCA,24.858,18.416,18.722,URINE
M3WF05_FELCA,Proteasome subunit alpha type,PSMA1,12.389,19.083,19.213,URINE+SERUM
A0A5F5XCX3_FELCA,Proteasome 20S subunit alpha 1,PSMA1,23.944,23.351,23.298,URINE+SERUM+PLASMA
A0A2I2V2W1_FELCA,Proteasome 20S subunit alpha 2,PSMA2,15.757,20.090,20.152,URINE+SERUM
M3XAA2_FELCA,Proteasome subunit alpha type,PSMA2,15.805,20.599,20.599,URINE+SERUM
A0A337SD26_FELCA,Proteasome subunit alpha type,PSMA3,18.504,20.780,19.647,URINE+PLASMA
A0A337S5C8_FELCA,Proteasome subunit alpha type,PSMA4,19.874,20.376,20.469,URINE+SERUM+PLASMA
A0A337SKX0_FELCA,Proteasome subunit alpha type,PSMA4,18.037,19.384,19.489,URINE+SERUM
A0A337SNJ1_FELCA,Proteasome subunit alpha type,PSMA6,17.605,18.528,18.494,URINE+SERUM+PLASMA
A0A2D0UF31_FELCA,Proteasome subunit alpha type,PSMA6,20.240,19.258,19.373,URINE+SERUM+PLASMA
A0A337SVW8_FELCA,Proteasome 20S subunit alpha 6,PSMA6,12.761,16.630,16.676,URINE+SERUM
A0A337S4A1_FELCA,Proteasome subunit alpha type-7,PSMA7,19.771,22.554,22.736,URINE+SERUM
M3W006_FELCA,Proteasome subunit alpha type,PSMA7,17.422,20.347,20.370,URINE+SERUM
A0A5F5XFT3_FELCA,Proteasome subunit beta,PSMB1,23.089,22.351,22.148,URINE+SERUM+PLASMA
A0A5F5XQW5_FELCA,Proteasome 20S subunit beta 1,PSMB1,15.844,21.010,21.290,URINE+SERUM
A0A2D0UJY9_FELCA,Proteasome subunit beta,PSMB2,23.087,22.928,22.837,URINE+SERUM+PLASMA
A0A5F5XNT6_FELCA,Proteasome subunit beta,PSMB3,18.425,18.391,18.184,URINE+SERUM+PLASMA
A0A2D0UF13_FELCA,Proteasome subunit beta type-4,PSMB4,17.663,19.447,19.588,URINE+SERUM
A0A337SNC1_FELCA,Proteasome subunit beta,PSMB5,20.582,19.423,19.774,URINE
A0A2I2U3F3_FELCA,Proteasome subunit beta,PSMB6,20.209,20.040,20.228,URINE+SERUM+PLASMA
M3WKX9_FELCA,Proteasome subunit beta,PSMB7,18.452,19.501,19.569,URINE+SERUM
A0A2D0UUN5_FELCA,Proteasome subunit beta,PSMB8,19.367,20.870,20.810,URINE+PLASMA
M3W4B6_FELCA,Proteasome activator complex subunit 1 (Proteasome activator 28 subunit alpha),PSME1,16.292,14.103,15.924,URINE+SERUM
A0A337SNE1_FELCA,Phosphotriesterase-related protein (Parathion hydrolase-related protein),PTER,20.535,20.373,21.295,URINE+SERUM+PLASMA
PTGDS_FELCA,Prostaglandin-H2 D-isomerase (EC 5.3.99.2) (Glutathione-independent PGD synthase) (Lipocalin-type prostaglandin-D synthase) (Prostaglandin-D2 synthase) (PGD2 synthase) (PGDS) (PGDS2),PTGDS,27.182,20.658,20.701,URINE
A0A2I2UXS9_FELCA,Prostaglandin E2 receptor EP3 subtype (Prostanoid EP3 receptor),PTGER3,20.405,13.035,12.027,URINE+SERUM
M3VXN4_FELCA,Prostaglandin F2 receptor inhibitor,PTGFRN,23.395,20.672,21.301,URINE
A0A2I2V040_FELCA,Prostaglandin reductase 1 (EC 1.3.1.48) (EC 1.3.1.74) (15-oxoprostaglandin 13-reductase) (Dithiolethione-inducible gene 1 protein) (Leukotriene B4 12-hydroxydehydrogenase) (NAD(P)H-dependent alkenal/one oxidoreductase),PTGR1,15.170,16.041,16.402,SERUM
A0A337SBR8_FELCA,Protein tyrosine kinase 7 (inactive),PTK7,20.908,16.018,15.063,URINE
A0A337S1R3_FELCA,Prothymosin alpha,PTMA,21.102,16.632,16.665,URINE
A0A337RYS5_FELCA,protein-tyrosine-phosphatase (EC 3.1.3.48),PTPRD,25.137,22.103,22.206,URINE
A0A2I2UTT3_FELCA,Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48),PTPRF,24.204,21.047,21.334,URINE
A0A337S5F4_FELCA,protein-tyrosine-phosphatase (EC 3.1.3.48),PTPRG,25.225,21.188,21.291,URINE
A0A5F5XBP3_FELCA,protein-tyrosine-phosphatase (EC 3.1.3.48),PTPRJ,19.773,20.890,21.054,URINE+SERUM
A0A337RY95_FELCA,protein-tyrosine-phosphatase (EC 3.1.3.48),PTPRK,23.035,21.181,20.648,URINE
A0A2I2URE9_FELCA,Protein tyrosine phosphatase receptor type N,PTPRN,16.810,15.723,15.550,URINE
A0A337S6M3_FELCA,protein-tyrosine-phosphatase (EC 3.1.3.48),PTPRO,18.495,20.949,21.245,URINE+SERUM
A0A337SCB7_FELCA,protein-tyrosine-phosphatase (EC 3.1.3.48),PTPRS,20.400,18.054,17.720,URINE
A0A337SQ52_FELCA,Pentraxin 4,PTX4,22.145,18.920,19.190,URINE
A0A2I2UHS4_FELCA,Pseudouridine 5'-phosphatase,PUDP,17.914,17.392,16.910,URINE
M3W8T7_FELCA,tRNA pseudouridine(55) synthase (EC 5.4.99.25),PUS10,19.176,19.372,20.141,URINE+SERUM+PLASMA
A0A2I2UQ14_FELCA,Peroxidasin,PXDN,22.070,22.975,20.517,URINE+PLASMA
A0A5F5XPQ2_FELCA,Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 2,PYROXD2,15.869,17.138,16.678,PLASMA
M3WST2_FELCA,Glutaminyl-peptide cyclotransferase (EC 2.3.2.5) (Glutaminyl cyclase) (Glutaminyl-tRNA cyclotransferase),QPCT,25.307,22.989,23.204,URINE
M3WH13_FELCA,glutaminyl-peptide cyclotransferase (EC 2.3.2.5),QPCTL,20.733,20.709,20.454,URINE+SERUM+PLASMA
A0A5F5Y4S8_FELCA,Nicotinate-nucleotide pyrophosphorylase [carboxylating] (EC 2.4.2.19) (Quinolinate phosphoribosyltransferase [decarboxylating]),QPRT,22.094,19.383,19.424,URINE
A0A2I2UE17_FELCA,Sulfhydryl oxidase (EC 1.8.3.2),QSOX1,25.673,22.661,22.679,URINE
A0A5F5XH70_FELCA,Ras-related protein Rab-10,RAB10,20.641,20.105,20.514,URINE+SERUM+PLASMA
A0A5F5XXR7_FELCA,Ras-related protein Rab-11A (EC 3.6.5.2),RAB11A,23.642,22.752,22.989,URINE+SERUM+PLASMA
A0A337S2P7_FELCA,RAB11 family interacting protein 5,RAB11FIP5,19.265,19.040,19.180,URINE+SERUM+PLASMA
M3WTD7_FELCA,Ras-related protein Rab-14,RAB14,19.154,15.634,14.965,URINE
A0A2I2UQJ5_FELCA,small monomeric GTPase (EC 3.6.5.2),RAB1B,21.750,19.613,19.180,URINE
A0A2I2UAX8_FELCA,small monomeric GTPase (EC 3.6.5.2),RAB27B,17.751,17.588,17.237,URINE+SERUM+PLASMA
A0A2I2U095_FELCA,"RAB35, member RAS onco family",RAB35,22.056,16.226,16.578,URINE
M3VYK6_FELCA,Ras-related protein Rab-3,RAB3D,21.122,19.202,18.567,URINE
A0A2I2UAA6_FELCA,Ras-related protein Rab-4,RAB4A,20.438,14.322,13.031,URINE+SERUM
A0A5F5XRP9_FELCA,Ras-related protein Rab-4,RAB4B,19.781,16.334,17.774,URINE+SERUM
A0A337SHI5_FELCA,small monomeric GTPase (EC 3.6.5.2),RAB5A,20.772,23.171,23.729,URINE+SERUM
A0A337SSM4_FELCA,small monomeric GTPase (EC 3.6.5.2),RAB5B,19.204,16.809,16.950,URINE
M3VXZ7_FELCA,small monomeric GTPase (EC 3.6.5.2),RAB5C,20.050,20.105,20.313,URINE+SERUM+PLASMA
A0A337SFP3_FELCA,Ras-related protein Rab-7a,RAB7A,19.220,17.363,17.164,URINE
M3WRD9_FELCA,Ras-related protein Rab-7a,RAB7A,19.012,11.745,12.925,URINE+SERUM
A0A2I2UMT8_FELCA,Ras-related protein Rab-8A (EC 3.6.5.2),RAB8A,22.056,16.226,16.578,URINE
A0A337SNI2_FELCA,Rac family small GTPase 3,RAC3,22.895,20.926,21.023,URINE
M3WAZ7_FELCA,Receptor activity modifying protein 2,RAMP2,19.497,12.934,12.743,URINE
M3WXV4_FELCA,GTP-binding nuclear protein Ran,RAN,18.726,16.777,17.849,URINE+SERUM
M3X4J3_FELCA,small monomeric GTPase (EC 3.6.5.2),RAP1A,21.701,19.494,18.863,URINE
A0A2I2UBH5_FELCA,"RAP2C, member of RAS onco family",RAP2C,16.130,16.205,17.547,SERUM
A0A2I2UHV5_FELCA,Retinoic acid receptor responder protein 2 (Chemerin),RARRES2,18.199,19.445,19.386,URINE+PLASMA
A0A2I2UGF8_FELCA,Retinol binding protein 1,RBP1,20.336,19.014,20.415,URINE+SERUM
RET4_FELCA,Retinol binding protein 4 (Feline conceptus protein 1) (fCP1) (Plasma retinol-binding protein) (PRBP) (RBP),RBP4,24.893,26.687,26.712,URINE+SERUM
A0A337S713_FELCA,RCAN family member 3,RCAN3,24.039,13.938,13.231,URINE
M3VTY8_FELCA,Reticulocalbin 3,RCN3,21.144,18.002,18.033,URINE
A0A2I2U2A3_FELCA,Radixin,RDX,25.537,21.844,22.169,URINE
A0A2I2UJB3_FELCA,Radixin,RDX,19.204,17.415,16.645,URINE
A0A5F5XK46_FELCA,Reversion inducing cysteine rich protein with kazal motifs,RECK,21.627,23.169,23.451,URINE+SERUM
A0A1E1FFM2_FELCA,Dickkopf 3 homolog,REIC Dkk-3,21.176,20.201,19.680,URINE
M3VZA9_FELCA,RELT TNF receptor,RELT,20.616,13.168,13.160,URINE
M3WNP8_FELCA,N-acylglucosamine 2-epimerase (EC 5.1.3.8) (GlcNAc 2-epimerase) (N-acetyl-D-glucosamine 2-epimerase) (Renin-binding protein),RENBP,18.618,17.694,16.935,URINE
A0A337S746_FELCA,Resistin,RETN,23.634,14.714,15.153,URINE
A0A337SCF8_FELCA,Resistin,RETN,23.953,18.925,18.153,URINE
A0A5F5XYD7_FELCA,"Beta-1,3-N-acetylglucosaminyltransferase (EC 2.4.1.222) (O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase)",RFNG,16.153,14.149,13.844,URINE
A0A337SGN2_FELCA,Repulsive guidance molecule BMP co-receptor a,RGMA,22.888,16.300,15.403,URINE
A0A2I2V4L0_FELCA,Regucalcin (EC 3.1.1.17) (Gluconolactonase) (Senescence marker protein 30),RGN,18.642,12.981,14.580,URINE+SERUM
A0A337SD93_FELCA,Inactive rhomboid protein (iRhom) (Rhomboid family member) (Rhomboid veinlet-like protein),RHBDF2,15.971,12.559,11.198,URINE+SERUM
M3WHT7_FELCA,Ammonium transporter Rh type C (Rhesus blood group family type C glycoprotein),RHCG,20.152,13.259,13.541,URINE
A0A5F5XH32_FELCA,Ammonium transporter Rh type C (Rhesus blood group family type C glycoprotein),RHCG,21.332,19.852,19.325,URINE
M3WU80_FELCA,Transforming protein RhoA,RHOA,19.563,17.951,17.931,URINE
A0A2I2UTY4_FELCA,Ras homolog family member Q,RHOQ,21.210,17.232,17.920,URINE
A0A2I2UD52_FELCA,2-iminobutanoate/2-iminopropanoate deaminase (EC 3.5.99.10) (Translation inhibitor L-PSP ribonuclease),RIDA,23.100,19.041,19.724,URINE
A0A5F5Y3Z8_FELCA,"Ribonuclease A family member 1, pancreatic",RNASE1,27.063,17.068,17.943,URINE
A0A337SES4_FELCA,Ribonuclease 4,RNASE4,19.662,22.006,21.654,URINE+PLASMA
M3WX61_FELCA,Ribonuclease A family member k6,RNASE6,24.234,18.730,18.066,URINE
A0A337S1U9_FELCA,Ribonuclease T2,RNASET2,23.684,21.225,20.875,URINE
A0A5F5XMF6_FELCA,RING-type E3 ubiquitin transferase (EC 2.3.2.27),RNF13,19.894,15.602,15.667,URINE
A0A337STQ6_FELCA,Ring finger protein 149,RNF149,18.181,17.495,18.024,URINE+SERUM+PLASMA
A0A2I2UIU2_FELCA,RING-type E3 ubiquitin transferase (EC 2.3.2.27),RNF167,20.486,20.275,19.863,URINE+SERUM+PLASMA
M3W6G1_FELCA,Roundabout guidance receptor 4,ROBO4,23.141,18.667,18.617,URINE
A0A2I2USV9_FELCA,Receptor tyrosine kinase like orphan receptor 1,ROR1,23.537,17.816,18.331,URINE
A0A2I2UXP2_FELCA,Receptor tyrosine kinase like orphan receptor 2,ROR2,23.357,19.898,19.778,URINE
M3X277_FELCA,RAS related,RRAS,21.443,19.411,18.641,URINE
M3WBP8_FELCA,RAS related 2,RRAS2,22.556,20.088,19.875,URINE
M3WH96_FELCA,"RTF1 homolog, Paf1/RNA polymerase II complex component",RTF1,18.214,13.465,12.636,URINE
A0A2I2U7X2_FELCA,Reticulon 4 receptor,RTN4R,22.778,20.912,20.612,URINE
A0A2I2U066_FELCA,Reticulon 4 receptor like 1,RTN4RL1,15.070,12.347,12.479,URINE
A0A337S5J7_FELCA,Reticulon 4 receptor like 2,RTN4RL2,24.879,21.696,21.635,URINE
M3VZI2_FELCA,Receptor like tyrosine kinase,RYK,17.103,13.280,11.150,URINE+SERUM
M3WK02_FELCA,S100 calcium binding protein A12,S100A12,15.992,14.648,13.652,URINE
A0A2I2URR0_FELCA,Protein S100 (S100 calcium-binding protein),S100A6,20.389,16.853,16.521,URINE
M3VZX1_FELCA,Protein S100 (S100 calcium-binding protein),S100A9,19.603,16.604,16.777,URINE
M3W6R4_FELCA,Sphingosine 1-phosphate receptor 1 (Sphingosine 1-phosphate receptor Edg-1),S1PR1,18.044,18.881,18.592,URINE+SERUM+PLASMA
Q1T771_FELCA,Serum amyloid A protein,SAA,16.918,18.117,18.084,URINE+PLASMA
SAA_FELCA,Serum amyloid A protein (SAA) [Cleaved into: Amyloid protein A (Amyloid fibril protein AA)],SAA1,20.646,20.047,20.530,URINE+SERUM+PLASMA
A0A337SKP2_FELCA,Serum amyloid A protein,SAA1 LOC105260977,16.640,16.610,17.645,SERUM
A0A5F5XKD6_FELCA,Suprabasin,SBSN,24.207,18.589,16.723,URINE+SERUM
A0A337RY68_FELCA,Scavenger receptor class B member 2,SCARB2,19.124,16.685,16.711,URINE
M3WQ85_FELCA,Carboxypeptidase (EC 3.4.16.-),SCPEP1,22.069,18.843,19.293,URINE
A0A5F5XHE0_FELCA,Secernin-2,SCRN2,22.734,27.315,26.175,URINE+PLASMA
M3WBA3_FELCA,Secernin-2,SCRN2,18.019,21.838,21.009,URINE+PLASMA
A0A2I2UX36_FELCA,"Signal peptide, CUB domain and EGF like domain containing 1",SCUBE1,21.876,22.246,16.288,URINE+PLASMA
A0A337SWS1_FELCA,"Signal peptide, CUB domain and EGF like domain containing 2",SCUBE2,24.141,20.411,19.269,URINE+SERUM
A0A5F5XNW4_FELCA,Syndecan 1,SDC1,20.425,15.364,16.319,URINE
A0A337S649_FELCA,Syndecan,SDC2,21.690,14.584,14.587,URINE
M3X6M9_FELCA,Syndecan 4,SDC4,26.999,19.775,19.907,URINE
A0A337S0T3_FELCA,Syndecan binding protein,SDCBP,24.459,25.942,27.042,URINE+SERUM
A0A5F5XYV1_FELCA,Syndecan binding protein,SDCBP,19.570,10.624,10.501,URINE
M3W808_FELCA,45 kDa calcium-binding protein (Stromal cell-derived factor 4),SDF4,23.823,20.173,20.484,URINE
A0A2I2UXY4_FELCA,Methanethiol oxidase (MTO) (EC 1.8.3.4) (Selenium-binding protein 1),SELENBP1,23.299,21.517,21.880,URINE
M3VXE7_FELCA,Methanethiol oxidase (MTO) (EC 1.8.3.4) (Selenium-binding protein 1),SELENBP1,21.978,20.097,20.259,URINE
A0A337S3N8_FELCA,Selenoprotein F,SELENOF,19.759,20.046,21.146,SERUM
A0A2I2U2J6_FELCA,L-selectin,SELL,21.246,21.299,21.196,URINE+SERUM+PLASMA
M3XD95_FELCA,Semaphorin 4B,SEMA4B,21.207,18.879,18.446,URINE
M3W1S6_FELCA,Semaphorin 4D,SEMA4D,17.728,13.384,13.747,URINE
A0A337SKV9_FELCA,Semaphorin 4D,SEMA4D,21.523,19.431,19.464,URINE
A0A337S4F4_FELCA,Semaphorin 5A,SEMA5A,18.088,15.830,14.580,URINE+SERUM
A0A337RVW7_FELCA,Semaphorin 5A,SEMA5A,19.469,18.082,18.802,URINE
A0A337S8G3_FELCA,Septin,SEPTIN2,19.263,20.448,19.870,PLASMA
A0A5F5XW04_FELCA,Serpin family A member 1,SERPINA1,28.422,29.994,30.158,URINE+SERUM
M3WCX1_FELCA,Serpin family A member 1,SERPINA1,28.405,29.915,30.002,URINE+SERUM
M3WCX2_FELCA,Serpin family A member 11,SERPINA11,14.648,14.593,14.343,URINE+SERUM+PLASMA
M3WCX6_FELCA,Serpin family A member 3,SERPINA3,22.075,23.414,23.445,URINE+SERUM
M3WCX4_FELCA,Serpin family A member 4,SERPINA4,21.825,24.520,24.423,URINE+PLASMA
A0A5F5Y5G3_FELCA,Serpin family A member 5,SERPINA5,19.597,18.960,19.050,URINE+SERUM+PLASMA
M3WCX0_FELCA,Corticosteroid-binding globulin (Serpin A6) (Transcortin),SERPINA6,26.750,24.490,24.529,URINE
M3W9H4_FELCA,Serpin B10,SERPINB10,21.042,19.302,20.729,URINE+SERUM
A0A2I2UQ88_FELCA,Serpin family B member 11,SERPINB11,16.202,15.840,10.176,URINE+SERUM
A0A2I2UMR7_FELCA,Serpin family B member 12,SERPINB12,24.345,20.665,22.455,URINE+SERUM
M3WLL8_FELCA,Antithrombin-III (Serpin C1),SERPINC1,28.217,31.240,31.351,URINE+SERUM
M3W543_FELCA,Serpin family D member 1,SERPIND1,24.565,28.173,28.209,URINE+SERUM
M3W4Q4_FELCA,Plasminogen activator inhibitor 1 (Endothelial plasminogen activator inhibitor) (Serpin E1),SERPINE1,14.194,15.930,16.537,URINE+SERUM
M3W5N1_FELCA,Serpin family F member 1,SERPINF1,25.228,28.640,28.739,URINE+SERUM
M3W5N0_FELCA,Serpin family F member 2,SERPINF2,23.381,25.169,25.131,URINE+PLASMA
A0A2I2U9A5_FELCA,Serpin family F member 2,SERPINF2,26.115,28.469,28.396,URINE+PLASMA
A0A5F5XDM5_FELCA,Serpin family G member 1,SERPING1,24.624,28.264,28.844,URINE+SERUM
A0A5F5Y090_FELCA,Serpin family G member 1,SERPING1,20.385,24.748,25.229,URINE+SERUM
A0A5F5XLC7_FELCA,Serpin family I member 1,SERPINI1,26.316,23.300,23.983,URINE
A0A5F5Y312_FELCA,Stratifin,SFN,22.361,18.778,18.986,URINE
A0A2I2UR94_FELCA,Secreted frizzled-related protein 1,SFRP1,18.622,13.708,13.866,URINE
M3X0E0_FELCA,Secreted frizzled related protein 4,SFRP4,22.408,14.360,15.232,URINE
M3WNK3_FELCA,Pulmonary surfactant-associated protein B (Pulmonary surfactant-associated proteolipid SPL(Phe)),SFTPB,20.349,13.475,13.253,URINE
A0A337SBP5_FELCA,Sarcoglycan alpha,SGCA,22.192,16.287,16.060,URINE
M3VVP5_FELCA,N-sulfoglucosamine sulfohydrolase,SGSH,24.370,22.325,21.909,URINE
A0A337RXI4_FELCA,SH2B adaptor protein 1,SH2B1,20.538,16.494,18.700,URINE+SERUM
M3WHM8_FELCA,SH3 domain-binding glutamic acid-rich-like protein 3,SH3BGRL3,28.897,18.311,18.348,URINE
A0A5F5XDP8_FELCA,Sex hormone-binding globulin,SHBG,23.473,26.606,26.463,URINE+PLASMA
A0A337SFV1_FELCA,Sex hormone-binding globulin,SHBG,21.835,24.629,24.748,URINE+SERUM
A0A5F5Y6V8_FELCA,Sex hormone-binding globulin,SHBG,16.185,21.343,21.227,URINE+PLASMA
A0A337S703_FELCA,Shisa family member 2,SHISA2,22.180,13.796,15.096,URINE+SERUM
A0A337SBU4_FELCA,Shisa family member 3,SHISA3,19.148,12.199,13.466,URINE+SERUM
M3VUS4_FELCA,Shisa family member 4,SHISA4,18.108,10.721,10.461,URINE
A0A2I2UZT1_FELCA,Protein shisa-5 (Scotin),SHISA5,28.067,19.419,18.609,URINE
A0A337S6F7_FELCA,Shisa family member 6,SHISA6,20.568,12.899,10.832,URINE+SERUM
A0A5F5Y5C4_FELCA,Shisa family member 7,SHISA7,18.119,10.903,10.320,URINE
A0A2I2UL92_FELCA,Shroom family member 1,SHROOM1,22.915,23.640,24.033,SERUM
M3W6U8_FELCA,Sialic acid acetylesterase,SIAE,23.616,18.053,18.494,URINE
M3VYU4_FELCA,Sialic acid acetylesterase,SIAE,22.681,20.374,21.267,URINE
A0A2I2UGY0_FELCA,Solute carrier family 12 member 1,SLC12A1,24.278,24.032,23.252,URINE
A0A5F5XD74_FELCA,Solute carrier family 12 member 3,SLC12A3,21.259,21.531,20.770,URINE+SERUM+PLASMA
M3WNL1_FELCA,Solute carrier family 12 member 4,SLC12A4,23.915,25.484,25.622,URINE+SERUM
A0A2I2USM1_FELCA,Monocarboxylate transporter 1 (Solute carrier family 16 member 1),SLC16A1,22.265,21.624,24.250,SERUM
A0A337SUE7_FELCA,Solute carrier family 22 member 1 (Organic cation transporter 1),SLC22A1,20.492,22.172,22.462,URINE+SERUM
A0A337SCZ5_FELCA,Solute carrier family 22 member 11,SLC22A11,19.018,15.079,13.442,URINE+SERUM
A0A337RV27_FELCA,Solute carrier family 22 member 12,SLC22A12,22.309,23.648,23.203,PLASMA
M3WGV2_FELCA,Solute carrier family 22 member 13,SLC22A13,21.535,19.526,20.894,URINE+SERUM
M3VX59_FELCA,Solute carrier family 23 member 1,SLC23A1,21.523,21.880,21.471,URINE+SERUM+PLASMA
A0A2I2UUV9_FELCA,"Solute carrier family 25 member 3 (Phosphate carrier protein, mitochondrial) (Phosphate transport protein)",SLC25A3,22.044,18.520,18.477,URINE
A0A2I2URL1_FELCA,"ADP/ATP translocase (ADP,ATP carrier protein)",SLC25A4,17.672,19.585,16.301,URINE+PLASMA
A0A5F5XZL1_FELCA,Solute carrier family 28 member 1,SLC28A1,20.866,14.622,14.377,URINE
A0A2I2UA74_FELCA,"Solute carrier family 2, facilitated glucose transporter member 5 (Fructose transporter) (Glucose transporter type 5, small intestine)",SLC2A5,19.429,19.433,17.801,URINE+PLASMA
M3VWU4_FELCA,Sodium-dependent phosphate transport protein 2A (Na(+)-dependent phosphate cotransporter 2A) (Sodium/phosphate cotransporter 2A) (Solute carrier family 34 member 1),SLC34A1,20.052,20.279,20.381,URINE+SERUM+PLASMA
M3VV37_FELCA,Solute carrier family 3 member 1,SLC3A1,24.716,26.398,26.409,URINE+SERUM
M3WLC0_FELCA,Solute carrier family 3 member 2,SLC3A2,22.815,17.919,18.190,URINE
A0A2I2U4M0_FELCA,Choline transporter-like protein,SLC44A2,20.002,23.861,23.940,URINE+SERUM
A0A2I2UF62_FELCA,Anion exchange protein,SLC4A4,16.804,12.978,11.171,URINE+SERUM
A0A337SG91_FELCA,Anion exchange protein,SLC4A4,21.195,19.150,19.929,URINE
A0A5F5XQN8_FELCA,Sodium/glucose cotransporter 1 (High affinity sodium-glucose cotransporter) (Solute carrier family 5 member 1),SLC5A1,21.419,17.660,18.418,URINE
A0A337SAB7_FELCA,Sodium/mannose cotransporter SLC5A10 (Sodium/glucose cotransporter 5) (Solute carrier family 5 member 10),SLC5A10,18.535,14.830,15.047,URINE
M3WJJ1_FELCA,Solute carrier family 5 member 12,SLC5A12,19.408,19.843,19.796,URINE+SERUM+PLASMA
A0A5F5XDQ5_FELCA,Solute carrier family 5 member 2,SLC5A2,21.128,18.951,18.670,URINE
M3WYV4_FELCA,Sodium-coupled monocarboxylate transporter 1 (Electrogenic sodium monocarboxylate cotransporter) (Solute carrier family 5 member 8),SLC5A8,20.189,20.494,21.598,SERUM
A0A5F5XEN6_FELCA,Solute carrier family 5 member 9,SLC5A9,18.023,18.025,17.774,URINE+SERUM+PLASMA
A0A2I2UPJ1_FELCA,Transporter,SLC6A1,19.275,15.002,14.316,URINE
A0A5F5XC30_FELCA,Transporter,SLC6A18,19.531,17.975,18.087,URINE
M3WBM7_FELCA,Transporter,SLC6A19,22.257,17.754,17.365,URINE
M3W1G1_FELCA,Transporter,SLC6A8,20.538,18.524,18.572,URINE
M3XF74_FELCA,Solute carrier organic anion transporter family member,SLCO4C1,21.298,19.253,19.294,URINE
M3VYI8_FELCA,SLIT and NTRK like family member 1,SLITRK1,17.471,18.795,18.667,URINE+PLASMA
A0A2I2U579_FELCA,SLIT and NTRK like family member 6,SLITRK6,16.807,14.559,14.904,URINE
A0A2I2UV69_FELCA,Secreted LY6/PLAUR domain containing 1,SLURP1,20.102,10.777,11.013,URINE
A0A2I2UAJ7_FELCA,Structural maintenance of chromosomes protein,SMC4,20.875,11.263,10.426,URINE
A0A337S693_FELCA,Small integral membrane protein 22,SMIM22,19.884,16.085,16.367,URINE
A0A5F5Y4Q7_FELCA,SPARC related modular calcium binding 1,SMOC1,19.783,19.284,19.825,URINE+SERUM+PLASMA
M3X374_FELCA,Sphingomyelin phosphodiesterase (EC 3.1.4.12),SMPD1,22.543,22.289,22.288,URINE+SERUM+PLASMA
A0A5F5XFM9_FELCA,Sphingomyelin phosphodiesterase acid like 3A,SMPDL3A,20.784,21.969,21.792,URINE+PLASMA
A0A2I2U480_FELCA,Alpha-synuclein,SNCA,17.926,17.876,19.682,SERUM
M3W8Q2_FELCA,Gamma-synuclein,SNCG,21.940,21.188,21.119,URINE+SERUM+PLASMA
M3X4X1_FELCA,Sorting nexin,SNX18,15.651,11.051,10.507,URINE
A0A2I2UPH5_FELCA,Superoxide dismutase [Cu-Zn] (EC 1.15.1.1),SOD1,25.621,22.100,22.374,URINE
A0A2I2U3N0_FELCA,Superoxide dismutase (EC 1.15.1.1),SOD2,19.551,15.788,15.876,URINE
A0A337SS20_FELCA,Superoxide dismutase [Cu-Zn] (EC 1.15.1.1),SOD3,23.696,21.120,21.746,URINE
A0A2I2V1M2_FELCA,Sorbitol dehydrogenase (SDH) (XDH) (EC 1.1.1.14) (EC 1.1.1.9) (L-iditol 2-dehydrogenase) (Polyol dehydrogenase) (Xylitol dehydrogenase),SORD,21.754,20.965,20.375,URINE
A0A5F5XL46_FELCA,Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (Sorting protein-related receptor containing LDLR class A repeats),SORL1,21.871,21.198,21.286,URINE+SERUM+PLASMA
M3WIG3_FELCA,Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (Sorting protein-related receptor containing LDLR class A repeats),SORL1,17.401,16.238,15.836,URINE
A0A5F5XK14_FELCA,Sortilin 1,SORT1,22.920,23.137,21.327,URINE+PLASMA
M3WM95_FELCA,Sortilin 1,SORT1,19.397,10.141,10.576,URINE
A0A5F5XKY6_FELCA,SPARC (Osteonectin) (Secreted protein acidic and rich in cysteine),SPARC,19.286,15.333,15.778,URINE
A0A5F5XR50_FELCA,SPARC like 1,SPARCL1,18.715,17.165,17.138,URINE
A0A2I2U991_FELCA,Cytospin-A,SPECC1L,18.507,22.294,22.455,URINE+SERUM
A0A2I2U9I8_FELCA,Serine protease inhibitor Kazal-type 1 (Pancreatic secretory trypsin inhibitor),SPINK1,23.594,19.704,19.540,URINE
A0A2I2UZ18_FELCA,Kazal-like domain-containing protein,SPINK2,19.179,14.444,14.102,URINE
M3WLW6_FELCA,Serine peptidase inhibitor Kazal type 5,SPINK5,23.038,20.720,19.223,URINE+SERUM
M3X7Y2_FELCA,"Serine peptidase inhibitor, Kunitz type 2",SPINT2,20.099,16.101,15.516,URINE
A0A5F5XHK0_FELCA,"Serine peptidase inhibitor, Kunitz type 2",SPINT2,18.875,13.838,15.650,URINE+SERUM
M3WYD3_FELCA,Theg spermatid protein like,SPMAP2L THEGL,21.364,18.430,18.532,URINE
M3WMU1_FELCA,"SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1",SPOCK1,20.431,20.271,20.347,URINE+SERUM+PLASMA
M3WI49_FELCA,"SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2",SPOCK2,18.947,14.587,15.465,URINE
A0A337RYL8_FELCA,"SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3",SPOCK3,18.556,16.328,15.910,URINE
A0A2I2UM84_FELCA,Spondin 2,SPON2,16.795,15.149,15.417,URINE
A0A2I2UVQ2_FELCA,Secreted phosphoprotein 1,SPP1,26.369,19.768,19.808,URINE
A0A5F5XTV6_FELCA,Secreted phosphoprotein 24 (Secreted phosphoprotein 2),SPP2,23.801,21.973,21.937,URINE
A0A2I2UR05_FELCA,Sepiapterin reductase (EC 1.1.1.153),SPR,20.037,18.912,19.396,URINE
A0A5F5XIW6_FELCA,SREBP regulating gene protein,SPRING1,19.069,14.952,15.681,URINE
M3VVT0_FELCA,SREBP regulating gene protein,SPRING1,16.738,12.785,13.984,URINE+SERUM
A0A2I2U6D2_FELCA,"Spectrin alpha, non-erythrocytic 1",SPTAN1,16.715,18.456,16.839,PLASMA
A0A337S5T6_FELCA,Sarcalumenin,SRL,20.725,16.511,16.269,URINE
A0A5F5XQY8_FELCA,Scavenger receptor cysteine rich family member with 5 domains,SSC5D,18.071,15.272,15.747,URINE
A0A2I2UHD5_FELCA,"Type 2 lactosamine alpha-2,3-sialyltransferase (CMP-NeuAc:beta-galactoside alpha-2,3-sialyltransferase VI) (ST3Gal VI) (Sialyltransferase 10)",ST3GAL6,22.063,18.825,18.909,URINE
M3WJN7_FELCA,"beta-galactoside alpha-(2,6)-sialyltransferase (EC 2.4.3.1)",ST6GAL1,20.082,17.945,19.544,URINE+SERUM
M3WN53_FELCA,Stabilin 1,STAB1,19.551,18.148,18.792,URINE
A0A5F5Y3A1_FELCA,Stanniocalcin-1 (STC-1),STC1,20.684,18.501,18.588,URINE
M3XCB8_FELCA,Stomatin,STOM,20.147,18.872,18.070,URINE
A0A337SUF8_FELCA,Stomatin,STOM,18.531,15.839,16.477,URINE
A0A2I2UP70_FELCA,Syntaxin 3,STX3,20.648,19.934,20.139,URINE+SERUM+PLASMA
M3VWX8_FELCA,Syntaxin-binding protein 2 (Protein unc-18 homolog 2) (Protein unc-18 homolog B),STXBP2,26.140,24.835,22.729,URINE+SERUM
A0A337RXK1_FELCA,Arylsulfatase (EC 3.1.6.1) (EC 3.1.6.14) (N-acetylglucosamine-6-sulfatase),SULF2,24.580,21.498,21.885,URINE
M3WBD8_FELCA,Sushi domain containing 2,SUSD2,21.476,18.251,16.726,URINE+SERUM
A0A5F5XF46_FELCA,Sushi domain containing 5,SUSD5,21.417,19.196,17.745,URINE+SERUM
M3VZE1_FELCA,Sushi domain containing 5,SUSD5,23.233,19.180,18.891,URINE
M3WVG6_FELCA,Synapse associated protein 1,SYAP1,21.482,21.777,22.742,SERUM
A0A5F5Y1D6_FELCA,MARVEL domain-containing protein,SYPL1,21.823,20.987,21.514,URINE+SERUM+PLASMA
A0A5F5XQX5_FELCA,Transgelin,TAGLN2,20.775,20.061,20.320,URINE+SERUM+PLASMA
A0A2I2U8C8_FELCA,TAR DNA-binding protein 43,TARDBP,17.210,18.667,19.005,URINE+SERUM
A0A2I2UTP2_FELCA,TBC1 domain family member 31,TBC1D31,23.363,15.763,15.710,URINE
A0A337SNU3_FELCA,TBC1 domain family member 32,TBC1D32,18.504,18.318,18.525,URINE+SERUM+PLASMA
A0A5F5XD47_FELCA,TBC1 domain family member 8B,TBC1D8B,19.716,16.548,16.375,URINE
A0A5F5XJ51_FELCA,Transcobalamin-2 (Transcobalamin II),TCN2,22.645,22.735,22.535,URINE+SERUM+PLASMA
M3X0W1_FELCA,Telomeric repeat-binding factor 2-interacting protein 1 (TERF2-interacting telomeric protein 1) (Repressor/activator protein 1 homolog),TERF2IP,23.558,23.978,23.373,URINE+SERUM+PLASMA
A0A5F5XNI1_FELCA,Transferrin,TF,31.824,33.076,33.301,URINE+SERUM
M3X260_FELCA,Transferrin,TF,25.459,26.797,26.910,URINE+SERUM
A0A5F5XXX0_FELCA,Transferrin,TF,26.985,28.219,28.321,URINE+SERUM
M3WBQ5_FELCA,Transferrin,TF,28.590,29.038,29.140,URINE+SERUM+PLASMA
B4X8D7_FELCA,Trefoil factor 1 (Trefoil factor family peptide 1),TFF1,26.834,19.383,18.060,URINE+SERUM
B4X8D8_FELCA,Trefoil factor 2,TFF2,26.135,19.665,19.521,URINE
M3WI50_FELCA,Tissue factor pathway inhibitor,TFPI,19.184,12.448,12.514,URINE
A0A5F5XDK9_FELCA,Tissue factor pathway inhibitor 2,TFPI2,25.875,18.523,18.444,URINE
TFR1_FELCA,Transferrin receptor protein 1 (TR) (TfR) (TfR1) (Trfr) (CD antigen CD71),TFRC,20.206,20.577,21.020,URINE+SERUM+PLASMA
M3WKJ1_FELCA,Transforming growth factor-beta-induced protein ig-h3,TGFBI,23.568,22.986,23.436,URINE+SERUM+PLASMA
A0A337SBT0_FELCA,TGF-beta receptor type-1 (EC 2.7.11.30) (Transforming growth factor-beta receptor type I),TGFBR1,21.064,19.130,18.304,URINE
A0A5F5XGQ1_FELCA,Serine/threonine-protein kinase receptor (EC 2.7.11.30),TGFBR2,22.100,20.131,21.208,URINE+SERUM
A0A5F5XD94_FELCA,Protein-glutamine gamma-glutamyltransferase 2 (EC 2.3.2.13) (EC 3.5.1.44) (Isopeptidase TGM2) (Protein-glutamine deamidase TGM2) (Protein-glutamine dopaminyltransferase TGM2) (Protein-glutamine histaminyltransferase TGM2) (Protein-glutamine noradrenalinyltransferase TGM2) (Protein-glutamine serotonyltransferase TGM2) (Tissue transglutaminase) (Transglutaminase-2),TGM2,22.591,20.922,21.215,URINE
A0A2I2UM78_FELCA,Transglutaminase 5,TGM5,23.778,24.126,24.628,URINE+SERUM+PLASMA
M3WF45_FELCA,Thrombospondin 1,THBS1,25.982,24.447,24.833,URINE
A0A2I2UG29_FELCA,Thrombospondin 2,THBS2,14.175,10.000,10.167,URINE
M3W148_FELCA,Thrombospondin 4,THBS4,18.829,18.940,18.899,URINE+SERUM+PLASMA
A0A5F5XNC0_FELCA,Thymocyte selection associated family member 2,THEMIS2,18.909,18.243,18.333,URINE+SERUM+PLASMA
A0A2I2UGV7_FELCA,Thy-1 membrane glycoprotein (Thy-1 antigen),THY1,26.357,19.971,19.781,URINE
A0A337S209_FELCA,receptor protein-tyrosine kinase (EC 2.7.10.1),TIE1,21.769,20.722,21.357,URINE
A0A337SK12_FELCA,T cell immunoreceptor with Ig and ITIM domains,TIGIT,20.073,15.485,14.846,URINE
A0A2I2UP29_FELCA,T cell immunoglobulin and mucin domain containing 4,TIMD4,28.154,21.247,20.736,URINE
A0A2I2U4F9_FELCA,Metalloproteinase inhibitor 1 (Tissue inhibitor of metalloproteinases 1),TIMP1,22.377,21.287,23.486,URINE+SERUM
M3W949_FELCA,Metalloproteinase inhibitor 1 (Tissue inhibitor of metalloproteinases 1),TIMP1,23.007,22.125,23.431,SERUM
A0A337SHQ6_FELCA,Metalloproteinase inhibitor 2 (Tissue inhibitor of metalloproteinases 2),TIMP2,22.400,22.107,23.348,SERUM
A0A2I2UAQ8_FELCA,Metalloproteinase inhibitor 3 (Tissue inhibitor of metalloproteinases 3),TIMP3,21.252,19.738,19.534,URINE
A0A337SA15_FELCA,Tubulointerstitial nephritis antigen,TINAG,24.882,17.001,17.313,URINE
A0A337S5K9_FELCA,Tubulointerstitial nephritis antigen like 1,TINAGL1,20.896,11.556,11.412,URINE
A0A337S2N1_FELCA,Triokinase/FMN cyclase (EC 2.7.1.28) (EC 2.7.1.29) (EC 4.6.1.15) (Bifunctional ATP-dependent dihydroxyacetone kinase/FAD-AMP lyase (cyclizing)),TKFC,19.668,21.438,21.412,URINE+PLASMA
M3X940_FELCA,Triokinase/FMN cyclase (EC 2.7.1.28) (EC 2.7.1.29) (EC 4.6.1.15) (Bifunctional ATP-dependent dihydroxyacetone kinase/FAD-AMP lyase (cyclizing)),TKFC,18.965,13.325,13.347,URINE
A0A5F5Y1L1_FELCA,Transketolase (EC 2.2.1.1),TKT,21.575,19.469,18.894,URINE
A0A2I2V2A4_FELCA,Talin 1,TLN1,19.937,17.144,17.099,URINE
M3XFJ6_FELCA,Transmembrane 7 superfamily member 3,TM7SF3,22.870,21.463,21.416,URINE
M3WPL3_FELCA,Transmembrane and coiled-coil domains 5B,TMCO5B,19.623,12.201,12.869,URINE
A0A2I2UKF8_FELCA,Transmembrane p24 trafficking protein 7,TMED7,23.402,20.321,20.965,URINE
A0A2I2UFI9_FELCA,Transmembrane p24 trafficking protein 9,TMED9,16.546,15.931,15.508,URINE
M3WBR7_FELCA,Transmembrane protein 102,TMEM102,14.797,15.157,14.987,URINE+SERUM+PLASMA
M3W5X2_FELCA,Transmembrane protein 106B,TMEM106B,24.087,13.447,15.241,URINE+SERUM
A0A337S0Q7_FELCA,Transmembrane protein 123,TMEM123,18.319,12.538,11.693,URINE
A0A5F5XDF0_FELCA,Transmembrane protein 132A,TMEM132A,22.039,21.629,21.495,URINE+SERUM+PLASMA
M3WP30_FELCA,Transmembrane protein 132A,TMEM132A,17.619,16.072,16.130,URINE
M3WSW8_FELCA,Transmembrane protein 256,TMEM256,21.076,12.139,12.223,URINE
A0A5F5XZP8_FELCA,Transmembrane protein 277,TMEM277 KLK1,31.815,18.948,19.404,URINE
A0A5F5XRV1_FELCA,Transmembrane protein 59,TMEM59,20.933,18.979,17.481,URINE+SERUM
A0A2I2U348_FELCA,Transmembrane protein 9,TMEM9,18.778,11.073,10.764,URINE
M3W8X2_FELCA,Transmembrane serine protease 2,TMPRSS2,20.835,17.758,17.207,URINE
M3WTN0_FELCA,Transmembrane serine protease 6,TMPRSS6,16.559,17.119,17.337,URINE+SERUM+PLASMA
A0A2I2UFV7_FELCA,Tenascin C,TNC,26.317,22.980,23.148,URINE
A0A2I2UUG3_FELCA,Tenascin C,TNC,22.661,19.993,20.589,URINE
A0A2I2UQD4_FELCA,TNF receptor superfamily member 11a,TNFRSF11A,20.953,17.917,17.734,URINE
A0A5F5XSD6_FELCA,TNF receptor superfamily member 14,TNFRSF14,21.008,20.154,18.858,URINE+SERUM
A0A2I2V223_FELCA,Tumor necrosis factor receptor superfamily member 1A (Tumor necrosis factor receptor 1) (Tumor necrosis factor receptor type I) (p55) (p60),TNFRSF1A,16.940,12.279,12.964,URINE
A0A337SE86_FELCA,TNF receptor superfamily member 1B,TNFRSF1B,24.351,21.446,22.174,URINE
A0A5F5Y208_FELCA,TNF receptor superfamily member 4,TNFRSF4,18.443,17.582,18.061,URINE+SERUM+PLASMA
A0A337SN48_FELCA,TNF superfamily member 12,TNFSF12,20.734,17.391,16.746,URINE
A0A337S3S3_FELCA,TNF superfamily member 13b,TNFSF13B,19.922,19.347,19.959,URINE+SERUM+PLASMA
A0A337SCZ0_FELCA,Tenascin N,TNN,19.659,14.356,14.250,URINE
M3X9A1_FELCA,Triosephosphate isomerase (EC 5.3.1.1),TPI1,22.728,19.883,20.177,URINE
A0A2I2URE8_FELCA,Tropomyosin alpha-1 chain (Alpha-tropomyosin) (Tropomyosin-1),TPM1,16.593,15.150,15.594,URINE
A0A2I2U057_FELCA,Tropomyosin 3,TPM3,21.320,20.102,20.270,URINE
A0A2I2UY85_FELCA,Tropomyosin 3,TPM3,18.303,18.537,19.422,SERUM
A0A5F5XI45_FELCA,Tropomyosin 3,TPM3,14.214,16.827,16.252,URINE+PLASMA
A0A337RXS4_FELCA,Nucleoprotein TPR,TPR,23.634,21.714,21.678,URINE
A0A337RUS6_FELCA,Triggering receptor expressed on myeloid cells like 1,TREML1,23.193,16.204,18.859,URINE+SERUM
A0A2I2UQM8_FELCA,RING-type E3 ubiquitin transferase (EC 2.3.2.27),TRIM36,20.952,18.440,21.381,URINE+SERUM
A0A337SU32_FELCA,Tumor susceptibility 101,TSG101,22.955,22.123,22.433,URINE+SERUM+PLASMA
A0A337SC81_FELCA,"Tsukushi, small leucine rich proteoglycan",TSKU,18.133,17.605,17.782,URINE+SERUM+PLASMA
M3VUZ7_FELCA,Tetraspanin,TSPAN1,23.314,20.260,18.777,URINE+SERUM
A0A2I2UDW9_FELCA,Tetraspanin,TSPAN3,20.688,19.920,20.738,URINE+SERUM+PLASMA
A0A2I2UB49_FELCA,Tetraspanin,TSPAN8,22.869,20.723,19.570,URINE+SERUM
M3WPX9_FELCA,Tetratricopeptide repeat protein 38,TTC38,17.989,17.605,18.823,SERUM
A0A337SAI4_FELCA,Titin,TTN,22.836,23.898,21.486,URINE+PLASMA
M3WEV9_FELCA,Transthyretin,TTR,28.037,31.190,31.234,URINE+SERUM
A0A337S1Z7_FELCA,Protein tweety homolog,TTYH3,21.957,23.472,19.135,URINE+PLASMA
A0A2I2U1M4_FELCA,Tubulin alpha-1A chain,TUBA1A,21.490,22.186,22.641,SERUM
A0A2I2UVC7_FELCA,Tubulin alpha chain,TUBA1A,20.095,17.994,18.029,URINE
A0A2I2UZ20_FELCA,Tubulin alpha chain,TUBA4A,20.857,18.697,18.339,URINE
A0A2I2UXF6_FELCA,Tubulin beta chain,TUBB2B,17.857,16.761,16.308,URINE
A0A2I2UBF3_FELCA,Tubulin beta chain,TUBB4A,20.190,19.853,20.426,URINE+SERUM+PLASMA
A0A5F5XDY3_FELCA,Tubulin beta 4B class IVb,TUBB4B,20.397,14.457,14.264,URINE
A0A2I2UAT5_FELCA,Tubulin beta chain,TUBB6,22.956,19.274,19.364,URINE
A0A5F5XBV5_FELCA,Tubulin gamma complex associated protein 6,TUBGCP6,22.430,17.694,17.636,URINE
M3X4Y2_FELCA,Twisted gastrulation BMP signaling modulator 1,TWSG1,22.357,18.766,18.734,URINE
A0A337RU81_FELCA,Thioredoxin,TXN,23.143,19.774,20.773,URINE
A0A2I2V2Q8_FELCA,protein disulfide-isomerase (EC 5.3.4.1),TXNDC5,17.818,16.587,17.257,URINE
A0A2I2V0W1_FELCA,"Thioredoxin reductase 1, cytoplasmic (EC 1.11.1.2) (EC 1.8.1.9) (Peroxidase TXNRD1) (Thioredoxin reductase TR1)",TXNRD1,20.809,19.635,19.025,URINE
RL40_FELCA,Ubiquitin-ribosomal protein eL40 fusion protein (Ubiquitin A-52 residue ribosomal protein fusion product 1) [Cleaved into: Ubiquitin; Large ribosomal subunit protein eL40 (60S ribosomal protein L40) (CEP52)],UBA52 UBCEP2,26.906,22.100,22.211,URINE
A0A2I2UFV8_FELCA,E2 ubiquitin-conjugating enzyme (EC 2.3.2.23),UBE2G2,23.847,16.307,16.255,URINE
A0A337S307_FELCA,E2 ubiquitin-conjugating enzyme (EC 2.3.2.23),UBE2L3,16.102,13.101,14.369,URINE+SERUM
M3X7A8_FELCA,Ubiquitin like 7,UBL7,21.081,13.550,14.113,URINE
M3VWB5_FELCA,UDP-glucose glycoprotein glucosyltransferase 1,UGGT1,21.032,20.924,21.029,URINE+SERUM+PLASMA
M3W230_FELCA,Uromodulin,UMOD,32.360,21.165,21.351,URINE
A0A337S3Y7_FELCA,Uroplakin-1b (Uroplakin Ib),UPK1B,16.947,15.245,14.599,URINE
M3WUK1_FELCA,Uroplakin 2,UPK2,18.968,11.795,10.606,URINE+SERUM
A0A5F5XVJ0_FELCA,Uroplakin 3A,UPK3A,17.142,16.510,14.666,URINE+SERUM
A0A5F5XS01_FELCA,Ubiquitin-related modifier 1,URM1,18.205,17.062,18.020,URINE
A0A2I2U2G1_FELCA,USH1 protein network component harmonin,USH1C,13.537,13.875,12.845,PLASMA
A0A5F5Y2F0_FELCA,VAMP associated protein B and C,VAPB,21.531,17.587,17.629,URINE
M3WEQ2_FELCA,Vasorin,VASN,26.603,19.982,19.679,URINE
M3WIA9_FELCA,Vesicle amine transport 1,VAT1,20.858,21.085,21.418,URINE+SERUM+PLASMA
A0A337RXZ6_FELCA,Vascular cell adhesion molecule 1,VCAM1,27.867,24.126,23.946,URINE
M3WED4_FELCA,Vascular cell adhesion molecule 1,VCAM1,25.386,20.647,20.537,URINE
A0A2I2UH10_FELCA,Versican core protein (Chondroitin sulfate proteoglycan core protein 2) (Large fibroblast proteoglycan) (PG-M),VCAN,17.386,15.494,14.895,URINE
M3VW05_FELCA,Transitional endoplasmic reticulum ATPase (EC 3.6.4.6) (15S Mg(2+)-ATPase p97 subunit) (Valosin-containing protein),VCP,19.506,18.657,18.280,URINE
A0A2I2UXU4_FELCA,Voltage-dependent anion-selective channel protein 1,VDAC1,23.583,23.109,23.690,URINE+SERUM+PLASMA
M3X2J1_FELCA,Voltage-dependent anion-selective channel protein 2,VDAC2,23.650,19.584,19.895,URINE
A0A2I2V1K5_FELCA,Voltage-dependent anion-selective channel protein 3,VDAC3,21.094,17.012,17.468,URINE
M3VYE6_FELCA,Villin-1,VIL1,23.801,22.622,22.177,URINE
A0A2I2U8W9_FELCA,Vimentin,VIM,24.141,21.359,21.713,URINE
A0A337SUD5_FELCA,Vasoactive intestinal peptide receptor 1,VIPR1,19.283,14.320,14.518,URINE
A0A2I2UCX4_FELCA,Very low density lipoprotein receptor,VLDLR,18.239,11.471,11.521,URINE
M3W8U6_FELCA,Vitelline membrane outer layer 1 homolog,VMO1,26.771,21.843,21.556,URINE
A0A5F5XTH2_FELCA,Vanin 1,VNN1,23.370,25.186,25.078,URINE+PLASMA
A0A2I2UUX6_FELCA,Vanin 1,VNN1,23.987,25.775,25.744,URINE+PLASMA
A0A337S0D4_FELCA,Vanin 1,VNN1,20.797,23.176,23.205,URINE+SERUM
A0A5F5XLU4_FELCA,Pantetheinase (EC 3.5.1.92) (Pantetheine hydrolase) (Vascular non-inflammatory molecule 1),VNN1,21.865,18.782,17.967,URINE
A0A5F5XLV1_FELCA,Pantetheinase (EC 3.5.1.92) (Pantetheine hydrolase) (Vascular non-inflammatory molecule 1),VNN1,21.248,17.621,17.514,URINE
A0A337SIC4_FELCA,Vacuolar protein sorting-associated protein 16 homolog,VPS16,19.541,18.351,17.355,URINE
A0A5F5XEZ3_FELCA,Vacuolar protein sorting-associated protein 18 homolog,VPS18,22.224,17.084,17.295,URINE
A0A5F5XGU3_FELCA,VPS18 core subunit of CORVET and HOPS complexes,VPS18,22.621,21.720,20.963,URINE
A0A2I2UFC7_FELCA,Vacuolar protein-sorting-associated protein 25 (ESCRT-II complex subunit VPS25),VPS25,19.099,16.430,16.272,URINE
A0A5F5XWJ8_FELCA,Vacuolar protein sorting-associated protein 28 homolog,VPS28,20.049,19.794,18.824,URINE
A0A337SJF6_FELCA,VPS37D subunit of ESCRT-I,VPS37D,20.296,18.943,18.350,URINE
A0A2I2UNJ3_FELCA,vesicle-fusing ATPase (EC 3.6.4.6),VPS4A,24.116,21.194,20.387,URINE
M3WXF7_FELCA,vesicle-fusing ATPase (EC 3.6.4.6),VPS4B,20.955,18.986,19.269,URINE
A0A5F5XJU3_FELCA,V-set and immunoglobulin domain containing 4,VSIG4,20.957,17.469,17.958,URINE
M3WEH0_FELCA,V-set and transmembrane domain containing 2B,VSTM2B,20.508,15.667,15.865,URINE
M3XCE8_FELCA,V-set and transmembrane domain containing 5,VSTM5,18.168,15.178,15.474,URINE
A0A337S1D0_FELCA,Vesicle trafficking 1,VTA1,21.857,21.031,21.114,URINE+SERUM+PLASMA
M3W9I5_FELCA,Vitronectin,VTN,27.509,27.511,27.516,URINE+SERUM+PLASMA
M3WSQ2_FELCA,von Willebrand factor A domain-containing protein 1,VWA1,19.109,17.233,17.674,URINE
M3XCS6_FELCA,von Willebrand factor C and EGF domains,VWCE,19.573,17.935,18.080,URINE
A0A061DD19_FELCA,von Willebrand factor (vWF),VWF,22.815,22.651,22.842,URINE+SERUM+PLASMA
A0A337S7R6_FELCA,von Willebrand factor (vWF),VWF,15.574,15.895,13.719,URINE+PLASMA
M3W7M9_FELCA,WDFY family member 4,WDFY4,15.618,14.072,14.054,URINE
A0A2I2UEP1_FELCA,WD repeat domain 1,WDR1,21.842,21.810,21.977,URINE+SERUM+PLASMA
A0A5F5XN85_FELCA,WD repeat-containing protein 37,WDR37,19.827,20.207,19.568,URINE+SERUM+PLASMA
A0A337SCH3_FELCA,WAP four-disulfide core domain protein 2,WFDC2,28.045,14.613,16.192,URINE+SERUM
M3W8X1_FELCA,X-prolyl aminopeptidase 2,XPNPEP2,17.044,12.279,14.869,URINE+SERUM
M3VVC0_FELCA,Xylosyltransferase 1 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase I),XYLT1,20.319,14.968,14.320,URINE
M3VZR2_FELCA,YEATS domain containing 2,YEATS2,22.315,24.118,23.804,URINE+PLASMA
A0A5F5XCJ6_FELCA,Protein YIPF3 (YIP1 family member 3),YIPF3,28.377,16.524,17.408,URINE
M3WFK3_FELCA,14-3-3 protein beta/alpha,YWHAB,20.659,19.814,20.622,URINE+SERUM+PLASMA
A0A337SCS9_FELCA,14-3-3 protein epsilon,YWHAE,23.432,20.186,20.473,URINE
M3VWG1_FELCA,14-3-3 protein gamma,YWHAG,20.879,19.898,20.189,URINE+SERUM+PLASMA
A0A5F5XZJ4_FELCA,14-3-3 protein theta,YWHAQ,21.789,19.379,20.001,URINE
M3WVC7_FELCA,14-3-3 protein zeta/delta,YWHAZ,22.451,19.706,19.244,URINE
A0A5K1VG18_FELCA,14-3-3 protein zeta/delta,YWHAZ,20.269,14.934,14.320,URINE
A0A2I2UTC5_FELCA,Zinc finger C4H2-type containing,ZC4H2,15.813,20.352,20.249,URINE+PLASMA
A0A5F5XBP5_FELCA,Zymogen granule protein 16B,ZG16B,20.543,19.307,22.462,URINE+SERUM
A0A337SLM1_FELCA,Zinc finger with KRAB and SCAN domains 1,ZKSCAN1,27.248,26.392,26.309,URINE+SERUM+PLASMA
M3WPT0_FELCA,Zinc finger with KRAB and SCAN domains 1,ZKSCAN1,26.582,25.386,25.465,URINE
A0A2I2UXF5_FELCA,Zinc finger with KRAB and SCAN domains 1,ZKSCAN1,24.677,23.231,23.298,URINE
A0A5F5XU81_FELCA,Secreted and transmembrane 1,,28.464,21.395,22.705,URINE+SERUM
A0A2I2U5G8_FELCA,Fibronectin type-III domain-containing protein,,25.746,25.705,25.575,URINE+SERUM+PLASMA
A0A5F5XGI8_FELCA,Filaggrin,,22.489,16.498,16.788,URINE
A0A5F5Y249_FELCA,Envelope polyprotein,,23.015,23.162,23.236,URINE+SERUM+PLASMA
A0A291NGR0_FELCA,IgA constant region,,25.308,21.497,21.439,URINE
A0A337S3R0_FELCA,Sushi domain-containing protein,,27.459,26.302,26.177,URINE
A0A5F5XER5_FELCA,Complement C3,,25.582,29.343,29.488,URINE+SERUM
A0A5F5XL80_FELCA,Anaphylatoxin-like domain-containing protein,,25.914,29.066,29.182,URINE+SERUM
A0A291NH43_FELCA,IgG lambda chain constant region,,15.010,17.169,16.373,URINE+PLASMA
A0A2I2V2Y7_FELCA,Sushi domain-containing protein,,26.561,23.649,23.404,URINE
A0A2I2ULZ3_FELCA,Superoxide dismutase [Cu-Zn] (EC 1.15.1.1),,25.222,18.020,19.869,URINE+SERUM
M3W0R2_FELCA,SRCR domain-containing protein,,22.376,15.545,15.038,URINE
A0A337SP31_FELCA,Galectin,,20.572,18.358,18.609,URINE
T2HUL6_FELCA,Restriction factor for feline retrovirus X,,18.315,20.123,19.808,URINE+PLASMA
A0A291NH71_FELCA,Ig lambda variable,,28.177,25.228,25.866,URINE
A0A291NH36_FELCA,IgG lambda chain constant region,,31.644,29.886,30.071,URINE
A0A291NH39_FELCA,IgG lambda chain constant region,,20.561,20.262,19.320,URINE
A0A976N0B1_FELCA,Endogenous retrovirus group V member 2 Env polyprotein-like,,24.643,19.183,19.665,URINE
M3X050_FELCA,Ig-like domain-containing protein,,22.830,19.819,19.958,URINE
A0A291NGR2_FELCA,IgA constant region,,26.152,21.357,21.770,URINE
A0A2I2V460_FELCA,Trans-golgi network protein 2,,23.552,20.737,21.275,URINE
A0A337SE59_FELCA,"Keratin, type I cytoskeletal 19 (Cytokeratin-19) (Keratin-19)",,22.093,19.241,18.920,URINE
A0A291NGW6_FELCA,IgH variable region,,16.363,17.526,17.299,PLASMA
A0A291NGQ8_FELCA,IgA constant region,,32.033,26.811,27.046,URINE
A0A291NH16_FELCA,Ig kappa chain,,22.924,20.642,20.310,URINE
A0A291NHD0_FELCA,IgG constant region,,30.195,31.183,31.337,SERUM
A0A291NH41_FELCA,Ig kappa chain,,19.351,16.527,17.145,URINE
M3X5X6_FELCA,Sushi domain-containing protein,,25.102,22.500,22.392,URINE
A0A291NGT6_FELCA,IgH variable region,,24.993,24.130,23.874,URINE
A0A2I2UCP1_FELCA,WAP domain-containing protein,,24.468,13.888,14.650,URINE
A0A5F5Y223_FELCA,Sushi domain-containing protein,,25.402,22.343,22.097,URINE
A0A2I2U526_FELCA,Cytochrome c domain-containing protein,,21.158,18.285,18.583,URINE
A0A5F5XCZ4_FELCA,Anaphylatoxin-like domain-containing protein,,24.358,26.678,26.587,URINE+PLASMA
A0A337SKT0_FELCA,EF-hand domain-containing protein,,20.029,18.733,18.877,URINE
A0A2I2UN09_FELCA,Ig-like domain-containing protein,,26.269,26.518,26.569,URINE+SERUM+PLASMA
A0A5F5XS16_FELCA,Sushi domain-containing protein,,21.873,17.136,16.235,URINE
A0A291NH33_FELCA,IgG lambda chain constant region,,28.684,27.803,28.063,URINE+SERUM+PLASMA
A0A5F5XWJ9_FELCA,Ig-like domain-containing protein,,19.621,18.396,18.199,URINE
A0A291NH74_FELCA,IgG lambda chain constant region,,27.994,26.341,26.114,URINE
M3X7R1_FELCA,Ig-like domain-containing protein,,24.481,22.648,22.665,URINE
A0A337S7U4_FELCA,Ig-like domain-containing protein,,27.406,28.108,28.448,SERUM
T2HUV9_FELCA,Restriction factor for feline retrovirus X,,24.538,21.789,21.688,URINE
A0A337SA19_FELCA,Ig-like domain-containing protein,,19.356,19.723,19.763,URINE+SERUM+PLASMA
A0A5F5XRP7_FELCA,Ig-like domain-containing protein,,19.937,16.750,16.782,URINE
A0A291NH73_FELCA,Ig lambda variable,,25.541,22.813,23.172,URINE
A0A5F5XZ87_FELCA,Sushi domain-containing protein,,25.070,22.016,21.943,URINE
A0A2I2V5I2_FELCA,Tripeptidyl-peptidase 1 (EC 3.4.14.9) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I),,25.292,21.648,21.915,URINE
A0A2I2UC18_FELCA,Phosphoglycerate kinase (EC 2.7.2.3),,21.523,18.310,18.396,URINE
A0A2I2ULR9_FELCA,14-3-3 protein epsilon,,23.490,20.797,21.100,URINE
A0A291NGT2_FELCA,IgH variable region,,25.025,24.344,24.062,URINE+SERUM+PLASMA
A0A2I2U5M6_FELCA,Ig-like domain-containing protein,,16.469,17.584,17.760,URINE+SERUM
A0A337SFW4_FELCA,Ig-like domain-containing protein,,19.057,15.303,14.477,URINE
A0A291NH67_FELCA,Ig lambda variable,,27.112,25.845,26.136,URINE
A0A337S672_FELCA,Butyrophilin-like protein 1,,20.092,16.583,17.499,URINE
A0A5F5Y4V7_FELCA,Ig-like domain-containing protein,,22.606,22.278,22.305,URINE+SERUM+PLASMA
A0A5F5XUA3_FELCA,"Mucin 2, oligomeric mucus/gel-forming",,19.355,20.774,21.305,URINE+SERUM
A0A2I2UR81_FELCA,Ig-like domain-containing protein,,23.433,19.553,19.862,URINE
A0A2I2U1K0_FELCA,Ig-like domain-containing protein,,23.902,22.624,22.720,URINE
A0A291NHD9_FELCA,IgG constant region,,29.414,30.522,30.621,URINE+SERUM
A0A291NH87_FELCA,Ig lambda variable,,26.471,24.670,24.811,URINE
A0A337SLR6_FELCA,Folate receptor-like domain-containing protein,,24.388,15.893,16.015,URINE
M3XE23_FELCA,Immunoglobulin V-set domain-containing protein,,20.327,16.923,17.106,URINE
A0A291NH84_FELCA,Ig lambda variable,,19.118,17.172,17.529,URINE
A0A291NHB4_FELCA,Ig lambda variable,,24.497,22.903,22.980,URINE
A0A337S804_FELCA,Ig-like domain-containing protein,,24.346,22.248,22.485,URINE
A0A2I2U6W9_FELCA,MHC class I-like antigen recognition-like domain-containing protein,,22.103,18.431,17.680,URINE
A0A5F5XCM1_FELCA,Sushi domain-containing protein,,25.503,22.236,22.071,URINE
A0A337S723_FELCA,Histone H4,,23.006,18.623,18.943,URINE
A0A291NH77_FELCA,Ig lambda variable,,29.595,27.010,27.206,URINE
A0A5F5XIJ2_FELCA,Complement C3,,18.344,20.107,19.795,URINE+PLASMA
A0A291NGY8_FELCA,IgH variable region,,22.420,22.221,22.232,URINE+SERUM+PLASMA
M3WIA6_FELCA,Amine oxidase (EC 1.4.3.-),,21.354,21.744,21.624,URINE+SERUM+PLASMA
A0A291NGZ4_FELCA,Ig kappa chain,,29.693,27.245,27.321,URINE
A0A5F5XKA4_FELCA,Anaphylatoxin-like domain-containing protein,,19.505,22.889,22.617,URINE+PLASMA
A0A291NHC4_FELCA,Ig lambda variable,,21.899,21.229,20.881,URINE
A0A291NHA5_FELCA,Ig lambda variable,,25.031,23.512,23.383,URINE
A0A291NHG6_FELCA,IgG constant region,,22.372,25.304,25.947,URINE+SERUM
A0A291NGZ9_FELCA,Ig kappa chain,,24.985,23.021,23.589,URINE
A0A337RXE8_FELCA,Heat shock protein family A (Hsp70) member 1B,,23.489,22.573,23.205,URINE+SERUM+PLASMA
A0A5F5XT84_FELCA,Ig-like domain-containing protein,,18.533,17.844,18.393,URINE+SERUM+PLASMA
A0A291NHE9_FELCA,IgG constant region,,22.777,24.710,24.601,URINE+PLASMA
A0A291NHA8_FELCA,Ig lambda variable,,23.487,21.394,21.709,URINE
A0A291NGT3_FELCA,IgH variable region,,24.314,24.150,24.020,URINE+SERUM+PLASMA
A0A291NH42_FELCA,Ig kappa chain,,20.579,18.867,19.287,URINE
A0A5F5XMZ4_FELCA,SEA domain-containing protein,,23.369,17.673,18.511,URINE
A0A337S4X8_FELCA,CUB domain-containing protein,,19.738,17.960,17.999,URINE
Q9J054_FELCA,Infection accessory factor,,17.556,19.845,19.672,URINE+PLASMA
A0A2I2UI16_FELCA,Ig-like domain-containing protein,,23.187,22.170,22.591,URINE
A0A5F5XM97_FELCA,Anaphylatoxin-like domain-containing protein,,22.871,26.960,27.224,URINE+SERUM
A0A5F5Y205_FELCA,Ig-like domain-containing protein,,22.659,20.449,20.011,URINE
O97640_FELCA,Fibrinogen A-alpha chain,,19.098,24.178,16.711,URINE+PLASMA
A0A291NH85_FELCA,Ig lambda variable,,25.398,23.319,22.972,URINE
A0A5F5Y0U4_FELCA,"Keratin, type II cytoskeletal 8 (Cytokeratin-8) (Keratin-8)",,21.318,16.502,15.506,URINE
A0A291NH29_FELCA,Ig kappa chain,,19.180,16.962,16.598,URINE
A0A5F5XZG6_FELCA,Ig-like domain-containing protein,,22.128,20.545,19.616,URINE
M1PYE6_FELCA,Keratin 72,,19.537,17.763,18.009,URINE
A0A337SA21_FELCA,Ig-like domain-containing protein,,16.895,12.841,13.002,URINE
A0A337S1X7_FELCA,Ig-like domain-containing protein,,23.525,22.576,22.650,URINE+SERUM+PLASMA
A0A291NH90_FELCA,Ig lambda variable,,22.022,19.285,20.122,URINE
M3XG70_FELCA,SMB domain-containing protein,,19.208,16.784,16.848,URINE
A0A291NGT9_FELCA,IgH variable region,,21.123,20.328,20.003,URINE
A0A291NH93_FELCA,Ig lambda variable,,24.922,22.801,22.965,URINE
A0A291NGW2_FELCA,IgH variable region,,12.212,16.861,16.593,URINE+PLASMA
A9NJ73_FELCA,lysozyme (EC 3.2.1.17),,20.120,18.691,18.929,URINE
A0A291NH95_FELCA,Ig lambda variable,,22.015,21.976,21.220,URINE+SERUM+PLASMA
A0A291NGX0_FELCA,IgH variable region,,15.152,15.486,14.885,URINE+SERUM+PLASMA
A0A291NH81_FELCA,IgG lambda chain constant region,,25.496,23.166,23.362,URINE
A0A337SDR6_FELCA,Protein S100-A11 (Calgizzarin) (S100 calcium-binding protein A11),,18.490,18.258,18.709,URINE+SERUM+PLASMA
A0A291NHA0_FELCA,Ig lambda variable,,24.693,21.924,21.750,URINE
A0A5F5XCM6_FELCA,Ig-like domain-containing protein,,21.393,20.809,20.831,URINE+SERUM+PLASMA
A0A291NH00_FELCA,IgH variable region,,19.794,19.658,19.738,URINE+SERUM+PLASMA
A0A291NHA9_FELCA,Ig lambda variable,,21.782,20.165,20.237,URINE
A0A291NGZ6_FELCA,Ig kappa chain,,27.840,25.386,25.508,URINE
A0A291NH96_FELCA,Ig lambda variable,,20.412,20.741,18.960,URINE+PLASMA
A0A291NHC0_FELCA,Ig lambda variable,,20.369,21.209,21.457,SERUM
A0A291NHA2_FELCA,Ig lambda variable,,27.486,25.147,25.078,URINE
A0A291NHB8_FELCA,Ig lambda variable,,21.259,24.815,24.747,URINE+PLASMA
A0A5F5Y006_FELCA,CUB domain-containing protein,,15.880,20.844,21.809,URINE+SERUM
A0A291NGV1_FELCA,IgH variable region,,20.918,20.385,20.142,URINE+SERUM+PLASMA
A0A291NGW5_FELCA,IgH variable region,,19.838,18.514,18.187,URINE
A0A291NH02_FELCA,IgH variable region,,19.561,20.949,21.369,URINE+SERUM
A0A291NGY1_FELCA,IgH variable region,,24.742,24.213,24.130,URINE+SERUM+PLASMA
A0A291NGU6_FELCA,IgH variable region,,24.208,23.528,23.057,URINE
A0A291NGU9_FELCA,IgH variable region,,19.814,19.521,19.657,URINE+SERUM+PLASMA
A0A291NGW9_FELCA,IgH variable region,,22.511,21.973,21.858,URINE+SERUM+PLASMA
A0A291NGT1_FELCA,IgH variable region,,28.933,28.595,28.759,URINE+SERUM+PLASMA
A0A337SA37_FELCA,Phospholipid scramblase,,21.292,17.761,18.102,URINE
A0A4P2TLQ8_FELCA,BAFF-R protein,,22.337,11.214,10.000,URINE+SERUM
A0A2I2UM04_FELCA,Heat shock cognate 71 kDa protein (Heat shock 70 kDa protein 8),,22.158,20.940,20.633,URINE
M3VU82_FELCA,Peptidase S1 domain-containing protein,,19.258,19.469,21.008,SERUM
M3XDV4_FELCA,Ig-like domain-containing protein,,22.661,21.706,21.843,URINE+SERUM+PLASMA
A0A291NHA1_FELCA,Ig lambda variable,,24.240,22.068,22.312,URINE
A0A291NGU8_FELCA,IgH variable region,,23.679,23.246,22.706,URINE+SERUM+PLASMA
A0A291NH80_FELCA,Ig lambda variable,,25.225,23.579,23.642,URINE
E3UTY8_FELCA,S100A12,,23.065,19.456,19.386,URINE
A0A291NH69_FELCA,IgG lambda chain constant region,,21.836,18.832,17.913,URINE
M3VU84_FELCA,Peptidase S1 domain-containing protein,,20.715,22.773,21.951,URINE+PLASMA
A0A291NH98_FELCA,Ig lambda variable,,22.830,21.829,22.030,URINE
A0A291NH32_FELCA,Ig kappa chain,,21.405,19.622,19.751,URINE
A0A291NH99_FELCA,Ig lambda variable,,22.699,21.963,22.127,URINE+SERUM+PLASMA
A0A5F5XVX5_FELCA,Ig-like domain-containing protein,,19.888,19.151,19.323,URINE+SERUM+PLASMA
M3XG22_FELCA,Ig-like domain-containing protein,,23.445,21.769,21.833,URINE
A0A291NH94_FELCA,Ig lambda variable,,20.759,15.863,17.638,URINE+SERUM
A0A291NH23_FELCA,Ig kappa chain,,22.609,20.752,20.864,URINE
A0A2I2UNI7_FELCA,UBC core domain-containing protein,,18.665,20.480,21.595,URINE+SERUM
A0A291NGV6_FELCA,IgH variable region,,19.833,20.519,20.327,URINE+SERUM+PLASMA
A0A291NGX3_FELCA,IgH variable region,,22.911,21.691,21.847,URINE
A0A5F5XYD4_FELCA,IF rod domain-containing protein,,17.141,12.575,13.343,URINE
A0A291NGU3_FELCA,IgH variable region,,27.004,26.457,26.113,URINE+SERUM+PLASMA
A0A291NGW1_FELCA,IgH variable region,,19.610,21.290,21.264,URINE+PLASMA
A0A291NGZ5_FELCA,IgH variable region,,19.143,18.662,18.558,URINE+SERUM+PLASMA
A0A291NHB2_FELCA,Ig lambda variable,,21.481,18.895,19.526,URINE
A0A291NGU1_FELCA,IgH variable region,,19.501,19.237,19.354,URINE+SERUM+PLASMA
A0A5F5XTV7_FELCA,Immunoglobulin V-set domain-containing protein,,18.744,16.108,18.117,URINE+SERUM
A0A291NH88_FELCA,Ig lambda variable,,26.395,23.757,23.949,URINE
A0A291NGX9_FELCA,IgH variable region,,24.626,23.684,23.187,URINE
A0A5F5Y0A1_FELCA,Ig-like domain-containing protein,,20.523,16.257,17.197,URINE
A0A291NH89_FELCA,Ig lambda variable,,25.474,22.835,22.968,URINE
A0A291NH13_FELCA,IgH variable region,,24.676,24.205,24.124,URINE+SERUM+PLASMA
A0A291NGZ0_FELCA,IgH variable region,,17.225,16.689,17.025,URINE+SERUM+PLASMA
A0A291NGW0_FELCA,IgH variable region,,16.846,18.222,18.059,URINE+PLASMA
A0A2I2UYJ1_FELCA,Lactate/malate dehydrogenase C-terminal domain-containing protein,,18.393,12.835,12.182,URINE
A0A291NH06_FELCA,Ig kappa chain,,21.646,19.576,19.564,URINE
A0A337S8X8_FELCA,AHNAK nucleoprotein,,21.497,17.197,17.015,URINE
A0A291NGZ3_FELCA,IgH variable region,,19.455,16.796,16.647,URINE
A0A291NH97_FELCA,Ig lambda variable,,22.771,23.250,23.244,URINE+SERUM+PLASMA
A0A291NGW7_FELCA,IgH variable region,,24.156,23.362,23.468,URINE+SERUM+PLASMA
A0A337SEH4_FELCA,"Keratin, type II cytoskeletal 8 (Cytokeratin-8) (Keratin-8)",,19.866,15.633,15.551,URINE
A0A2I2UTJ7_FELCA,Ig-like domain-containing protein,,18.383,17.946,16.698,URINE+SERUM
A0A291NH59_FELCA,IgG lambda chain constant region,,29.244,26.971,27.074,URINE
A0A5F5XIG1_FELCA,Peptidase S1 domain-containing protein,,24.753,20.818,20.654,URINE
A0A291NGX1_FELCA,IgH variable region,,24.732,25.482,25.345,URINE+SERUM+PLASMA
A0A2I2UC78_FELCA,Uncharacterized protein,,17.792,16.487,16.281,URINE
A0A291NGS0_FELCA,IgA constant region,,18.853,18.833,19.597,URINE+SERUM+PLASMA
A0A291NH78_FELCA,Ig lambda variable,,23.187,22.461,22.733,URINE+SERUM+PLASMA
A0A291NHB1_FELCA,Ig lambda variable,,24.687,22.579,23.031,URINE
A0A337S574_FELCA,Histone H2A/H2B/H3 domain-containing protein,,19.054,16.218,17.076,URINE
A0A291NGX5_FELCA,IgH variable region,,23.626,23.033,23.295,URINE+SERUM+PLASMA
A0A5F5XP86_FELCA,Ig-like domain-containing protein,,20.211,19.385,19.711,URINE+SERUM+PLASMA
A0A291NGT7_FELCA,IgH variable region,,21.701,23.526,23.687,URINE+SERUM
A0A337SPY8_FELCA,NTR domain-containing protein,,22.625,15.427,15.087,URINE
A0A337SNS0_FELCA,Olfactory receptor,,19.189,17.312,17.858,URINE
A0A337SNT6_FELCA,CUB domain-containing protein,,18.679,16.271,16.277,URINE
A0A291NGZ7_FELCA,IgH variable region,,19.964,19.518,19.624,URINE+SERUM+PLASMA
A0A2I2U998_FELCA,EF-hand domain-containing protein,,19.455,17.742,17.559,URINE
A0A291NHB5_FELCA,Ig lambda variable,,18.534,17.995,17.014,URINE
A0A291NGY4_FELCA,IgH variable region,,23.447,22.667,22.378,URINE
A0A291NH86_FELCA,Ig lambda variable,,19.820,18.829,18.853,URINE+SERUM+PLASMA
A0A291NHA6_FELCA,Ig lambda variable,,18.494,19.002,19.209,URINE+SERUM+PLASMA
A0A291NGT5_FELCA,IgH variable region,,25.156,23.451,23.668,URINE
A0A2I2U5I7_FELCA,Ig-like domain-containing protein,,20.961,17.299,16.916,URINE
A0A291NH27_FELCA,Ig kappa chain,,19.051,18.299,18.494,URINE+SERUM+PLASMA
B5LX42_FELCA,Tubulin beta chain,,18.621,18.690,18.630,URINE+SERUM+PLASMA
A0A5F5Y6H2_FELCA,AHNAK nucleoprotein,,19.182,17.750,18.653,URINE
A0A291NH92_FELCA,Ig lambda variable,,21.665,22.063,22.293,URINE+SERUM+PLASMA
A0A5F5XI16_FELCA,L1 transposable element RRM domain-containing protein,,21.708,15.104,16.593,URINE+SERUM
A0A2I2URM2_FELCA,Glutathione S-transferase (EC 2.5.1.18),,19.590,14.497,15.184,URINE
A0A5F5XFA5_FELCA,Ig-like domain-containing protein,,19.354,18.980,18.596,URINE+SERUM+PLASMA
A0A291NGS9_FELCA,IgA constant region,,23.262,18.120,18.237,URINE
A0A2I2UJ66_FELCA,Kazal-like domain-containing protein,,16.739,15.163,15.574,URINE
A0A337SA71_FELCA,Selenoprotein P N-terminal domain-containing protein,,26.213,25.559,25.726,URINE+SERUM+PLASMA
A0A2I2U8P7_FELCA,Histone H2B,,22.386,18.493,19.269,URINE
A0A291NHD4_FELCA,Ig lambda variable,,19.778,19.310,18.685,URINE
A0A5F5XIK4_FELCA,Ig-like domain-containing protein,,18.302,20.821,21.089,URINE+SERUM
A0A291NH79_FELCA,Ig lambda variable,,22.245,20.604,20.740,URINE
A0A291NGT4_FELCA,IgH variable region,,19.895,18.662,18.594,URINE
